bakfs2015_6k.htm - Generated by SEC Publisher for SEC Filing
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934


For the month of February, 2016

(Commission File No. 1-14862 )

 

 
BRASKEM S.A.
(Exact Name as Specified in its Charter)
 
N/A
(Translation of registrant's name into English)
 


Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)



Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.


 
        

 

 

 

 

Braskem S.A.

Financial Statements

at December 31, 2015

and Independent Auditors' Report

 

 

 

 

 


 

 

Independent auditors’ report on the financial statements

 

 

To the Board of Directors and Management

Braskem S.A.

Camaçari - Bahia

 

 

We have audited the accompanying individual (Company) and consolidated financial statements of Braskem S.A. (“Company”), respectively referred to as Company and Consolidated, which comprise the balance sheet as of December 31, 2015, the statements of profit or loss and comprehensive income, changes in equity and cash flows for the year then ended, and notes, comprising a summary of significant accounting policies and other explanatory information.

 

Management’s responsibility for the financial statements

Management is responsible for the preparation and fair presentation of the individual financial statements in accordance with Brazilian accounting practices and the consolidated financial statements in accordance with International Financial Reporting Standards and Brazilian accounting practices, and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

Auditors’ responsibility

Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with Brazilian and International Standards on Auditing. Those standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.

 

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on our judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, we consider internal control relevant to the entity's preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity's internal control. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of accounting estimates made by Management, as well as evaluating the overall presentation of the financial statements.

 

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

 

 

 


 

 

Opinion on the individual financial statements

In our opinion, the Company financial statements present fairly, in all material respects, the financial position of Braskem S.A. as of December 31, 2015, and of its financial performance and its consolidated cash flows for the year then ended in accordance with Brazilian accounting practices.

 

Opinion on the consolidated financial statements

In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of Braskem S.A. as of December 31, 2015, and of its consolidated financial performance and its consolidated cash flows for the year then ended, in accordance with International Financial Reporting Standards issued by the International Accounting Standards Board – IASB and the accounting practices adopted in Brazil.

 

Emphasis of a matter

We call attention to note 23 (d) to the financial information that discloses the allegations, events and actions taken by the Company with respect to the ongoing internal investigations and the development of the class action brought in US courts. Our opinion does not contain modifications in relation to this matter.

 

Other matters

 

Audit of the prior year's amounts

The individual and consolidated financial statements of Braskem S.A. as at and for the year ended December 31, 2014 were audited by another auditor who expressed an unmodified opinion on those financial statements on February 12, 2015.

 

Statements of value added

We have also examined the individual and consolidated statements of value added prepared under the responsibility of the Company’s management for the year ended December 31, 2015, whose reporting is required by the Brazilian Corporate Law, which governs corporations, and considered supplementary information under the International Financial Reporting Standards (IFRS), which do not require the presentation of the statement of value added. Those statements have been subjected to the same audit procedures described before and, in our opinion, are fairly presented, in all material respects, in relation to the basic financial statements taken as a whole.

 

 

São Paulo, February 16, 2016

 

 

KPMG Auditores Independentes

CRC 2SP014428/O-6

Original report in Portuguese signed by

Anselmo Neves Macedo

Accountant CRC 1SP160482/O-6

 

 


 

Braskem S.A.

 

Balance sheet at December 31

All amounts in thousands of reais                                                                                                                                                                                   

 

       

Consolidated

 

Parent company

Assets

Note

 

2015

 

2014

 

2015

 

2014

           

 

     

 

Current assets

                 
 

Cash and cash equivalents

5

 

7,439,723

 

3,993,359

 

4,773,251

 

2,416,288

 

Financial investments

6

 

1,172

 

89,729

 

1,172

 

78,243

 

Trade accounts receivable

7

 

2,735,144

 

2,692,612

 

2,526,510

 

5,382,456

 

Inventories

8

 

5,517,206

 

5,368,146

 

4,131,128

 

3,810,498

 

Taxes recoverable

10

 

1,272,004

 

2,129,837

 

762,824

 

1,416,523

 

Dividends and interest on capital

 

 

1,998

 

  

 

87,655

 

69,955

 

Prepaid expenses

 

 

166,170

 

99,469

 

139,668

 

72,997

 

Related parties

9

 

10,507

 

66,616

 

118,661

 

132,413

 

Derivatives operations

16.2

 

53,662

 

33,555

 

12,616

 

33,555

 

Other receivables

 

 

300,901

 

287,876

 

248,488

 

201,025

   

 

 

 

 

 

 

 

 

 

   

 

 

17,498,487

 

14,761,199

 

12,801,973

 

13,613,953

   

 

               

Non-current assets

 

               
 

Financial investments

6

 

46,193

 

42,494

 

46,193

 

42,495

 

Trade accounts receivable

7

 

19,822

 

25,050

 

4,279,433

 

23,129

 

Advances to suppliers

8

 

135,046

 

68,988

 

135,046

 

68,988

 

Taxes recoverable

10

 

1,304,056

 

1,045,428

 

1,198,301

 

962,551

 

Deferred income tax and social contribution

19

 

3,226,507

 

870,206

 

2,179,354

 

493,303

 

Judicial deposits

 

 

277,093

 

230,945

 

268,572

 

223,940

 

Related parties

9

 

144,633

 

138,501

 

124,645

 

137,477

 

Insurance claims

 

 

63,199

 

143,932

 

60,778

 

139,751

 

Derivatives operations

16.2

 

12,280

 

39,350

 

  

 

  

 

Other receivables

 

 

298,057

 

91,905

 

125,898

 

47,575

 

Investments in subsidiaries and jointly-controlled investments

11

 

82,290

 

120,024

 

4,589,947

 

4,633,042

 

Other investments

 

 

4,064

 

6,511

 

3,828

 

6,123

 

Property, plant and equipment

12

 

33,961,963

 

29,001,490

 

16,542,078

 

17,297,907

 

Intangible assets

13

 

2,887,604

 

2,835,728

 

2,572,341

 

2,610,027

   

 

 

 

 

 

 

 

 

 

   

 

 

42,462,807

 

34,660,552

 

32,126,414

 

26,686,308

   

 

               

Total assets

 

 

59,961,294

 

49,421,751

 

44,928,387

 

40,300,261

 

The Management notes are an integral part of the financial statements.

 

1


 

Braskem S.A.

 

Balance sheet at December 31

All amounts in thousands of reais Continued

 

       

Consolidated

 

Parent company

Liabilities and shareholders' equity

Note

 

2015

 

2014

 

2015

 

2014

           

 

     

 

Current liabilities

                 
 

Trade payables

 

 

11,698,695

 

10,852,410

 

9,557,676

 

10,443,712

 

Borrowings

14

 

1,968,540

 

1,418,542

 

2,567,124

 

2,134,951

 

Project finance

15

 

302,266

 

26,462

 

 

 

 

 

Derivatives operations

16.2

 

57,760

 

95,626

 

8,351

 

18,588

 

Payroll and related charges

 

 

605,059

 

533,373

 

446,125

 

412,890

 

Taxes payable

17

 

744,660

 

203,392

 

221,305

 

117,696

 

Dividends

 

 

753,668

 

215,888

 

753,668

 

218,664

 

Advances from customers

 

 

119,680

 

99,750

 

44,528

 

45,887

 

Sundry provisions

20

 

93,942

 

88,547

 

67,190

 

53,049

 

Post-employment benefits

21

 

 

 

336,357

 

 

 

336,357

 

Accounts payable to related parties

9

 

 

 

 

 

4,297,735

 

447,357

 

Other payables

22

 

337,959

 

212,945

 

207,730

 

110,814

   

 

 

 

 

 

 

 

 

 

   

 

 

16,682,229

 

14,083,292

 

18,171,432

 

14,339,965

   

 

               

Non-current liabilities

 

               
 

Trade payables

 

 

57,148

     

3,420,281

   
 

Borrowings

14

 

25,370,260

 

18,918,021

 

8,207,012

 

7,863,666

 

Project finance

15

 

11,975,167

 

7,551,033

 

 

 

 

 

Derivatives operations

16.2

 

1,184,741

 

594,383

 

1,184,741

 

594,383

 

Taxes payable

17

 

26,716

 

30,699

 

25,825

 

30,634

 

Accounts payable to related parties

9

 

 

 

  

 

10,905,207

 

10,008,077

 

Ethylene XXI Project Loan

18

 

1,538,784

 

792,188

 

 

 

 

 

Deferred income tax and social contribution

19

 

731,241

 

603,490

 

 

 

 

 

Post-employment benefits

21

 

154,707

 

69,176

 

54,166

 

 

 

Provision for losses on subsidiaries

 

 

 

 

 

 

137,013

 

654,766

 

Advances from customers

 

 

31,116

 

88,402

 

12,813

 

26,147

 

Sundry provisions

20

 

653,972

 

505,677

 

571,349

 

439,915

 

Other payables

22

 

217,502

 

291,040

 

167,060

 

254,933

   

 

 

 

 

 

 

 

 

 

   

 

 

41,941,354

 

29,444,109

 

24,685,467

 

19,872,521

   

 

               

Shareholders' equity

24

               
 

Capital

 

 

8,043,222

 

8,043,222

 

8,043,222

 

8,043,222

 

Capital reserve

 

 

232,430

 

232,430

 

232,430

 

232,430

 

Revenue reserves

 

 

2,882,019

 

736,180

 

2,882,019

 

736,180

 

Other comprehensive income

 

 

(9,085,256)

 

(2,924,057)

 

(9,085,256)

 

(2,924,057)

 

Treasury shares

 

 

(49,819)

 

(48,892)

 

(927)

 

 

 

Accumulated profits

 

 

  

 

  

 

  

 

  

   

 

 

 

 

 

 

 

 

 

 

Total attributable to the Company's shareholders

 

 

2,022,596

 

6,038,883

 

2,071,488

 

6,087,775

   

 

               
 

Non-controlling interest

 

 

(684,885)

 

(144,533)

 

 

 

  

   

 

               
   

 

 

1,337,711

 

5,894,350

 

2,071,488

 

6,087,775

   

 

               

Total liabilities and shareholders' equity

 

 

59,961,294

 

49,421,751

 

44,928,387

 

40,300,261

                                                                 

The Management notes are an integral part of the financial statements.

 

2


 

Braskem S.A.

 

Statement of operations

Years ended December 31

All amounts in thousands of reais, except earnings per share

 

         

 

 

Consolidated

 

 

 

Parent company

     

Note

 

2015

 

2014

 

2015

 

2014

                       

Net sales revenue

 

26

 

47,282,996

 

46,031,389

 

33,406,033

 

26,927,750

 

Cost of products sold

 

 

 

(36,902,086)

 

(40,057,341)

 

(25,675,861)

 

(23,544,968)

                       

Gross profit

     

10,380,910

 

5,974,048

 

7,730,172

 

3,382,782

                       

Income (expenses)

                   
 

Selling and distribution

 

 

 

(1,122,012)

 

(1,155,800)

 

(813,888)

 

(692,879)

 

General and administrative

 

 

 

(1,325,342)

 

(1,210,124)

 

(864,572)

 

(801,433)

 

Research and development

 

 

 

(176,431)

 

(138,441)

 

(110,583)

 

(96,800)

 

Results from equity investments

 

11(c)

 

2,219

 

3,929

 

752,037

 

621,002

 

Other operating income (expenses), net

 

28

 

(707,153)

 

95,596

 

(346,398)

 

344,574

                       

Operating profit

     

7,052,191

 

3,569,208

 

6,346,768

 

2,757,246

                       

Financial results

 

29

               
 

Financial expenses

     

(4,193,533)

 

(2,745,864)

 

(5,017,326)

 

(2,762,120)

 

Financial income

     

1,701,027

 

355,221

 

3,196,009

 

945,580

                       
         

(2,492,506)

 

(2,390,643)

 

(1,821,317)

 

(1,816,540)

                       

Profit before income tax and

                   

social contribution

     

4,559,685

 

1,178,565

 

4,525,451

 

940,706

                       
 

Current and deferred income tax and social contribution

 

19

 

(1,660,905)

 

(452,264)

 

(1,385,140)

 

(76,642)

         

(1,660,905)

 

(452,264)

 

(1,385,140)

 

(76,642)

                       

Profit for the year

     

2,898,780

 

726,301

 

3,140,311

 

864,064

                       

Attributable to:

                   
 

Company's shareholders

     

3,140,311

 

864,064

 

 

 

 

 

Non-controlling interest in Braskem Idesa

     

(241,531)

 

(137,763)

 

 

 

 

                       

Profit for the year

     

2,898,780

 

726,301

 

 

 

 

 

 

The Management notes are an integral part of the financial statements.

 

3


 

Braskem S.A.

 

Statement of comprehensive income

Years ended December 31

All amounts in thousands of reais Continued

 

         

 

 

Consolidated

 

 

 

Parent company

     

Note

 

2015

 

2014

 

2015

 

2014

                       

Profit for the year

 

 

 

2,898,780

 

726,301

 

3,140,311

 

864,064

     

 

               

Other comprehensive income or loss:

 

 

               

Items that will be reclassified subsequently to profit or loss

 

 

               
 

Fair value of cash flow hedge

 

 

 

(686,991)

 

(352,700)

 

(587,825)

 

(166,798)

 

Income tax and social contribution

 

 

 

228,415

 

116,532

 

199,860

 

56,711

 

Fair value of cash flow hedge - Braskem Idesa

     

 

 

 

 

(74,375)

 

(139,428)

 

Income tax and social contribution

     

 

 

 

 

21,416

 

44,868

 

Fair value of cash flow hedge from jointly-controlled

 

 

 

2,295

 

 

 

2,295

 

 

     

 

 

(456,281)

 

(236,168)

 

(438,629)

 

(204,647)

     

 

               
 

Exchange variation of foreign sales hedge

 

16.3(a.i)

 

(8,437,079)

 

(2,119,069)

 

(8,437,079)

 

(2,119,068)

 

Income tax and social contribution on exchange variation

 

 

 

2,868,607

 

720,483

 

2,868,607

 

720,483

 

Exchange variation of foreign sales hedge - Braskem Idesa

 

16.3(a.ii)

 

(1,589,544)

 

(656,783)

 

(1,192,158)

 

(492,587)

 

Income tax on exchange variation - Braskem Idesa

 

 

 

476,518

 

197,035

 

357,389

 

147,776

     

 

 

(6,681,498)

 

(1,858,334)

 

(6,403,241)

 

(1,743,396)

     

 

               
 

Foreign subsidiaries currency translation adjustment

 

 

 

644,308

 

147,453

 

709,722

 

144,880

     

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

(6,493,471)

 

(1,947,049)

 

(6,132,148)

 

(1,803,163)

     

 

               

Items that will not be reclassified to profit or loss

 

 

               
     

 

               
 

Defined benefit plan actuarial loss

 

 

 

(849)

 

 

 

(849)

 

  

     

 

               
 

Total

 

 

 

(849)

 

 

 

(849)

 

  

     

 

               
     

 

               

Total comprehensive loss for the year

 

 

 

(3,595,540)

 

(1,220,748)

 

(2,992,686)

 

(939,099)

     

 

               

Attributable to:

 

 

               
 

Company's shareholders

 

 

 

(2,992,686)

 

(939,099)

 

 

 

 

 

Non-controlling interest in Braskem Idesa

 

 

 

(602,854)

 

(281,649)

       
     

 

 

 

 

 

       

Total comprehensive loss for the year

 

 

 

(3,595,540)

 

(1,220,748)

       
                       
                       
                 

 

 

Parent company

                 

2015

 

2014

     

Note

         

Basic and diluted

 

Basic and diluted

Profit per share attributable to the shareholders of the Company

 

25

               

at the end of the year (R$)

 

 

               
 

Earnings per share - common

 

 

         

3.9474

 

1.0857

 

Earnings per share - preferred shares class "A"

 

 

         

3.9474

 

1.0857

 

Earnings per share - preferred shares class "B"

 

 

         

0.6065

 

0.6062

 

The Management notes are an integral part of the financial statements.

 

4


 

Braskem S.A.

 

Statement of changes in equity

All amounts in thousands of reais

 

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated

     

Attributed to shareholders' interest

         
             

Revenue reserves

             

Total

       
                     

Unrealized

 

Other

         

Braskem

 

Non-controlling

 

Total

         

Capital

 

Legal

 

Retention of

 

profit

 

comprehensive

 

Treasury

 

Retained

 

shareholders'

 

interest in

 

shareholders'

 

Note

 

Capital

 

reserve

 

reserve

 

profits

 

reserve

 

income

 

shares

 

earnings

 

interest

 

Braskem Idesa

 

equity

                                               

At december 31, 2013

 

 

8,043,222

 

232,430

 

26,895

 

28,412

 

354,842

 

(1,092,691)

 

(48,892)

 

 

 

7,544,218

 

137,116

 

7,681,334

 

 

                                           

Comprehensive income for the year:

 

                                           

Profit for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

864,064

 

864,064

 

(137,763)

 

726,301

Exchange variation of foreign sales hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(1,743,396)

 

 

 

 

 

(1,743,396)

 

(114,938)

 

(1,858,334)

Fair value of cash flow hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(204,647)

 

 

 

 

 

(204,647)

 

(31,521)

 

(236,168)

Foreign subsidiaries currency translation adjustment

 

 

 

 

  

 

 

 

 

 

 

 

144,880

 

  

 

  

 

144,880

 

2,573

 

147,453

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,803,163)

 

 

 

864,064

 

(939,099)

 

(281,649)

 

(1,220,748)

 

 

                                           

Equity valuation adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Realization of additional property, plant and equipment price-level restatement, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(27,238)

 

 

 

27,238

 

 

 

 

 

 

Realization of deemed cost of jointly-controlled investment, net of taxes

 

 

 

 

   

 

 

 

 

 

 

 

(965)

 

 

 

965

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(28,203)

 

 

 

28,203

 

 

 

 

 

 

 

 

                                           

Contributions and distributions to shareholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Prescribed dividends

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

682

 

682

 

 

 

682

Additional dividends approved by the General Meeting

 

 

 

 

 

 

 

 

 

 

(354,842)

 

 

 

 

 

 

 

(354,842)

 

 

 

(354,842)

Legal reserve

 

 

 

 

 

 

44,647

 

 

 

 

 

 

 

 

 

(44,647)

 

 

 

 

 

 

Mandatory minimum dividends

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(212,076)

 

(212,076)

 

 

 

(212,076)

Additional dividends proposed

 

 

 

 

 

 

 

 

 

 

270,517

 

 

 

 

 

(270,517)

 

 

 

 

 

 

Retained earnings

 

 

 

 

  

 

   

 

365,709

 

  

 

  

 

 

 

(365,709)

 

 

 

 

 

 

 

 

 

 

 

 

 

44,647

 

365,709

 

(84,325)

 

 

 

 

 

(892,267)

 

(566,236)

 

 

(566,236)

 

 

                                            

At December 31, 2014

 

 

8,043,222

 

232,430

 

71,542

 

394,121

 

270,517

 

(2,924,057)

 

(48,892)

 

 

 

6,038,883

 

(144,533)

 

5,894,350

 

 

                                           

Comprehensive income for the year:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,140,311

 

3,140,311

 

(241,531)

 

2,898,780

Exchange variation of foreign sales hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(6,403,241)

 

 

 

 

 

(6,403,241)

 

(278,257)

 

(6,681,498)

Fair value of cash flow hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(438,629)

 

 

 

 

 

(438,629)

 

(17,652)

 

(456,281)

Foreign currency translation adjustment

 

 

  

 

  

 

  

 

   

 

  

 

709,722

 

 

 

  

 

709,722

 

(65,414)

 

644,308

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,132,148)

 

 

 

3,140,311

 

(2,991,837)

 

(602,854)

 

(3,594,691)

 

 

                                           

Equity valuation adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Realization of additional property, plant and equipment price-level restatement, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(27,236)

 

 

 

27,236

 

 

 

 

 

 

Realization of deemed cost of jointly-controlled investment, net of taxes

   

 

 

 

 

 

 

 

 

 

 

(966)

 

 

 

966

 

 

 

 

 

 

Actuarial gains post-employment benefits of subsidiaries , net of taxes

 

 

  

 

  

 

  

 

  

 

   

 

(849)

 

  

 

  

 

(849)

 

 

 

(849)

 

 

 

 

 

 

 

 

 

 

 

 

 

(29,051)

 

 

 

28,202

 

(849)

 

 

 

(849)

 

 

                                           

Contributions and distributions to shareholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital increase

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

62,502

 

62,502

Repurchase of treasury shares

24(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

(927)

 

 

 

(927)

 

 

 

(927)

Prescribed dividends

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

479

 

479

 

 

 

479

Additional dividends proposed

   

 

 

 

 

 

 

 

 

(270,517)

 

 

 

 

 

 

 

(270,517)

 

 

 

(270,517)

Legal reserve

24(f.1)

 

 

 

 

 

158,450

 

 

 

 

 

 

 

 

 

(158,450)

 

 

 

 

 

 

Proposed dividends

24(f.1)

 

 

 

 

 

 

 

 

 

247,364

 

 

 

 

 

(1,000,000)

 

(752,636)

 

 

 

(752,636)

Retained earnings

24(f.1)

 

   

 

  

 

  

 

2,010,542

 

  

 

 

 

  

 

(2,010,542)

 

 

 

 

 

 

     

 

 

 

 

158,450

 

2,010,542

 

(23,153)

 

 

 

(927)

 

(3,168,513)

 

(1,023,601)

 

62,502

 

(961,099)

                                               

At December 31, 2015

   

8,043,222

 

232,430

 

229,992

 

2,404,663

 

247,364

 

(9,085,256)

 

(49,819)

 

  

 

2,022,596

 

(684,885)

 

1,337,711

 

The Management notes are an integral part of the financial statements.

 

5


 

Braskem S.A.

 

Statement of changes in equity

All amounts in thousands of reais

 

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Parent Company

             

Revenue reserves

 

             
                     

Unrealized

 

Other

         

Total

         

Capital

 

Legal

 

Retention of

 

profit

 

comprehensive

 

Treasury

 

Retained

 

shareholders'

 

Note

 

Capital

 

reserve

 

reserve

 

profits

 

reserve

 

income

 

shares

 

earnings

 

equity

                                       

At december 31, 2013

 

 

8,043,222

 

232,430

 

26,895

 

28,412

 

354,842

 

(1,092,691)

 

 

 

 

 

7,593,110

 

 

                                   

Comprehensive income for the year:

 

                                   

Profit for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

864,064

 

864,064

Exchange variation of foreign sales hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(1,743,396)

 

 

 

 

 

(1,743,396)

Fair value of cash flow hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(204,647)

 

 

 

 

 

(204,647)

Foreign subsidiaries currency translation adjustment

 

 

 

 

 

 

 

 

  

 

 

 

144,880

 

 

 

 

 

144,880

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,803,163)

     

864,064

 

(939,099)

 

 

                     

 

         

Equity valuation adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

   

Realization of additional property, plant and equipment price-level restatement, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(965)

 

 

 

965

 

 

Realization of deemed cost of jointly-controlled investment, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(27,238)

 

 

 

27,238

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(28,203)

     

28,203

 

 

 

 

                   

 

 

 

         

Contributions and distributions to shareholders:

 

                                   

Absorption of losses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

682

 

682

Loss on interest in subsidiary

 

 

 

 

 

 

 

 

 

 

(354,842)

 

 

 

 

 

 

 

(354,842)

Legal reserve

 

 

 

 

 

 

44,647

 

 

 

 

 

 

 

 

 

(44,647)

 

 

Mandatory minimum dividends

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(212,076)

 

(212,076)

Additional dividends proposed

 

 

 

 

 

 

 

 

 

 

270,517

 

 

 

 

 

(270,517)

 

 

Retained earnings

 

 

 

 

 

 

 

 

365,709

 

 

 

 

 

 

 

(365,709)

 

 

 

 

 

 

 

 

 

44,647

 

365,709

 

(84,325)

 

 

     

(892,267)

 

(566,236)

 

 

                         

 

       

At December 31, 2014

 

 

8,043,222

 

232,430

 

71,542

 

394,121

 

270,517

 

(2,924,057)

 

 

 

 

 

6,087,775

 

 

                                   

Comprehensive income for the year:

 

 

 

 

 

 

 

 

 

 

 

 

 

     

 

 

 

Profit for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,140,311

 

3,140,311

Exchange variation of foreign sales hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(6,403,241)

 

 

 

 

 

(6,403,241)

Fair value of cash flow hedge, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(438,629)

 

 

 

 

 

(438,629)

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

 

709,722

 

 

 

 

 

709,722

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,132,148)

     

3,140,311

 

(2,991,837)

 

 

                                 

Equity valuation adjustments:

 

 

 

 

 

     

 

 

 

 

 

     

 

 

 

Realization of deemed cost of jointly-controlled investment, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(966)

 

 

 

966

 

 

Realization of additional property, plant and equipment price-level restatement, net of taxes

   

 

 

 

 

 

 

 

 

 

 

(27,236)

 

 

 

27,236

 

 

Post-employment benefits of subsidiaries actuarial gains, net of taxes

 

 

 

 

 

 

 

 

 

 

 

 

(849)

 

 

 

 

 

(849)

 

 

 

 

 

 

 

 

 

 

 

 

 

(29,051)

     

28,202

 

(849)

 

 

                                   

Contributions and distributions to shareholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

     

 

 

 

Repurchase of treasury shares

24(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

(927)

 

 

 

(927)

Prescribed dividends

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

479

 

479

Additional dividends proposed

   

 

 

 

 

 

 

 

 

(270,517)

 

 

 

 

 

 

 

(270,517)

Legal reserve

24(f.1)

 

 

 

 

 

158,450

 

 

 

 

 

 

 

 

 

(158,450)

 

 

Proposed dividends

24(f.1)

 

 

 

 

 

 

 

 

 

247,364

 

 

 

 

 

(1,000,000)

 

(752,636)

Retained earnings

24(f.1)

 

 

 

 

 

 

 

2,010,542

 

 

 

 

 

 

 

(2,010,542)

 

 

     

 

 

 

 

158,450

 

2,010,542

 

(23,153)

 

 

 

(927)

 

(3,168,513)

 

(1,023,601)

                                       

At December 31, 2015

   

8,043,222

 

232,430

 

229,992

 

2,404,663

 

247,364

 

(9,085,256)

 

(927)

 

 

 

2,071,488

 

The Management notes are an integral part of the financial statements.

 

6


 

Braskem S.A.

 

Statement of cash flows

Years ended December 31

All amounts in thousands of reais

 

         

Consolidated

 

Parent company

     

Note

 

2015

 

2014

 

2015

 

2014

                       

Profit before income tax and social contribution

     

4,559,685

 

1,178,565

 

4,525,451

 

940,706

         

 

 

 

 

 

 

 

Adjustments for reconciliation of profit

     

 

 

 

 

 

 

 

 

Depreciation, amortization and depletion

     

2,114,929

 

2,056,362

 

1,774,973

 

1,317,928

 

Results from equity investments

 

11(c)

 

(2,219)

 

(3,929)

 

(752,037)

 

(621,002)

 

Interest and monetary and exchange variations, net

     

3,249,558

 

1,560,734

 

3,235,082

 

1,580,449

 

Gain from divestment in subsidiary

 

1(a)

 

 

 

(277,338)

 

 

 

(277,338)

 

Other

     

130,758

 

9,805

 

28,779

 

5,151

         

 

 

 

 

 

 

 

         

10,052,711

 

4,524,199

 

8,812,248

 

2,945,894

                       

Changes in operating working capital

                   
 

Held-for-trading financial investments

     

118,929

 

(19,057)

 

109,913

 

(7,755)

 

Trade accounts receivable

     

(38,586)

 

144,087

 

(1,400,963)

 

(848,467)

 

Inventories

     

(161,419)

 

(270,351)

 

(347,679)

 

(331,705)

 

Taxes recoverable

     

831,507

 

486,082

 

464,733

 

111,672

 

Prepaid expenses

     

(66,701)

 

(36,472)

 

(66,671)

 

(31,518)

 

Other receivables

     

(132,865)

 

27,832

 

37,751

 

53,700

 

Trade payables

     

(2,205,683)

 

(419,476)

 

(574,871)

 

229,652

 

Taxes payable

     

221,371

 

(539,262)

 

96,077

 

(688,383)

 

Advances from customers

     

(37,356)

 

(261,886)

 

(14,693)

 

(20,047)

 

Sundry provisions

     

153,690

 

38,674

 

145,575

 

18,020

 

Other payables

     

708,267

 

677,071

 

(267,825)

 

128,692

         

 

 

 

 

 

 

 

Cash from operations

     

9,443,865

 

4,351,441

 

6,993,595

 

1,559,755

                       
 

Interest paid

     

(1,034,811)

 

(356,333)

 

(431,567)

 

(530,907)

 

Project finance - transactions costs paid

 

15

 

(51,355)

 

(65,098)

 

 

 

 

 

Income tax and social contribution paid

     

(232,302)

 

(138,144)

 

(46,784)

 

(45,217)

         

 

 

 

 

 

 

 

Net cash generated by operating activities

     

8,125,397

 

3,791,866

 

6,515,244

 

983,631

                       

Proceeds from the sale of fixed assets

     

1,282

 

10,646

 

605

 

10,344

Proceeds from the sale of investments

 

1(a)

 

 

 

315,000

 

 

 

315,000

Cash effect of discontinued operations

     

 

 

 

 

 

 

23,149

Acquisitions of investments in subsidiaries and associates

     

 

 

(55)

 

 

 

(10,708)

Acquisitions to property, plant and equipment

(i)

12(a)

 

(4,057,123)

 

(5,301,778)

 

(1,026,669)

 

(1,216,985)

Acquisitions of intangible assets

 

13

 

(20,106)

 

(30,269)

 

(20,088)

 

(27,151)

Held-for-maturity financial investments

     

2,441

 

29,380

 

(28)

 

29,380

         

 

 

 

 

 

 

 

Net cash used in investing activities

     

(4,073,506)

 

(4,977,076)

 

(1,046,180)

 

(876,971)

                       

Short-term and Long-term debit

                   
 

Obtained borrowings

     

5,481,546

 

6,174,678

 

2,918,405

 

3,544,652

 

Payment of borrowings

     

(6,087,217)

 

(6,692,638)

 

(4,515,350)

 

(3,934,408)

Project finance

 

15

 

 

 

 

 

 

 

 

 

Obtained funds

     

1,501,939

 

1,894,507

 

 

 

 

 

Payment of borrowings

     

(510,715)

 

 

 

 

 

 

Related parties

     

 

 

 

 

 

 

 

 

Obtained loans

     

 

 

 

 

1,108,868

 

626,928

 

Payment of loans

     

 

 

 

 

(2,142,746)

 

(889,256)

 

Transactions current active

     

 

 

 

 

1,766

 

1,018,781

Dividends paid

     

(482,117)

 

(482,147)

 

(482,117)

 

(482,147)

Repurchase of treasury shares

     

(927)

 

  

 

(927)

 

 

         

 

 

 

 

 

 

 

Net cash provided by (used in) financing activities

     

(97,491)

 

894,400

 

(3,112,101)

 

(115,450)

                       

Exchange variation on cash of foreign subsidiaries

     

(508,036)

 

(51,690)

 

 

 

  

         

 

 

 

 

 

 

 

Increase (decrease) in cash and cash equivalents

     

3,446,364

 

(342,500)

 

2,356,963

 

(8,790)

                       

Represented by

                   
 

Cash and cash equivalents at the beginning of the year

     

3,993,359

 

4,335,859

 

2,416,288

 

2,425,078

 

Cash and cash equivalents at the end of the year

     

7,439,723

 

3,993,359

 

4,773,251

 

2,416,288

         

 

 

 

 

 

 

 

Increase (decrease) in cash and cash equivalents

     

3,446,364

 

(342,500)

 

2,356,963

 

(8,790)

 

 

 

 

 

 

 

 

 

 

 

 

(i) Includes capitalized financial charges paid: Consolidated 2015 - R$786,063 (2014 - R$623,162) and Parent company 2015 - R$119,666 (2014 - R$74,550).

   

 

The Management notes are an integral part of the financial statements.

 

7


 

Braskem S.A.

 

Statement of value added

Years ended December 31

All amounts in thousands of reais

 

     

Consolidated

 

Parent comapny

     

2015

 

2014

 

2015

 

2014

                   

Revenue

 

53,115,698

 

52,761,200

 

39,023,849

 

31,527,548

 

Sale of goods, products and services, including discontinued operations

 

53,803,890

 

52,689,183

 

39,342,353

 

31,229,283

 

Other income (expenses), net

 

(636,824)

 

153,095

 

(272,015)

 

376,346

 

Allowance for doubtful accounts

 

(51,368)

 

(81,078)

 

(46,489)

 

(78,081)

Inputs acquired from third parties

 

(42,208,079)

 

(45,412,436)

 

(29,807,759)

 

(26,984,572)

 

Cost of products, goods and services sold

 

(40,772,490)

 

(43,912,319)

 

(28,680,882)

 

(17,151,231)

 

Material, energy, outsourced services and others

 

(1,436,092)

 

(1,503,512)

 

(1,117,036)

 

(9,836,363)

 

Impairment of assets

 

503

 

3,395

 

(9,841)

 

3,022

Gross value added

 

10,907,619

 

7,348,764

 

9,216,090

 

4,542,976

                 

Depreciation, amortization and depletion

 

(2,114,929)

 

(2,056,362)

 

(1,774,973)

 

(1,317,928)

                 

Net value added produced by the entity

 

8,792,690

 

5,292,402

 

7,441,117

 

3,225,048

                 

Value added received in transfer

 

1,703,502

 

359,861

 

3,948,130

 

1,566,965

 

Results from equity investments

 

2,219

 

3,929

 

752,037

 

621,002

 

Financial income

 

1,701,027

 

355,221

 

3,196,009

 

945,580

 

Other

 

256

 

711

 

84

 

383

                   

Total value added to distribute

 

10,496,192

 

5,652,263

 

11,389,247

 

4,792,013

                   
                   

Personnel

 

1,209,732

 

1,095,545

 

740,476

 

521,546

 

Direct compensation

 

943,263

 

836,525

 

551,092

 

394,135

 

Benefits

 

204,766

 

196,911

 

129,871

 

85,102

 

FGTS (Government Severance Pay Fund)

 

61,703

 

62,109

 

59,513

 

42,309

                 

Taxes, fees and contribuitions

 

1,968,053

 

902,864

 

2,296,187

 

467,470

 

Federal

 

1,668,930

 

522,134

 

1,500,585

 

172,160

 

State

 

276,024

 

363,551

 

784,988

 

295,334

 

Municipal

 

23,099

 

17,179

 

10,614

 

(24)

                 

Remuneration on third parties' capital

 

4,419,627

 

2,927,553

 

5,212,273

 

2,938,933

 

Financial expenses (including exchange variation)

 

4,173,254

 

2,708,331

 

5,007,564

 

2,775,028

 

Rentals

 

246,373

 

219,222

 

204,709

 

163,905

                 

Remuneration on own capital

 

2,898,780

 

726,301

 

3,140,311

 

864,064

 

Profit for the year

 

3,140,311

 

864,064

 

3,140,311

 

864,064

 

Non-controlling interests in loss for the year

 

(241,531)

 

(137,763)

 

 

 

 

                   

Value added distributed

 

10,496,192

 

5,652,263

 

11,389,247

 

4,792,013

 

The Management notes are an integral part of the financial statements.

 

8


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

1                    Operations

 

Braskem S.A. (hereinafter “Parent Company”) is a public company headquartered in the city of Camaçari, Bahia (“BA”), which jointly with its subsidiaries (hereinafter “Braskem” or “Company”), operates 36 industrial units, 29 of which in the Brazilian states of Alagoas (“AL”), Bahia (“BA”), Rio de Janeiro (“RJ”), Rio Grande do Sul (“RS”) and São Paulo (“SP”), five are located in the United States, in the states of Pennsylvania, Texas and West Virginia and two are located in Germany, in the cities of Wesseling and Schkopau. These units produce thermoplastic resins – polyethylene (“PE”), polypropylene (“PP”) and polyvinyl chloride (“PVC”), as well as basic petrochemicals.

 

Braskem is also engaged in the import and export of chemicals, petrochemicals and fuels, the production, supply and sale of utilities such as steam, water, compressed air, industrial gases, as well as the provision of industrial services and the production, supply and sale of electric energy for its own use and use by other companies. Braskem also invests in other companies, either as a partner or as shareholder.

 

The Company is controlled by Odebrecht S.A. (“Odebrecht”), which directly and indirectly holds interests of 50.11% and 38.32% in its voting and total capital, respectively.

 

(a)               Significant corporate and operating events impacting these financial statements

 

(i)   On December 31, 2013, the parent company entered into a share sales agreement with Odebrecht Ambiental (“OA”), through which it sold its interest in the subsidiary Distribuidora de Águas Triunfo S.A. (“DAT”) for R$315,000. On February 3, 2014, the Extraordinary Shareholders’ Meeting of DAT approved the change in its management and consequently the transfer of the management of its operations to OA, upon the recognition of a gain (“Other operating income (expenses), net”) of R$277,338.

 

(ii) In September 2015, the parent company entered into a private agreement for the transfer of all its shares issued by the subsidiary Braskem Idesa S.A.P.I ("Braskem Idesa") to the subsidiary Braskem Netherlands B.V ("Braskem Netherlands").

 

(b)               Naphtha agreement with Petrobras

 

On December 23, 2015, Braskem and Petrobras entered into a new agreement for the annual supply of 7 million tons of petrochemical naphtha for five years as of December 23, 2015 (Note 9).

 

(c)               Net working capital

 

On December 31, 2015, net working capital at the Parent Company was negative R$5,369,459 (R$726,012 in 2014). On the other hand, consolidated net working capital was positive R$816,258 (R$677,907 in 2014).  The consolidated figures are used in the management of working capital, since the Company uses mechanisms to transfer funds between the companies efficiently without jeopardizing the fulfillment of the commitments of each of the entities forming the consolidated statements. For this reasons, any analysis of the Parent Company’s working capital will not reflect the actual liquidity position of the consolidated group.

 

2                    Summary of significant accounting policies

 

The principal accounting policies applied consistently in the preparation of these financial statements are described in the notes of the items on which they have impacts.

 

 

9


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

2.1              Basis of preparation and presentation of the financial statements

 

The financial statements have been prepared under the historical cost convention and were adjusted, when necessary, to reflect the fair value of assets and liabilities.

 

The preparation of financial statements requires the use of certain estimates. It also requires Management to exercise its judgment in the process of applying the Company’s accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements are disclosed in Note 3.

 

The issue of these financial statements was authorized by the Executive Director on February 16, 2016.

 

2.1.1        Consolidated financial statements

 

The consolidated financial statements were prepared and presented in accordance with accounting practices adopted in Brazil, including the standards issued by the Brazilian Accounting Pronouncements Committee (“CPC”), and in accordance with the International Financial Reporting Standards (“IFRS”) issued by the IASB.

 

All the financial statements’ relevant information are properly supported and correspond to the information used by Management in the Company’s management.

 

The individual and consolidated Statement of Value Added (“DVA”) is required under Brazilian Corporation Law and under the accounting practices adopted in Brazil for public companies. IFRS does not require the presentation of this statement. As a result, under IFRS, it is presented as supplementary information, without prejudice to financial statements.

 

10


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(a)               Consolidation

 

The consolidated financial statements comprise the financial statements of the Parent Company and the following entities:

 

 

 

 

 

 

 

Total and voting interest - %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Headquarters

 

2015

 

2014

Direct and Indirect subsidiaries

 

 

 

 

 

 

 

 

  

Alclor Química de Alagoas Ltda ("Alclor")

 

(i)

 

Brazil

 

100.00

 

100.00

  

Braskem America Finance Company ("Braskem America Finance")

 

-

 

EUA

 

100.00

 

100.00

 

Braskem America, Inc. (“Braskem America”)

 

-

 

EUA

 

100.00

 

100.00

 

Braskem Argentina S.A. (“Braskem Argentina”)

 

-

 

Argentina

 

100.00

 

100.00

 

Braskem International GmbH ("Braskem Austria")

 

(ii)

 

Austria

 

100.00

 

100.00

 

Braskem Austria Finance GmbH ("Braskem Austria Finance")

 

(ii)

 

Austria

 

100.00

 

100.00

 

Braskem Chile Ltda. ("Braskem Chile")

 

(iii)

 

Chile

 

-

 

-

 

Braskem Europe GmbH ("Braskem Alemanha")

 

-

 

Germany

 

100.00

 

100.00

 

Braskem Finance Limited (“Braskem Finance”)

 

-

 

Cayman Islands

 

100.00

 

100.00

 

Braskem Idesa

 

-

 

Mexico

 

75.00

 

75.00

 

Braskem Idesa Servicios S.A. de CV ("Braskem Idesa Serviços")

 

-

 

Mexico

 

75.00

 

75.00

 

Braskem Importação e Exportação Ltda. ("Braskem Importação")

 

(iv)

 

Brazil

 

-

 

100.00

 

Braskem Incoporated Limited ("Braskem Inc")

 

-

 

Cayman Islands

 

100.00

 

100.00

 

Braskem Mexico Proyectos S.A. de C.V. SOFOM ("Braskem México Sofom")

 

-

 

Mexico

 

100.00

 

 

 

Braskem Mexico, S. de RL de CV ("Braskem México")

 

-

 

Mexico

 

100.00

 

100.00

 

Braskem Mexico Servicios S. RL de CV ("Braskem México Serviços")

 

-

 

Mexico

 

100.00

 

100.00

 

Braskem Holanda

 

-

 

Netherlands

 

100.00

 

100.00

 

Braskem Netherlands Finance B.V. (“Braskem Holanda Finance”)

 

-

 

Netherlands

 

100.00

 

 

 

Braskem Netherlands Inc. B.V. (“Braskem Holanda Inc”)

 

-

 

Netherlands

 

100.00

 

 

 

Braskem Participações S.A. ("Braskem Participações")

 

(iv)

 

Brazil

 

-

 

100.00

 

Braskem Petroquímica Chile Ltda. (“Petroquímica Chile”)

 

-

 

Chile

 

100.00

 

100.00

 

Braskem Petroquímica Ibérica, S.L. ("Braskem Espanha")

 

(v)

 

Spain

 

-

 

100.00

 

Braskem Petroquímica Ltda. ("Braskem Petroquímica")

 

-

 

Brazil

 

100.00

 

100.00

 

Braskem Qpar S.A. ("Braskem Qpar")

 

(iii)

 

Brazil

 

-

 

-

 

Quantiq Distribuidora Ltda. ("Quantiq")

 

-

 

Brazil

 

100.00

 

100.00

 

IQAG Armazéns Gerais Ltda. ("IQAG")

 

-

 

Brazil

 

100.00

 

100.00

 

Lantana Trading Co. Inc. (“Lantana”)

 

-

 

Bahamas

 

100.00

 

100.00

 

Norfolk Trading S.A. (“Norfolk”)

 

(vi)

 

Uruguay

 

-

 

100.00

 

Politeno Empreendimentos Ltda. (“Politeno Empreendimentos”)

 

(iv)

 

Brazil

 

-

 

100.00

  

 

 

 

 

 

 

 

-

 

-

Specific Purpose Entity ("SPE")

 

 

 

 

 

-

 

-

  

Fundo de Investimento Multimercado Crédito Privado Sol (“FIM Sol”)

 

 

 

Brazil

 

100.00

 

100.00

  

Fundo de Investimento Caixa Júpiter Multimercado

    Crédito Privado Longo Prazo ("FIM Júpiter")

Brazil

 

100.00

 

100.00

 

(i)         In the process of merger.

(ii)        In the process of dissolution.

(iii)      Merged in December 2014.

(iv)      Merged in February 2015.

(v)        Dissolved in September 2015.

(vi)      Dissolved in March 2015.

 

 

11


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(a.i)     Reconciliation of equity and profit (loss) for the year between parent company and consolidated

 

       

Shareholders' equity

 

Profit for the year

       

2015

 

2014

 

2015

 

2014

                   

 

Parent company

   

2,071,488

 

6,087,775

 

3,140,311

 

864,064

 

Braskem shares owned by subsidiary Braskem Petroquímica

   

(48,892)

 

(48,892)

 

 

 

 

 

Non-controlling interest of Braskem Idesa

   

(684,885)

 

(144,533)

 

(241,531)

 

(137,763)

Consolidated

   

1,337,711

 

5,894,350

 

2,898,780

 

726,301

 

 

2.1.2        Parent company financial statements

The parent company financial statements have been prepared in accordance with accounting practices adopted in Brazil, following the provisions in Federal Law 6,404/76 (“Brazilian Corporation Law”), and subsequent amendments, and the standards issued by CPC and are disclosed together with the consolidated financial statements.

 

2.2              Foreign currency translation

 

(a)               Functional and presentation currency

 

The functional and presentation currency of the Company is the real.

 

(b)               Functional currency other than the Brazilian real

 

Some subsidiaries have a different functional currency from that of the Parent Company, as follows:

 

     

Functional currency

       

Subsidiaries

   
 

Braskem Alemanha, Braskem Austria e Braskem Austria Finance

 

Euro

 

Braskem America, Braskem America Finance, Braskem Holanda Finance, Braskem Holanda Inc e 

Braskem México Sofom

 

U.S.dollar

 

Braskem Holanda

(i)

U.S.dollar

 

Braskem Idesa , Braskem Idesa Serviços, Braskem México e Braskem México Serviços

(ii)

Mexican peso

 

(i)                  Two events determined the change of the functional currency of the subsidiary Braskem Holanda from Brazilian real to U.S. dollar as of 2015. The first was the definition of Braskem Holanda as the party responsible for the purchase and sale of naphtha and basic petrochemicals produced by Braskem in the export markets, which is fully made in U.S. dollar, with its own administrative and commercial structure. The second event was the creation of two wholly-owned subsidiaries of Braskem Holanda to raise funds in the international financial market and transfer these funds to the Parent Company and its subsidiaries in Brazil and abroad. These financial transactions are conducted in U.S. dollar. Thus, Management decided to change prospectively the functional currency of Braskem Holanda as of January 1, 2015. Assets, liabilities, capital and other items comprising the shareholders’ equity of Braskem Holanda whose functional currency was the Brazilian real on December 31, 2014 were converted into U.S. dollar at a fixed exchange rate of US$1 to R$2.6562 on December 31, 2014.

(ii)                 Braskem Idesa will go operational in 2016. Due to the impact of this operation on the local market, the Management will evaluate during this first year of operation if the Mexican peso should, in fact, continue to be the functional currency of this subsidiary.

 

 

The other subsidiaries adopt the Brazilian real as functional currency.

 

12


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(c)               Exchange variation effects

 

The main effects from exchange variation that impacted these financial statements are shown below:

 

 

 

End of period rate at December 31

 

Average rate

 

2015

 

2014

 

Variation

 

2015

 

2014

 

Variation

U.S. dollar - Brazilizan real

3.9048

 

2.6562

 

47.01%

 

3.3387

 

2.3547

 

41.79%

U.S. dollar - Mexican peso

17.3700

 

14.7180

 

18.02%

 

15.8846

 

13.3113

 

19.33%

U.S. dollar - Euro

0.9187

 

0.8231

 

11.61%

 

0.9019

 

0.7545

 

19.55%

 

2.3              New or revised pronouncements with first-time adoption in 2016

 

The Company evaluated the Brazilian Securities and Exchange Commission (“CVM”) Resolution 739/15, which altered several pronouncements and concluded that none of the amendments will cause any impact on its financial statements.   

 

New or revised pronouncements that are not yet effective

 

IFRS 9 – “Financial instruments” – this pronouncement was issued by IASB in July 2014 to address the classification and measurement, impairment and hedge accounting, all in a single document. The main amendment refers to the change in the calculation and disclosure methodology of the allowance for doubtful accounts due to the adoption of the concept of provision for expected loss instead of incurred loss. In addition, the Company will evaluate if its receivables have a significant financial component and therefore define whether the simplified or general method to calculate the provision will be adopted. This standard has not yet been issued by the CPC and should be adopted as from 2018.

 

IFRS 15 – “Revenue from contracts with customers” – this pronouncement was issued by IASB in May 2014 and addresses the recognition of revenue from contracts with customers. The Company assessed its contracts and, considering the changes to the standard, concluded that it is not expected to materially impact its financial statements. This standard has not yet been issued by the CPC and will be adopted as from January 2018.

 

IFRS 16 – “Leases” – this pronouncement was issued by IASB in January 2016 and requires lessees to recognize the liability of the future payments and the right of use of the leased asset for virtually all lease contracts, including operating leases. This standard has not yet been issued by the CPC and will be adopted as from January 2019. Management is yet to assess IFRS 16's full impact.

 

3                    Application of critical estimates and judgments

 

Critical estimates and judgments are those that require the most difficult, subjective or complex judgments by management, usually as a result of the need to make estimates that affect issues that are inherently uncertain. Estimates and judgments are continually reassessed and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Actual results can differ from planned results due to differences in the variables, assumptions or conditions used in making estimates.

 

The Company makes a series of other estimates that are presented in the respective notes, such as allowance for doubtful accounts, fair-value adjustment of inventories and provision for repairing environmental damage.

 

In order to provide an understanding of the way the Company forms its judgments on future events, the variables and assumptions used in critical estimates are presented below:

 

 

13


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

3.1              Deferred income tax and social contribution

 

The recognition and the amount of deferred taxes assets depend on the generation of future taxable income, which requires the use of an estimate related to the Company’s future performance. These estimates are included in the business plan, which is annually submitted to the Board of Directors for approval. This plan is prepared by the Executive Board using as main variables the price of the products manufactured by the Company, price of inputs, gross domestic product, exchange variation, interest rate, inflation rate and fluctuations in the supply and demand of inputs and finished products. These variables are obtained from expert external consultants, historical performance of the Company and its capacity to generate taxable income, internal programs focused on operational efficiency, and specific incentives from the Brazilian government for the petrochemical sector in Brazil.

 

3.2              Fair value of derivative and non-derivative financial instruments

 

The Company evaluates the derivative financial instruments at their fair value and the main sources of information are the stock exchanges, commodities and futures markets, disclosures of the Central Bank of Brazil and quotation services like Bloomberg and Reuters. Nevertheless, the high volatility of the foreign exchange and interest rate markets in Brazil has been causing significant changes in future rates and interest rates over short periods of time, leading to significant changes in the market value of swaps and other financial instruments.

 

The fair values of non-derivative, quoted financial instruments are based on current bid prices. If the market for a financial asset and for unlisted securities is not active, the Company establishes fair value by using valuation techniques. These include the use of recent arm’s length transactions, reference to other instruments that are substantially the same, discounted cash flow analysis, and option pricing models that make maximum use of market inputs and rely as little as possible on information provided by the Company’s Management.

 

3.3              Useful life of assets

 

The Company recognizes the depreciation and depletion of its long-lived assets based on their useful life estimated by independent appraisers and approved by the Company’s technicians taking into consideration the experience of these professionals in the management of Braskem’s plants. The useful lives initially established by independent appraisers are normally reviewed at the end of every year by the Company’s technicians in order to check whether they need to be changed. This review may take place during the year in case of possible non-recurring events.

 

The main factors that are taken into consideration in the definition of the useful life of the assets that compose the Company’s industrial plants are the information of manufacturers of machinery and equipment, level of the plants’ operations, quality of preventive and corrective maintenance and the prospects of technological obsolescence of assets.

 

The Company’s management also decided that (i) depreciation should cover all assets value because when the equipment and installations are no longer operational, they are sold by amounts that are immaterial; and (ii) land is not depreciated because it has an indefinite useful life.

 

 

 

14


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

The useful lives applied to the assets determined the following average depreciation and depletion rates:

 

     

(%)

     

2015

 

2014

Buildings and improvements

   

3.42

 

3.38

Machinery, equipment and installations

   

8.42

 

7.29

Mines and wells

   

8.89

 

8.83

Furniture and fixtures

   

10.48

 

10.82

IT equipment

   

20.55

 

20.15

Lab equipment

   

9.80

 

9.59

Security equipment

   

9.91

 

9.79

Vehicles

   

19.09

 

19.91

Other

   

18.98

 

18.19

 

3.4              Impairment test and analysis

 

(a)               Tangible and intangible assets with defined useful lives

 

On the reporting date of each of its financial statements, the Company conducts an analysis to determine the existence of any indication that the book balance of long-lived tangible assets and intangible assets with defined useful lives may not be recoverable. This analysis is conducted to assess the existence of scenarios that could adversely affect its cash flow and, consequently, its ability to recover the investment in such assets. These scenarios arise from issues of a macroeconomic, legal, competitive or technological nature.

 

Some significant and notable aspects considered by the Company in this analysis include: (i) the possibility of an oversupply of products manufactured by the Company or of a significant reduction in demand due to adverse economic factors; (ii) the prospects of material fluctuations in the prices of products and inputs; (iii) the likelihood of the development of new technologies or raw materials that could materially reduce production costs and consequently impact sales prices, ultimately leading to the obsolescence of the industrial facilities of the Company; and (iv) changes in the general regulatory environment that make the production process of Braskem infeasible or that significantly impact the sale of its products. For this analysis, the Company maintains an in-house team with a more strategic vision of the business and also remains in permanent contact with a team of external consultants. If the aforementioned variables indicate any material risk to cash flows, the Management of Braskem conducts impairment tests in accordance with Note 3.4(b).

 

The assets are allocated to the Cash Generating Units (“CGU”) as follows:

 

Basic Petrochemicals operating segment:

 

·           CGU UNIB Bahia: represented by assets of the basic petrochemicals plants located in the state of Bahia;

·           CGU UNIB South: represented by assets of the basic petrochemicals plants located in the state of Rio Grande do Sul;

·           CGU UNIB Southeast: represented by assets of the basic petrochemicals plants located in the states of Rio de Janeiro and São Paulo;

 

 

15


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

Polyolefins operating segment:

 

·           CGU Polyethylene: represented by assets of the PE plants located in Brazil;

·           CGU Polypropylene: represented by assets of the PP plants located in Brazil;

·           CGU Renewables: represented by the assets of the Green PE plant located in Brazil;

 

Vinyls operating segment:

 

·           CGU Vinyls: represented by assets of PVC plants and chloride soda located in Brazil;

 

International businesses operating segment:

 

·           CGU Polypropylene USA: represented by assets of PP plants located in the United States;

·           CGU Polypropylene Europe: represented by assets of PP plants located in Germany;

 

Chemical Distribution operating segment:

 

·           Represented by assets of the subsidiaries Quantiq and IQAG.

 

In 2016, the Company will report a new operating segment from the beginning of the industrial operations of the subsidiary Braskem Idesa.

 

(b)               Intangible assets with indefinite useful lives

 

The balances of goodwill from future profitability arising from business combinations and intangible assets with indefinite useful lives are tested for impairment once a year. These tests are based on the projected cash generation for a five-year period, which are extracted from the business plan of the Company and cited in Note 3.1. In addition to the projected cash flow for the period from 2016 to 2020, perpetuity is also calculated based on the long-term vision. Note that real growth is not considered for the calculation of perpetuity. Cash flows and perpetuity are adjusted to present value at a discount rate based on the Weighted Average Cost of Capital (“WACC”).

 

The goodwill allocated to the Polyolefins operating segment (Note 13 (a)) was generated in a business combination that resulted in the simultaneous acquisition of polypropylene and polyethylene plants. The main raw materials of these plants were already supplied by the Parent Company, which allowed for the obtainment of significant synergies in the operation. These synergies were one of the main drivers of that acquisition. Accordingly, the Company’s management tested this goodwill for impairment in the ambit of their operating segment since the benefits of the synergies are associated with all units acquired.

 

The remaining existing goodwill is allocated to the UNIB South CGU and to the Vinyls operating segment (Note 13(a)).

 

3.5              Provisions and contingent liabilities

 

Existing contingent liabilities and provisions are mainly related to litigation in the judicial and administrative spheres arising from primarily labor, pension, civil and tax lawsuits and administrative procedures.

 

The Management of Braskem, based on the opinion of its external legal advisors, classifies these proceedings in terms of probability of loss as follows:

 

16


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

Probable loss – these are proceedings for which there is a higher probability of loss than of a favorable outcome, i.e., the probability of loss exceeds 50%. For these proceedings, the Company recognizes a provision that is determined as follows:

 

(i)       labor claims – the amount of the provision corresponds to the amount to be disbursed as estimated by the Company’s legal counsels;

 

(ii)     tax claims - the amount of the provision corresponds to the value of the matter plus charges corresponding to the variation in the Selic rate; and

 

(iii)   other claims – the amount of the provision corresponds to the value of the matter.

 

Possible loss – these are proceedings for which the possibility of loss is greater than remote. The loss may occur, however, the elements available are not sufficient or clear to allow for a conclusion on whether the trend is for a loss or a gain. In percentage terms, the probability of loss is between 25% and 50%. For these claims, except for the cases of business combinations, the Company does not recognize a provision and mentions the most significant ones in a note to the financial statements (Note 23). In business combination transactions, in accordance with the provision in CPC 15 and IFRS 3, the Company records the fair value of the claims based on the assessment of loss (Note 20). The amount of the provision corresponds to the value of the matter, plus charges corresponding to the variation in the Selic rate, multiplied by the probability of loss, as determined by our external counsels.

 

The Company’s management believes that the estimates related to the outcome of the proceedings and the possibility of future disbursement may change in view of the following: (i) higher courts may decide in a similar case involving another company, adopting a final interpretation of the matter and, consequently, advancing the termination of the of a proceeding involving the Company, without any disbursement or without implying the need of any financial settlement of the proceeding; and (ii) programs encouraging the payment of the debts implemented in Brazil at the Federal and State levels, in favorable conditions that may lead to a disbursement that is lower than the one that is recognized in the provision or lower than the value of the matter.

 

3.6              Hedge accounting

 

The Parent Company designated liabilities in foreign currency to hedge the future cash flows generated by its exports. This decision was based on two important assumptions and judgments: (i) the performance of exports according to its business plan (Note 3.1), which are inherent to the market and business where it operates, and (ii) the ability of the Company to refinance its liabilities in U.S. dollar, since the priority financing in U.S. dollar is part of the Company’s guidelines and strategy. In addition to the ability to refinance its U.S. dollar liabilities, the maintenance of a minimum level of net liabilities in U.S. dollar is envisaged in the Financial Policy of the Company.

 

The subsidiary Braskem Idesa designated all of the financing it obtained for the construction of its industrial plant to protect part of its sales to be made in the same currency as said financing, the U.S. dollar. The sales estimate is included in the project that was presented to the banks/lenders, which, due to the consistency of the projection, granted Braskem Idesa a financing line to be paid exclusively using the cash generated by these sales. All the commercial considerations of the project were based on market studies conducted by expert consulting firms during the feasibility-analysis phase.

 

All hedge transactions conducted by the Company are in compliance with the accounting procedures and practices adopted by Braskem, and effectiveness tests are conducted for each transaction every quarter, which prove the effectiveness of its hedge strategy.

 

 

17


 

 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

The Company determined that hedged items for the Parent Company and the subsidiary Braskem Idesa will be characterized by the first sales in U.S. dollars in each quarter until the amount designated for each period is reached (Note 16). The liabilities designated for hedge will be aligned with the hedging maturity schedule and the Company’s financial strategy.

 

4                    Risk management

 

Braskem is exposed to market risks arising from variations in commodity prices, foreign exchange rates and interest rates, credit risks of its counterparties in cash equivalents, financial investments and trade accounts receivable, and liquidity risks to meet its obligations from financial liabilities.

 

Braskem adopts procedures for managing market and credit risks that are in conformity with its Financial Policy approved by the Board of Directors on August 9, 2010. The purpose of risk management is to protect the cash flows of Braskem and reduce the threats to the financing of its operating working capital and investment programs.

 

4.1              Market risks

 

Braskem prepares a sensitivity analysis for foreign exchange rate and interest rate risks to which it is exposed, which is presented in Note 16.5.

 

(a)               Exposure to commodity risks

 

Braskem is exposed to the variation in the prices of various commodities (naphtha, PE, PP, PVC, etc.) and, in general, seeks to transfer the variations caused by fluctuations in market prices.

 

(b)               Exposure to foreign exchange risk

 

Braskem has commercial operations denominated in or pegged to foreign currencies. Braskem’s inputs and products have prices denominated in or strongly influenced by international prices of commodities, which are usually denominated in U.S. dollar. Additionally, Braskem has long-term loans in foreign currencies that expose it to variations in the foreign exchange rate between the functional currency (Brazilian real, Mexican peso and Euro) and the foreign currency, in particular the U.S. dollar. Braskem manages its exposure to foreign exchange risk through the combination of debt, financial investments, accounts receivable and raw material purchases denominated in foreign currencies and through derivative operations. Braskem’s Financial Policy for managing foreign exchange risks provides for the maximum and minimum coverage limits that must be observed and which are continuously monitored by its Management.

 

On December 31, 2015, Braskem prepared a sensitivity analysis for its exposure to the risks of fluctuation in the U.S. dollar, as informed in Note 16.5.

 

(c)               Exposure to interest rate risk

 

Braskem is exposed to the risk that a variation in floating interest rates causes an increase in its financial expense due to payments of future interest. Debt denominated in foreign currency subject to floating rates is mainly subject to fluctuations in Libor. Debt denominated in local currency is mainly subject to the variation in the Long-Term Interest Rate (“TJLP”) and in the Interbank Certificate of Deposit (“daily CDI”) rate.

 

In 2014 and 2015, Braskem held swap contracts (Note 16.2.1) in which it: (a.ii) receives the pre-contractual rate and pays the CDI overnight rate; and (b.ii.i) receives Libor and pays a fixed rate.

 

On December 31, 2015, Braskem prepared a sensitivity analysis for the exposure to the floating interest rates Libor, CDI and TJLP, as disclosed in Notes 16.5(b.1) and (b.2).

 

 

18


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

4.2              Exposure to credit risk

 

The transactions that subject Braskem to the concentration of credit risks are mainly in current accounts with banks, financial investments and trade accounts receivable in which Braskem is exposed to the risk of the financial institution or customer involved. In order to manage this risk, Braskem maintains bank current accounts and financial investments with major financial institutions, weighting concentrations in accordance with the credit rating and the daily prices observed in the Credit Default Swap market for the institutions, as well as netting contracts that minimize the total credit risk arising from the many financial transactions entered into by the parties.

 

On December 31, 2015, Braskem held netting contracts with Banco Citibank S.A., HSBC Bank Brasil S.A. – Banco Múltiplo, Banco Itaú BBA S.A., Banco Safra S.A., Banco Santander S.A.,  Banco Votorantim S.A., Banco West LB do Brasil S.A., Banco Caixa Geral – Brasil S.A., and Banco Bradesco S.A.  Approximately 34% of the amounts held in “Cash and cash equivalents” (Note 5) are contemplated by these agreements. The effective netting of these amounts is possible only in the event of default by one of the parties.

 

With respect to the credit risk of customers, Braskem protects itself by performing a rigorous analysis before granting credit and obtaining secured and unsecured guarantees when considered necessary.

 

The maximum exposure to credit risk of non-derivative financial instruments on the reporting date is the sum of their carrying amounts less any provisions for impairment losses. On December 31, 2015, the balance of trade accounts receivable was net of allowance for doubtful accounts (Note 7).

 

4.3              Liquidity risk

 

Braskem has a calculation methodology to determine operating cash and minimum cash for the purpose of, respectively: (i) ensuring the liquidity needed to comply with obligations of the following month; and (ii) ensuring that the Company maintains liquidity during potential crises. These amounts are calculated mainly based on the projected operating cash generation, less short-term debts and working capital needs.

 

Braskem has two revolving credit lines for the purpose of managing liquidity risks, which may be used without restrictions in the amounts of: (i) US$750 million, up to December 2019; and (ii) US$500 million up to September 2019. These credit facilities enable Braskem to reduce the amount of cash it holds. As of December 31, 2015, none of these credit lines had been used.

 

The table below shows Braskem’s financial liabilities by maturity. These amounts are calculated from undiscounted cash flows and may not be reconciled with the balance sheet.

 

       

Consolidated

       

Maturity

   
       

Until

 

Between one and

 

Between three and

 

More than

   
       

one year

 

three years

 

five years

 

five years

 

Total

                         

Trade payables

     

11,900,747

 

57,148

 

 

 

 

 

11,957,895

Borrowings

     

2,073,046

 

5,205,794

 

8,169,825

 

28,311,338

 

43,760,003

Project finance

     

335,321

 

1,720,628

 

2,291,048

 

11,963,813

 

16,310,810

Derivatives

     

57,760

 

(6,497)

 

1,191,238

 

 

 

1,242,501

Ethylene XXI Project Loan

     

 

 

 

 

 

 

1,538,784

 

1,538,784

Other payables

 

(i)

 

112,533

 

160,761

 

 

 

 

 

273,294

At December 31, 2015

     

14,479,407

 

7,137,834

 

11,652,111

 

41,813,935

 

75,083,287

 

(i)         Amounts payable to BNDES Participações S.A. (“BNDESPAR”) (Note 22).

 

 

19


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

4.4              Capital management

 

The ideal capital structure, according to Braskem’s Management, considers the balance between own capital and the sum of all payables less the amount of cash and cash equivalents and financial investments. This composition meets the Company’s objectives of perpetuity and of offering an adequate return to shareholders and other stakeholders. This structure also permits borrowing costs to remain at adequate levels to maximize shareholder remuneration.

 

Due to the impact of the U.S. dollar on the Company’s operations, the Management of Braskem believes that the own capital used for capital management purposes should be measured in this currency and on a historical basis. Moreover, the Company may temporarily maintain a capital structure that is different from this ideal. This occurs, for example, during periods of growth, when the Company may finance a large portion of its projects through borrowings, provided that this option maximizes return for shareholders once the financed projects start operating. In order to adjust and maintain the capital structure, the Management of Braskem may also consider the sale of non-strategic assets, the issue of new shares or even adjustments to dividend payments. 

 

As is also the case of liquidity, capital is not managed at the Parent Company level, but rather at the consolidated level.

 

5                    Cash and cash equivalents

 

         

Consolidated

 

Parent Company

         

2015

 

2014

 

2015

 

2014

                       

Cash and banks

   

(i)

873,966

 

227,237

 

270,965

 

52,164

Cash equivalents:

     

 

 

 

 

 

 

 

 

Domestic market

     

2,428,995

 

2,253,648

 

2,184,405

 

1,336,267

 

Foreign market

   

(i)

4,136,762

 

1,512,474

 

2,317,881

 

1,027,857

Total

     

7,439,723

 

3,993,359

 

4,773,251

 

2,416,288

 

(i)         On December 31, 2015, it includes cash and banks of R$96,830 (R$26,830 in 2014) and cash equivalents of R$37,809 (R$307,034 in 2014) of the subsidiary Braskem Idesa, available for use in its project (Note 11(d.i)).

 

This item includes cash, bank deposits and highly liquid financial investments available for redemption within three months. These assets are convertible into a known cash amount and are subject to insignificant risk of change in value.

 

Cash equivalents in Brazil are mainly represented by fixed-income instruments and time deposits held by the FIM Jupiter fund. Cash equivalents abroad mainly comprise fixed–income instruments issued by first-class financial institutions (time deposit) with high market liquidity.

 

 

20


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

6                    Financial investments

 

       

Consolidated

 

Parent Company

       

2015

 

2014

 

2015

 

2014

Held-for-trading

   

 

 

 

 

 

 

 

 

Investments in FIM Sol

 

 

 

85,573

 

 

 

74,088

 

Other

   

1,172

 

4,155

 

1,172

 

4,155

Held-to-maturity

   

 

 

 

 

 

 

 

 

Quotas of investment funds in credit rights

 

46,193

 

42,495

 

46,193

 

42,495

 

Investments in foreign currency

(i)

 

 

399,005

 

 

 

 

 

Compensation of investments in foreign currency

(i)

 

 

(399,005)

 

 

 

 

Total

   

47,365

 

132,223

 

47,365

 

120,738

             

In current assets

   

1,172

 

89,729

 

1,172

 

78,243

In non-current assets

   

46,193

 

42,494

 

46,193

 

42,495

Total

   

47,365

 

132,223

 

47,365

 

120,738

 

(i)    The subsidiary Braskem Holanda had a balance of financial investments that was offset by an export prepayment agreement of the Parent Company, in the amount of US$150,000, as provided for in the credit assignment agreement entered into between these two companies and Banco Bradesco. These operations were settled in May 2015.

 

7                    Trade accounts receivable

 

The Company’s collection period is generally 30 days; therefore, the amount of the trade accounts receivable corresponds to their fair value on the date of the sale. The Company realizes part of its trade accounts receivable through the sale of trade notes to funds that acquire receivables. These operations are not entitled to recourse, for which reason the trade notes are written-off at the moment of the operation.

 

 

         

Consolidated

 

Parent Company

         

2015

 

2014

 

2015

 

2014

Consumers

                   
 

Domestic market

     

1,439,133

 

1,523,458

 

1,370,971

 

1,455,216

 

Foreign market

     

1,643,807

 

1,517,035

 

5,724,982

 

4,219,228

Allowance for doubtful accounts

   

(327,974)

 

(322,831)

 

(290,010)

 

(268,859)

Total

     

2,754,966

 

2,717,662

 

6,805,943

 

5,405,585

                       

In current assets

     

2,735,144

 

2,692,612

 

2,526,510

 

5,382,456

In non-current assets

     

19,822

 

25,050

 

4,279,433

 

23,129

Total

     

2,754,966

 

2,717,662

 

6,805,943

 

5,405,585

 

 

The breakdown of trade accounts receivable by maturity is as follows:

 

 

         

Consolidated

 

Parent company

         

2015

 

2014

 

2015

 

2014

                       

Accounts receivables not past due

   

2,466,098

 

2,256,932

 

6,265,391

 

4,299,973

Past due securities:

     

 

 

 

 

 

 

 

Up to 90 days

     

309,585

 

531,966

 

462,797

 

874,568

91 to 180 days

     

52,757

 

45,271

 

144,629

 

126,480

As of 180 days

     

254,500

 

206,324

 

223,136

 

373,423

         

3,082,940

 

3,040,493

 

7,095,953

 

5,674,444

Allowance for doubtful accounts

   

(327,974)

 

(322,831)

 

(290,010)

 

(268,859)

Total customers portfolio

   

2,754,966

 

2,717,662

 

6,805,943

 

5,405,585

 

21


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

The changes in the balance of the allowance for doubtful accounts are presented below:

 

         

Consolidated

 

Parent company

         

2015

 

2014

 

2015

 

2014

                       

Balance of provision at the beginning of the year

   

(322,831)

 

(282,753)

 

(268,859)

 

(200,794)

Provision in the year

     

(51,368)

 

(81,078)

 

(46,490)

 

(78,081)

Write-offs

     

46,225

 

41,000

 

25,339

 

35,819

Addition through merger of Braskem Qpar

   

 

 

 

 

 

 

(25,803)

Balance of provision at the end of the year

   

(327,974)

 

(322,831)

 

(290,010)

 

(268,859)

 

The methodology adopted by the Company for recognizing the provision for impairment is based on the history of losses and considers the sum of (i) 100% of the amount of receivables past due for over 180 days; (ii) 50% of the amount of receivables past due for over 90 days; (iii) 100% of the amount of receivables under judicial collection (iv) all the receivables from the first renegotiation maturing within more than 24 months; and (v) 100% of the receivables arising from a second renegotiation with customers. Receivables from subsidiaries are not considered in this calculation. This methodology is revised on an annual basis by the Management of the Company.

 

 

8                    Inventories

 

         

Consolidated

 

Parent company

         

2015

 

2014

 

2015

 

2014

                       

Finished goods

     

3,928,446

 

3,681,204

 

2,812,657

 

2,325,911

Raw materials, production inputs and packaging

   

1,008,217

 

1,067,512

 

879,608

 

963,550

Maintenance materials

     

289,568

 

247,327

 

196,432

 

187,773

Advances to suppliers

     

315,234

 

346,885

 

304,816

 

324,893

Imports in transit and other

   

110,787

 

94,206

 

72,661

 

77,359

Total

     

5,652,252

 

5,437,134

 

4,266,174

 

3,879,486

                       

In current assets

     

5,517,206

 

5,368,146

 

4,131,128

 

3,810,498

In non-current assets

     

135,046

 

68,988

 

135,046

 

68,988

Total

     

5,652,252

 

5,437,134

 

4,266,174

 

3,879,486

 

Inventories are stated at average cost of purchase or production or the estimated price of sale or acquisition, excluding taxes, whichever is lower (market value).

 

The value of finished products includes raw materials, ancillary and maintenance materials used, depreciation of industrial facilities, expenses with Company’s and third-party personnel involved in industrial production and maintenance, and logistics expenses with the transfer of these products from the plants to the sale terminals.

 

A portion of the final inventory of finished products and raw materials was adjusted to fair value, since its value was lower than the cost of production/acquisition. This adjustment totaled R$2,875 (R$83,265 in 2014). For this estimate, the Company considers the purchase/sale price projected for the period during which it expects to sell or consume the product. This period is determined based on the historical data for the turnover of the respective inventory.

 

Advances to suppliers and expenditures with imports in transit are mainly related to operations for the acquisition of raw materials.

 

22


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

9                    Related parties

 

The Parent Company and its subsidiaries carry out transactions among themselves and with other related parties in the ordinary course of its operations and activities. The Company believes that all the conditions set forth in the contracts with related parties meet the Company’s interests. To ensure that these contracts present terms and conditions that are as favorable to the Company as those it would enter into with any other third parties is a permanent objective of Braskem’s management.

 

23


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(i)                 Consolidated

 

         

 

 

 

 

 

 

 

 

Consolidated

         

2015

 

2014

         

Associated companies, Jointly-controlled investment and Related companies

 

Associated companies, Jointly-controlled investment and Related companies

           
         

Odebrecht and

 

Petrobras and

         

Odebrecht and

 

Petrobras and

       

Balance sheet

 

Note

 

subsidiaries

 

subsidiaries

 

Other

 

Total

 

subsidiaries

 

subsidiaries

 

Other

 

Total

Assets

                                   

Current

     

 

 

 

 

 

   

 

 

 

 

 

 
 

Trade accounts receivable

   

12,851

 

141,550

 

33,997

 

188,398

4,347

0

104,857

 

33,009

 

142,213

 

Inventories

     

138,619

(i)

 

 

 

 

138,619

108,929

(i)

123,377

(i)

 

 

232,306

 

Related parties

     

 

 

9,927

 

580

 

10,507

 

55

 

66,375

 

186

 

66,616

 

Other

     

 

 

 

 

 

4,535

 

4,535

         

 

 

 

Non-current

     

 

 

 

 

Advances to suppliers

   

58,443

(i)

 

58,443

 

68,988

(i)

68,988

 

Related parties

   

 

 

 

-

 

Intracompany loan

   

 

 

78,332

78,332

 

72,200

72,200

 

Other

     

 

 

66,301

66,301

 

66,301

66,301

Total assets

     

209,913

296,110

34,577

540,600

 

182,319

 

433,110

37,730

653,159

         

Liabilities

     

Current

     
 

Trade payables

     

284,973

 

1,400,485

 

2,011

 

1,687,469

 

459,412

 

1,497,675

1,957,087

Total liabilities

     

284,973

1,400,485

 

2,011

1,687,469

 

459,412

 

1,497,675

1,957,087

                           

Transactions

                       
 

Sales of products

     

64,093

 

1,620,335

475,836

2,160,264

 

82,750

 

1,817,056

326,586

2,226,392

 

Purchases of raw materials, finished goods

 
 

services and utilities

     

3,692,625

(ii)

12,488,618

108,688

16,289,931

 

3,631,198

(ii)

18,183,600

70,700

21,885,498

 

Financial income (expenses)

   

6,723

6,723

 

964

964

 

General and administrative expenses

   

 

     
 

Post-employment benefits plan ("EPE")

21.2.2

 

44,466

44,466

 

 

 

 

20,695

20,695

 

Gain from divestment of asset

   

 

 

 

277,338

(iii)

277,338

Total transactions

     

3,756,718

 

14,115,676

628,990

 

18,501,384

 

3,991,286

 

20,001,620

417,981

24,410,887

                                     

(i) Amount related to advances to raw material suppliers.

(ii) It includes expenses for construction of subsidiary Braskem Idesa project, of which R$3,177,121 for 2015 (R$3,297,400 for 2014) (Note 15).

(iii) Amount related to divestment in subsidiary (Note 1(a)(i)).

 

24


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(ii)               Parent Company

 

         

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2015

         

Associated companies, Jointly-controlled investment and associated companies

 

Related companies

 

EPE

 

 

         

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

     

Odebrecht and

 

Petrobras and

     

FIM Sol and

   

Balance sheet

 

Note

 

Inc.

 

Holanda

 

Netherlands Inc

 

Petroquímica

 

America

 

Austria

 

Argentina

 

Other

 

subsidiaries

 

subsidiaries

 

Other

 

FIM Júpiter

 

Total

Assets

               

Current

 

 

 
 

Cash and equivalents

 

1,461,914

1,461,914

 

Trade accounts receivable

     

645,621

144,433

 

38,890

202,937

66,976

12,851

 

138,226

1,249,934

 

Inventories

     

138,619

(ii)

138,619

 

Dividends and interest on capital

 

84,150

84,150

 

Related parties

 

 

20,039

 

46,648

 

41,987

 

62

 

9,925

 

118,661

 

Other receivables

 
         

Non-current

     
 

Trade accounts receivable

     

4,261,535

(i)

4,261,535

 

Advances to suppliers

 

58,443

(ii)

58,443

 

Related parties

 
 

Current accounts

 
 

Loan agreements

     

16,541

113

78,332

94,986

 

Other receivables

                        

29,659

   

29,659

Total assets

     

4,278,076

 

645,621

 

  

248,622

 

85,538

  

202,937

 

109,076

 

209,975

 

256,142

 

1,461,914

 

7,497,901

         

Liabilities

     

Current

     
 

Trade payables

     

 

3,068,634

686,084

 

21

2,862

 

27,715

 

1,381,150

5,166,466

 

Accounts payable to related parties

     

 

 

Advance to export

     

15,629

 

4,065,040

 

 

 

22,171

4,102,840

 

Other payables

     

9,538

149,520

 

689

35,148

194,895

         

Non-current

     
 

Trade Payables

     

3,280,511

(i)

3,280,511

 

Accounts payable to related parties

     

 

 

Advance to export

     

149,684

9,634,023

 

 

1,105,058

10,888,765

 

Payable notes

     

14,995

  

 

1,447

 

 

                       

16,442

Total liabilities

     

3,460,819

3,078,172

 

13,699,063

837,051

 

1,127,939

   

38,010

 

27,715

 

1,381,150

 

    

23,649,919

         

Transações

     
 

Sales of products

     

205,900

3,142,740

2,395,057

 

35,447

 

 

234,457

 

681,102

 

57,770

 

1,513,391

8,265,864

 

Purchases of raw materials, finished products

     
 

services and utilities

     

1,457,037

2,752,092

1,923,210

 

49,342

 

497,885

 

11,847,426

18,526,992

 

Financial income (expenses)

     

(869,178)

930,767

(6,370,438)

 

(113)

 

(367,263)

81,774

 

64,899

 

12,161

 

(3)

 

6,723

(6,510,671)

 

General and administrative expenses

     
 

Post-employment benefits

 

21.2.2

                     

41,589

  

41,589

Total transactions

     

793,759

6,825,599

 

(6,370,438)

 

4,318,154

(331,816)

81,774

 

299,356

 

742,605

 

555,652

 

13,367,540

 

41,589

 

20,323,774

     

(i)

The Parent Company reclassified as non-current assets and liabilities, the securities receivable and payable with the related company based on the expected settlement period.

(ii)

Amount related to advances to raw material suppliers.

 

25


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

 

       

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014

       

Associated companies, Jointly-controlled investment and associated companies

 

Related companies

 

EPE

 

 

       

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

     

Odebrecht and

 

Petrobras and

           

Balance sheet

Note

 

Inc.

 

Holanda

 

Petroquímica

 

Qpar

 

America

 

Austria

 

Argentina

 

Other

 

subsidiaries

 

subsidiaries

 

Other

 

FIM Sol

 

Total

Assets

Current

 

Trade accounts receivable

1,490,895

1,490,895

 

Related parties

   

2,740,452

472,347

248,350

68,940

 

116,520

144,367

3,326

103,403

25,031

 

3,922,736

 

Inventories

108,929

(i)

123,377

(i)

232,306

 

Related parties

   

37

15

24,658

53,684

54

 

18,081

55

35,642

187

 

132,413

 

Other

   

67,575

2,380

69,955

       

Non-current

   
 

Advances to suppliers

   

68,988

(i)

68,988

 

Related parties

   
 

Current accounts

   

1,863

1,863

 

Loan agreements

   

10,787

77

 

101,858

112,722

 

Other receivables

             

22,892

       

22,892

Total assets

   

2,751,276

472,362

340,583

 

122,624

54

116,520

189,660

181,298

364,280

25,218

1,490,895

6,054,770

       

Liabilities

   

Current

   
 

Trade payables

   

5,476,274

11,879

15

1,566

11,748

1,484,614

6,986,096

 

Accounts payable to related parties

   
 

Advance to export

   

 

191,619

 

12,319

54,304

258,242

 

Other payables

   

1,040

 

89,449

345

98,281

189,115

   

Non-current

 

Advance to export

   

8,797,501

751,705

345,306

9,894,512

 

Current accounts

   

 

97

97

 

Payable notes

   

112,021

                 

1,447

           

113,468

Total liabilities

   

5,589,335

8,989,120

101,328

  

764,384

399,610

  

101,391

11,748

1,484,614

  

 

17,441,530

                                 

Transações

                             
 

Sales of products

   

526,614

726,116

957,705

280,139

8,381

 

232,151

315,309

82,700

1,326,559

239,503

 

4,695,177

 

Purchases of raw materials, finished products

   
 

services and utilities

   

4,099,980

319,064

424,601

18,840

274,480

12,996,530

27,953

18,161,448

 

Financial income (expenses)

   

(158,331)

(1,568,565)

(7)

(114,041)

(60,753)

8,732

12,893

964

(1,879,108)

 

General and administrative expenses

   

 

 

Post-employment benefits

21.2.2

 

15,484

15,484

 

Gain from divestment of asset

                   

277,338

(ii)

      

277,338

Total transactions

   

4,468,263

(842,449)

1,276,762

704,740

(105,660)

(60,753)

 

240,883

347,042

634,518

 

14,324,053

 

282,940

  

21,270,339

                                                     

(i)

Amount related to advances to raw material suppliers.

(ii)

Amount related to divestment in subsidiary (Note 1(a)(i)).

 

26


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

As provided for in the Company’s bylaws, the Board of Directors has the exclusive power to decide on any contract but those related to the purchase of raw materials that exceed R$5,000 per operation or R$15,000 altogether per year. This provision encompasses contracts between the Parent Company and its subsidiaries and any of its common shareholders, directors of the Company, its parent company or subsidiary or its respective related parties. Additionally, the Company has a Finance and Investment Committee that, among other things, monitors the contracts with related parties that are approved by the Board of Directors.

 

Pursuant to Brazilian Corporation Law, officers and directors are prohibited from: (i) performing any acts of liberality with the use of the Company’s assets and in its detriment; (ii) intervening in any operations in which these officers and directors have a conflict of interest with the Company or in resolutions in which they participate; and (iii) receiving, based on their position, any type of personal advantage from third parties, directly or indirectly, without an authorization under the Bylaws or by the shareholders’ meeting.

 

The related parties that have significant relationship with the Company are as follows:

 

 

 

The main transactions with related parties, except subsidiaries of the Company, are summarized below:

 

·           Odebrecht and its subsidiaries:

 

(i)         In May 2014, an alliance agreement was signed with CNO for maintenance services at the industrial plants in Brazil with duration of four years and estimated total value of R$121 million;

 

(ii)       The lease agreement with CNO for the floors in the building where the offices of Braskem are located in São Paulo came into force as of January 1, 2014. The agreement is worth R$226 million and is valid through December 2028;

 

(iii)      An agreement was executed with CNO in September 2012 for the engineering, procurement and construction services of the subsidiary Braskem Idesa Project for an estimated value of US$3 billion and duration through 2015;

 

(iv)      In September 2009, the Company entered into an agreement with Aquapolo (a special purpose entity formed by Odebrecht Ambiental and the water utility Companhia de Saneamento Básico do Estado de São Paulo – SABESP for the production of industrial reuse water) for the acquisition of 9.5 million m³/year of reuse water by the plants located in the São Paulo Petrochemical Complex. The agreement is valid through 2053 and has an estimated annual value of R$65 million;

 

27


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(v)       In October 2012, an agreement was executed with Cetrel for the acquisition of 4 million m³/year of reuse water by the plants located in the Industrial Complex of Camaçarí. The contract is worth an estimated R$120 million and is valid through April 2028;

 

(vi)      In March 2013, an agreement was executed with UTA for the acquisition of 14.5 million m³/year of industrial water by the plants located in the Industrial Complex of Camaçarí. The contract is worth an estimated R$2.2 billion and is valid through March 2043;

 

(vii)    In December 2013, an agreement was executed with DAT for the acquisition of 29 million m³/year of industrial water by the plants located in the Industrial Complex of Triunfo. The contract is worth an estimated R$2.9 billion and is valid through December 2053.

 

·           Petrobras and its subsidiaries:

 

(i)         Naphtha

 

On December 23, 2015, an agreement was executed with Petrobras for the purchase of 7 million tons/year of petrochemical naphtha for five years. This agreement includes commercial renegotiation rights for both parties as of the third year, in case of changes in certain market conditions. The established price is 102.1% of ARA international benchmark, which is the average price of inputs in the European ports of Amsterdam, Rotterdam and Antwerp.

 

(ii)       Naphtha (amendments to agreements)

 

On August 29, 2014, Braskem and Petrobras entered into a new amendment to the naphtha supply contract of 2009, which extended the original contract duration by 6 months (from September 1, 2014 to February 28, 2015). In this amendment, the naphtha pricing formula of the original contract was maintained. It was also established that, if a new long-term contract had been executed, the pricing formula in the new contract would be applied retroactively to any purchases made during the duration of the amendment. On the other hand, if a new long-term contract was not executed, the average price base negotiated between the parties would be valid throughout the duration of the amendment. After applying the average price scenario, it was determined that Braskem was entitled to a refund of R$242,917. This amount was recorded in the first quarter of 2015 under “Cost of goods sold” and settled in the second quarter of 2015.

 

On February 27, 2015, Braskem and Petrobras executed a new amendment valid through August 31, 2015, under the same conditions as in the previous amendment. The naphtha price formula stipulated in the original contract was maintained in this amendment, but if the parties did not sign a new long-term contract, a price adjustment would be applied based on the international naphtha benchmark. For this amendment, a pricing complement was determined for payment to Petrobras in the amount of R$18,486, registered in the second quarter of 2015 under "Cost of goods sold."

 

On September 1, 2015, Braskem and Petrobras signed a new agreement valid until October 31, 2015, under the same conditions as in the previous amendment. For this amendment, a refund for Braskem was calculated in the amount of R$64,434, registered in the fourth quarter of 2015 under "Cost of goods sold."

 

On October 30, 2015, Braskem and Petrobras signed a new amendment to the agreement for the supply of petrochemical naphtha up to December 15, 2015. The price practiced for the duration of this amendment was already definitive.

 

28


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(iii)      Braskem has propylene purchase agreements with Petrobras for the plants located in the Petrochemical Complexes of Triunfo, Rio de Janeiro and São Paulo. These agreements provide for the full supply of approximately 910 thousand tons/year of propylene. The contracted propylene price is based on various international references linked to the most important markets for propylene and polypropylene, particularly the U.S., European and Asian markets.

 

(iv)      The Company has an agreement with Petrobras for the supply of: (i) 392.5 tons/year of ethane, and 392.5 tons/year of propane, valid through December 2020; (ii) 438.0 Nm³/year of HLR, valid through January 2020.  In addition, the Company had an agreement for the supply of 159.83 GWh/year of electricity, which was terminated in August 2015.

 

(v)       Since October 2015, Braskem has gasoline sales agreements with Petrobras with monthly duration.

 

(vi)      In January 2015, an amendment to the agreement with Petrobras for the supply of approximately 10.5 thousand tons of caustic soda was signed for the estimated total value of R$15 million and maturing in December 2015.

 

(vii)    In July 2015, an agreement was executed with Petrobras for the sale of 30 thousands m³ of aliphatic solvent was signed for R$72 million with duration up to March 2016.

 

(viii)   In April 2008, an agreement was executed with Petrocoque for the acquisition of 312.2 thousand tons/year of steam by the Polyethylene units. The contract is worth an estimated R$238.7 million and is valid through September 2019.

 

(ix)      In December 2012, an agreement was executed with RPR for the sale through spot trading of petroleum/condensate to Braskem was signed with Petrobras for an estimated amount of R$142 million. This agreement was terminated in September 2015.

 

(x)       In June 2015, an agreement was executed with Transpetro for the acquisition of naphtha and condensate handling and storage services by Braskem’s Basic Petrochemicals Unit, located in the Industrial Complex of Triunfo. The contract is worth an estimated R$16 million and is valid through June 2016.

 

 

(iii)             Key management personnel

 

The Company considers “Key management personnel” to be the members of the Board of Directors and the Executive Board, composed of the CEO and vice-presidents. Not all the members of the Executive Board are members of the statutory board.

 

   

Parent company and consolidated

Income statement transactions

 

2015

 

2014

Remuneration

       

Short-term benefits

 

46,562

 

35,963

Post-employment benefit

 

272

 

256

Long-term incentives

 

 

 

560

Total

 

46,834

 

36,779

 

29


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

10                Taxes recoverable

 

     

Consolidated

 

Partner Company

     

2015

 

2014

 

2015

 

2014

                   

Parent Company and subsidiaries in Brazil

 

             
 

IPI

 

23,996

 

20,456

 

22,615

 

16,945

 

Value-added tax on sales and services (ICMS) - normal operations

(a)

403,842

 

413,066

 

310,754

 

307,689

 

ICMS - credits from PP&E

 

121,954

 

136,308

 

115,354

 

129,979

 

Social integration program (PIS) and social contribution on revenue

(COFINS) - normal operations

(b)

69,431

 

675,983

 

69,004

 

663,140

 

PIS and COFINS - credits from PP&E

 

230,030

 

244,194

 

217,482

 

232,510

 

Income tax and social contribution (IR and CSL)

(c)

944,863

 

692,723

 

779,277

 

597,980

 

REINTEGRA program

(d)

274,654

 

263,771

 

271,823

 

258,735

 

Federal supervenience

(e)

173,436

 

170,264

 

168,507

 

166,448

 

Other

 

14,281

 

9,217

 

6,309

 

5,648

   

 

 

 

 

 

 

 

 

Foreign subsidiaries

 

 

 

 

 

 

 

 

 

Value-added tax

(f)

277,751

 

547,947

 

 

 

 

 

Income tax (IR)

 

40,263

 

 

 

 

 

 

 

Other

 

1,559

 

1,336

 

 

 

  

Total

 

2,576,060

 

3,175,265

 

1,961,125

 

2,379,074

   

 

             

Current assets

 

1,272,004

 

2,129,837

 

762,824

 

1,416,523

Non-current assets

 

1,304,056

 

1,045,428

 

1,198,301

 

962,551

Total

 

2,576,060

 

3,175,265

 

1,961,125

 

2,379,074

 

(a)               ICMS – normal operations

 

Accumulated ICMS credits over the past few years arises mainly from incentivized domestic sales subject to deferred taxation and export sales.

 

The Management of the Company has been prioritizing a series of actions to maximize the use of these credits and currently does not expect losses on their realization. These include the maintenance of the terms of the agreements with the states in which the Company produces petrochemical products in order to defer the ICMS tax levied on naphtha purchases, which increases the effective monetization of the balances.

 

(b)               PIS and COFINS

 

The Company has PIS and COFINS tax credits arising materially from the incentivized domestic outflows and exports.

 

The realization of these credits occurs in two ways: (i) offset of overdue or falling due liabilities related to taxes levied by the Federal Revenue Service; or (ii) cash reimbursement.

 

(c)               IR and CSL

 

Accumulated IR and CSL arises from prepayments of these taxes and retentions on income from financial investments over the past few years.

The realization of these credits occurs in two ways: (i) offset of overdue or falling due liabilities related to taxes levied by the Federal Revenue Service; or (ii) cash reimbursement. Several tax refund protocols were already filed with Brazil’s Federal Revenue Service.

30


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(d)               REINTEGRA Program

 

The REINTEGRA program aims to refund to exporters the federal taxes levied on the production chain for goods sold abroad. The amount to be refunded is equivalent to the following percentages of all export revenue, in accordance with Federal Law 13,043/14 and Executive Order 8,543/15:

 

(i)    3%, between October 1, 2014 and February 28, 2015;

(ii)   1%, between March 1, 2015 and November 30, 2015; and

(iii)  0.1% between December 1 , 2015 and December 31, 2016. 

 

Such credits may be realized in two ways: (i) by offsetting own debits overdue or undue related to taxes levied by the Federal Revenue Service; or (ii) by a cash reimbursement.

 

In the fiscal year ended December 31, 2015, the Company recognized credits in the amount of R$102,273 (R$65,701 in 2014) and offset the amount of R$91,389 (R$69,192 in 2014). In the Statement of Operations, credits are recognized in the item “Cost of Products Sold.”

 

(e)               Federal supervenience

 

This item includes credits arising from legal discussions regarding the legality and constitutionality of various taxes and contributions in which the Company has already obtained a favorable ruling or has unquestionable case law in its favor. These amounts will be realized after the use of other credits described above in this Note.

 

(f)                Value added tax – foreign subsidiaries

 

On December 31, 2015, this line included:

 

(i)       R$56,605 from sales by Braskem Alemanha to other countries. These credits are reimbursed in cash by the local government;

 

(ii)     R$189,157 from purchases of machinery and equipment for the subsidiary Braskem Idesa project (Note 11(d)). This credit will be reimbursed in cash by the local government after their validation according to established tax procedures. In fiscal year 2015, Braskem Idesa was reimbursed the amount of R$811,016 (US$263,927) (R$634,911 in 2014 (US$250,454)).

 

31


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

11                Investments

 

(a)               Information on investments

  

           

Interest in total and

 

Adjusted net profit (loss)

 

Adjusted

           

voting capital (%) - 2015

 

for the year

 

equity

           

Direct

 

Direct and indirect

 

2015

 

2014

 

2015

 

2014

                               

 

Subsidiaries

                         
 

Alclor

     

100.00

 

100.00

 

(3,053)

 

34,909

 

35,435

 

15,595

 

Braskem Alemanha

   

5.66

 

100.00

 

431,421

 

(98,721)

 

2,040,998

 

1,077,918

 

Braskem America

     

100.00

 

384,727

 

(24,468)

 

1,947,177

 

1,047,206

 

Braskem America Finance

     

100.00

 

913

 

117

 

3,065

 

1,664

 

Braskem Argentina

 

(i)

 

99.67

 

100.00

 

(10,993)

 

9,819

 

16,146

 

27,140

 

Braskem Austria

 

 

100.00

 

100.00

 

11,325

 

(3,176)

 

5,118

 

(7,378)

 

Braskem Austria Finance

   

100.00

 

(32)

 

(24)

 

75

 

3

 

Braskem Chile

   

(33)

 
 

Braskem Espanha

   

100.00

   

(9)

 

Braskem Holanda

 

(ii)

 

100.00

 

100.00

 

(88,633)

 

(64,486)

 

958,377

 

1,394,982

 

Braskem Holanda Finance

 

-

   

100.00

 

(11)

 

(68,930)

 

(12)

 

(213,489)

 

Braskem Holanda Inc

 

 

   

100.00

 

(131)

   

(158)

 
 

Braskem Finance

 

(iii)

 

100.00

 

100.00

 

76,476

   

(137,013)

 
 

Braskem Idesa

   

75.00

 

(399,433)

 

(551,051)

 

(1,991,690)

 

(578,125)

 

Braskem Idesa Serviços

   

75.00

 

5,659

 

1,081

 

8,860

 

5,483

 

Braskem Importação

   

3

 

 

 

203

 

Braskem Inc.

 

(iv)

 

100.00

 

100.00

 

344,665

 

345,893

 

843,579

 

498,915

 

Braskem México

 

 

 

66.67

 

100.00

 

124,398

 

58,622

 

206,806

 

337,975

 

Braskem México Sofom

 

(iii)

   

100.00

 

1,861

 

 

 

1,566

 

 

 

Braskem México Serviços

 

(v)

   

100.00

 

2,318

 

167

 

3,424

 

1,625

 

Braskem Participações

   

46,193

 

 

 

45,634

 

Braskem Petroquímica

   

100.00

 

100.00

 

342,495

 

226,924

 

2,018,696

 

1,795,269

 

Braskem Qpar

   

 

   

497,665

 
 

IQAG

     

0.12

 

100.00

 

7,023

 

3,763

 

16,934

 

8,448

 

Lantana

     

100.00

 

(336)

 

(84)

 

(1,047)

 

(711)

 

Norfolk

   

(411)

 

 

 

(433)

 

Petroquímica Chile

 

(i)

 

99.99

 

100.00

 

243

 

785

 

7,707

 

7,609

 

Politeno Empreendimentos

   

13,700

 

 

 

14,298

 

Quantiq

   

99.90

 

100.00

 

6,347

 

50

 

244,345

 

239,506

       

Jointly-controlled investment

 
 

RPR

     

33.20

 

33.20

 

24,784

 

(3,166)

 

145,551

 

125,955

 

Odebrecht Comercializadora de Energia S.A. ("OCE")

 

20.00

 

20.00

 

10,490

 

129

 

11,441

 

734

 

Polipropileno Del Sur S.A. ("Propilsur")

 

(vi)

   

49.00

 

 

 

(72)

 

 

 

121,547

             

Associates

       
 

Borealis Brasil S.A. ("Borealis")

     

20.00

 

20.00

 

(3,914)

 

7,246

 

158,366

 

174,433

 

Companhia de Desenvolvimento

                           
 

Rio Verde ("Codeverde")

 

(vi)

 

35.97

 

35.97

 

 

 

(596)

 

 

 

46,342

                                 
                                 

 

(i)         Sale of products in the export markets.

(ii)       Sale of products and funding operations in the international markets.

(iii)      Raising of funds in the international market.

(iv)      Sale of naphtha and other products, in addition to execution of funding transactions in the international market.

(v)       Provision of services to the subsidiary Braskem Idesa.

(vi)      Investees with provision for loss at amount equivalent to the investment.

 

32


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(b)               Changes in investments – parent company

 

 

 

Balance at

2014

     

Capital

increase

(decrease)

 

Dividends

and interest

on equity

 

Equity in results of investees

 

Goodwill

amortization

 

Other

 

Equity

valuation

adjustments

 

Currency

translation

adjustments

 

Balance at

2015

           

Effect

of results

 

Adjustment of

profit in inventories

         
   

Merger

                 

Subsidiaries and jointly-controlled investment

                                         
                                           

Domestic subsidiaries

                                         

Alclor

15,595

22,892

 

(3,053)

 

35,434

Braskem Participações

45,634

 

(45,634)

   

 

Braskem Petroquímica

1,911,604

 

59,932

 

 

 

(179,000)

 

342,495

 

(14,811)

 

(31,556)

   

2,088,664

Politeno Empreendimentos

14,298

 

(14,298)

 

Quantiq

243,466

   

(1,507)

 

6,347

 

(4,494)

 

35

   

243,847

RPR

41,822

   

(2,345)

 

5,861

   

2,295

 

696

 

48,329

OCE

148

 

   

 

55

 

(4)

 

2,090

             

2,289

 

2,272,567

     

22,947

 

(182,856)

 

353,740

 

(19,305)

 

(31,521)

 

 

 

2,295

 

696

 

2,418,563

                                         

Foreign subsidiaries

                                       

Braskem Alemanha

61,014

   

24,420

   

(48)

 

30,142

 

115,528

Braskem Austria

 

11,325

   

(6,843)

 

 

 

635

 

5,117

Braskem Argentina

26,155

   

(10,995)

 

(1,994)

   

13,166

Braskem Holanda

1,394,890

   

396,248

   

(88,633)

 

(5,942)

 

 

 

(1,326,633)

(i)

(8,407)

 

590,822

 

952,345

Braskem Inc.

497,945

   

344,665

 

(2,865)

   

839,745

Braskem México

337,975

   

(338,057)

   

124,394

   

82,494

 

206,806

Petroquímica Chile

7,609

             

243

 

(704)

 

 

 

(144)

   

7,004

 

2,325,588

     

58,191

     

405,419

 

(11,505)

 

 

 

(1,333,620)

 

(8,455)

 

704,093

 

2,139,711

                                                   
 

4,598,155

 

 

 

81,138

 

(182,856)

 

759,159

 

(30,810)

 

(31,521)

 

(1,333,620)

 

(6,160)

 

704,789

 

4,558,274

                                            

Domestic subsidiaries

34,887

     

897

 

 

 

(3,214)

   

(897)

   

31,673

                                                   

Total

4,633,042

     

82,035

 

(182,856)

 

755,945

 

(30,810)

 

(31,521)

 

(1,334,517)

 

(6,160)

 

704,789

 

4,589,947

 

(i)       In September 2015, the Parent Company transferred its direct interest in the subsidiary Braskem Idesa to the subsidiary Braskem Holanda (Note 1(a)). This operation did not impact the result and shareholders' equity of the Parent Company, but only produced the same effects previously recorded as provision for losses at Braskem Idesa, which are now reflected in the investment in Braskem Holanda.

 

33


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(c)               Breakdown of equity accounting results

 

   

 

 

Consolidated

 

 

 

Parent company

   

2015

 

2014

 

2015

 

2014

               

Equity in results of subsidiaries, associate and jointly-controlled

 

2,219

 

3,929

 

725,135

755,174

Amortization of fair value adjustment

     

(31,521)

(i)

(82,842)

Provision for losses on investments

     

58,410

(71,626)

Other

     

13

20,296

   

2,219

 

3,929

 

752,037

 

621,002

 

(i)       Amortization of fair value adjustments comprises the following:

 

·      R$28,085, related to the amortization of fair value adjustments on the assets and liabilities from business combination. This amount is distributed in the following items of the consolidated statement of operations: “cost of sales” of R$38,010 and “financial results” of R$4,541. The effect of deferred income tax and social contribution was R$14,466.

 

·      R$3,436, corresponding to the amortization of fair value adjustments on property, plant and equipment of the subsidiary Braskem Petroquímica.

 

(d)               Braskem Idesa

 

Braskem holds 75% indirect interest in Braskem Idesa, and the remaining 25% pertains to Etileno XXI, S.A. de C.V.

 

Braskem Idesa is constructing a plant in Mexico, with capacity to produce around 750 kton of high-density polyethylene (*) and 300 kton of low-density polyethylene (*) using ethane as feedstock. The raw material will be supplied through a 20-year agreement with PEMEX-Gás for delivery of 66,000 barrels of ethane per day. The petrochemical complex reached 99% of physical progress on December 31, 2015, and is in the startup process.

(*) unaudited

 

In December 2015, the capitalization of advances for future capital increase balances which were recorded under non-current liabilities in Braskem Idesa was approved, amounting to R$250,006 (US$63,800).

34


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(d.i)    Summary of information from the partially owned subsidiary Braskem Idesa

 

The Company is presenting a summary of the financial statements of the subsidiary in which the non-controlling shareholder holds relevant interest, as follows:

 

 

Balance sheet

 

 

 

 

 

 

 

 

 

Assets

2015

 

2014

 

Liabilities

2015

 

2014

Current

       

Current

     
 

Cash and cash equivalents

134,639

 

333,864

   

Trade payables

429,400

 

620,953

 

Inventories

173,129

 

238,193

   

Project finance

302,266

 

26,462

 

Taxes recoverable

219,071

 

499,173

   

Other payables

106,911

 

101,596

 

Other receivables

150,109

 

96,349

     

838,577

 

749,011

   

676,948

 

1,167,579

           

Non-current

       

Non-current

     
 

Deferred tax

825,416

 

179,249

   

Project finance

11,975,167

 

7,551,033

 

Property, plant and equipment

15,134,641

 

9,440,389

   

Loan agreements

5,911,266

 

2,834,972

 

Intangible

80,870

 

-

   

Other payables

7,065

 

90,513

 

Other receivables

32,080

 

39,763

     

17,893,498

 

10,476,518

   

16,073,007

 

9,659,401

           
           

Shareholders' equity

(1,982,120)

 

(398,549)

                     

Total assets

16,749,955

 

10,826,980

 

Total liabilities and shareholders' equity

16,749,955

 

10,826,980

                   

-

                     

Statement of operations

 

 

 

 

Statement of cash flows

 

 

 

   

2015

 

2014

     

2015

 

2014

Gross profit (loss)

(14,575)

 

5,320

 

Cash flows from operating activities

     
 

Operating expenses, net

(83,467)

 

(52,834)

   

Cash generated by operating activities

1,808,983

 

992,401

 

Financial results

(354,844)

 

(240,936)

   

Interest paid

(502,279)

 

(336,998)

Loss before income tax

(452,886)

 

(288,450)

 

Net cash generated by operating activities

1,306,704

 

655,403

 

Income tax

63,022

 

(83,030)

           

Loss for the year

(389,864)

 

(371,480)

 

Net cash used in investing activities

(3,339,518)

 

(3,645,196)

           

Net cash provided by financing activities

     
             

Project finance

988,447

 

1,894,507

             

Related parties

898,213

 

653,118

               

1,886,660

 

2,547,625

                     
           

Exchange variation on cash

(53,071)

 

(33,843)

                     
           

Decrease in cash and cash equivalents

(199,225)

 

(476,011)

                     
           

Represented by:

     
             

Cash and cash equivalents at the beginning for the year

333,864

 

809,875

             

Cash and cash equivalents at the end for the year

134,639

 

333,864

                     
           

Decrease in cash and cash equivalents

(199,225)

 

(476,011)

 

The shareholders’ equity of Braskem Idesa was negative on December 31, 2015 and 2014. This is an acceptable situation considering that it is a company in the pre-operating phase. This situation will be reversed with the startup of operations in 2016.

 

35


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

12                Property, plant and equipment

 

(a)               Change

 

     

Consolidated

     

Land

 

Buildings and Improvements

 

Machinery, Equipment and Facilities

 

Projects and Stoppage in Progress (i)

 

Other

 

Total

                           

Cost

   

436,540

 

1,899,018

 

26,581,334

 

13,179,475

 

1,065,324

 

43,161,691

Accumulated depreciation/depletion

   

 

 

(848,243)

 

(12,772,515)

 

 

 

(539,443)

 

(14,160,201)

Balance as of December 31, 2014

   

436,540

 

1,050,775

 

13,808,819

 

13,179,475

 

525,881

 

29,001,490

                           

Acquisitions

   

79

 

2,296

 

151,553

 

3,116,931

 

201

 

3,271,060

Capitalized financial charges

   

 

   

786,063

   

786,063

Foreign currency translation adjustment

   

43,002

 

11,088

 

307,697

 

2,658,730

 

22,946

 

3,043,463

Transfers by concluded projects

     

3,536,983

 

10,451,774

 

(14,113,868)

 

125,111

 

 

Transfers to intangible

 

(ii)

 

 

 

 

 

(85,917)

 

 

 

(85,917)

Other, net of depreciation/depletion

 

(iii)

 

(2,890)

 

(12,367)

 

(35,370)

 

(602)

 

(51,229)

Depreciation / depletion

     

(66,976)

 

(1,820,213)

 

 

 

(115,778)

 

(2,002,967)

Net book value

   

479,621

 

4,531,276

 

22,887,263

 

5,506,044

 

557,759

 

33,961,963

Cost

   

479,621

 

5,435,600

 

37,401,007

 

5,506,044

 

1,212,365

 

50,034,637

Accumulated depreciation/depletion

   

 

 

(904,324)

 

(14,513,744)

 

 

 

(654,606)

 

(16,072,674)

Balance as of December 31, 2015

   

479,621

 

4,531,276

 

22,887,263

 

5,506,044

 

557,759

 

33,961,963

 

(i)         On December 31, 2015, the main amounts included in this account refer to the expenses with the subsidiary Braskem Idesa project (R$2,022,870) and expenses with planned shutdown maintenance which is in preparation or in progress (R$627,985). The balance corresponds mainly to diverse projects aimed at maintenance of plants’ production capacity. 

(ii)       Expenses up to May 31, 2015 in Braskem Idesa’s project were transferred to the definite accounts as follows: R$8,917,760 to “Machinery, equipment and installations” and R$3,476,205 to “Buildings and improvements.” These amounts will be depreciated as of the beginning of the commercial production of the subsidiary.

(iii)      This change includes R$80,870 from Braskem Idesa corresponding to the transfer to intangible assets when amounts are capitalized to the related accounts (Note 13).

 

   

Parent Company

   

Land

 

Buildings and Improvements

 

Machinery, Equipment and Facilities

 

Projects and Stoppage in Progress

 

Other

 

Total

                         

Cost

 

292,072

 

1,705,542

 

24,835,180

 

3,215,012

 

774,145

 

30,821,951

Accumulated depreciation/depletion

 

 

 

(835,374)

 

(12,201,493)

 

 

 

(487,177)

 

(13,524,044)

Balance as of December 31, 2014

 

292,072

 

870,168

 

12,633,687

 

3,215,012

 

286,968

 

17,297,907

                         

Acquisitions

 

79

 

2,296

 

141,873

 

762,015

 

740

 

907,003

Capitalized financial charges

   

119,666

 

 

 

119,666

Transfers by concluded projects

   

14,147

 

1,279,204

 

(1,399,861)

 

106,510

 

 

Transfers to intangible

     

(2,431)

 

 

 

(2,431)

Other, net of depreciation/depletion

   

(2,312)

 

(9,743)

 

(34,457)

 

(134)

 

(46,646)

Depreciation / depletion

   

(53,798)

 

(1,591,013)

 

(88,610)

 

(1,733,421)

Net book value

 

292,151

 

830,501

 

12,454,008

 

2,659,944

 

305,474

 

16,542,078

Cost

 

292,151

 

1,708,887

 

26,169,210

 

2,659,944

 

880,812

 

31,711,004

Accumulated depreciation/depletion

 

 

 

(878,386)

 

(13,715,202)

 

 

 

(575,338)

 

(15,168,926)

Balance as of December 31, 2015

 

292,151

 

830,501

 

12,454,008

 

2,659,944

 

305,474

 

16,542,078

 

The financial charges are capitalized on the balance of the projects in progress using (i) an average rate of all borrowings; and (ii) the portion of the foreign exchange variation that corresponds to a possible difference between the average rate of financing in the internal market and the rate mentioned in item (i) above. The capitalized amount is considered in the statement of cash flows as “Acquisitions to property, plant and equipment”.

 

36


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

The machinery, equipment and facilities of the Company require inspections, replacement of components and maintenance in regular intervals. The Company makes shutdowns in regular intervals that vary from two to six years to perform these activities. These shutdowns can involve the plant as a whole, a part of it, or even relevant pieces of equipment, such as industrial boilers, turbines and tanks. Shutdowns that take place every six years, for example, are usually made for the maintenance of industrial plants as a whole. Expenses with each scheduled shutdown are included in property, plant and equipment items that were the subject matter of the stoppage and are fully depreciated until the beginning of the following related stoppage. The expenditures with personnel, the consumption of small materials, maintenance and the related services from third parties are recorded, when incurred, as production costs. Property, plant and equipment items are depreciated on a straight-line basis. Projects in progress are not depreciated. Depreciation begins when the assets are available for use.

 

Based on the analysis cited in Note 3.4(a), the Management of Braskem believes that the plants will operate at their full capacity, or close to it, within the projected period, therefore impairment tests of these assets were not necessary. The prices of products manufactured by the Company are quoted in international markets and adjust to the prices of raw materials to preserve the historical margins of the business.

 

(b)               Property, plant and equipment by country

 

Consolidated

     

2015

 

2014

           

Brazil

   

17,637,392

 

18,434,300

Mexico

   

14,416,835

 

9,260,814

United States of America

   

1,609,956

 

1,086,228

Germany

   

297,278

 

218,753

Other

   

502

 

1,395

     

33,961,963

 

29,001,490

 

13                Intangible assets

 

                     

Parent

 

Consolidated

 

Company

 

Goodwill

                   
 

based on

         

Customers

       
 

expected future

 

Brands

 

Software

 

and Suppliers

       
 

profitability

 

and Patents

 

licenses

 

Agreements

 

Total

 

Total

Cost

3,187,722

 

213,031

 

497,813

 

729,711

 

4,628,277

 

4,150,882

Accumulated amortization

(1,128,804)

 

(91,121)

 

(292,250)

 

(280,374)

 

(1,792,549)

 

(1,540,855)

Balance as of December 31, 2014

2,058,918

 

121,910

 

205,563

 

449,337

 

2,835,728

 

2,610,027

 

 

 

 

 

 

 

 

 

 

 

 

Acquisitions

 

 

 

 

20,106

 

 

 

20,106

 

20,088

Foreign currency translation adjustment

 

 

3,782

 

14,603

 

66,071

 

84,456

 

 

Transfers from property, plant and equipment

projects and stoppage in progress

 

 

81,625

 

4,292

 

 

 

85,917

 

2,431

Other, net of amortization

 

 

 

 

(16)

 

 

 

(16)

 

 

Amortization

 

 

(9,661)

 

(43,791)

 

(85,135)

 

(138,587)

 

(60,205)

Net book value

2,058,918

 

197,656

 

200,757

 

430,273

 

2,887,604

 

2,572,341

Cost

3,187,722

 

298,438

 

536,786

 

795,782

 

4,818,728

 

4,173,401

Accumulated amortization

(1,128,804)

 

(100,782)

 

(336,029)

 

(365,509)

 

(1,931,124)

 

(1,601,060)

Balance as of December 31, 2015

2,058,918

 

197,656

 

200,757

 

430,273

 

2,887,604

 

2,572,341

                       

Average annual rates of amortization

   

4.44%

 

10.79%

 

6.01%

       

 

37


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

The Company adopts the following accounting practice for each class of intangible assets:

 

(a)               Goodwill based on future profitability

 

The existing goodwill was determined in accordance with the criteria established by the accounting practices adopted in Brazil before the adoption of the CPC and IFRS pronouncements and represent the excess of the amount paid over the amount of equity of the entities acquired.

 

The Company’s goodwill was systematically amortized until December 2008. As from 2009, it has been subject to annual impairment tests in accordance with the provisions in CPC 01 and IAS 36.

 

At the end of 2015, Braskem conducted an impairment test of the goodwill using the value in use method (discounted cash flow) and did not identify any loss, as shown in the table below:

 

 

   

 

 

 

 

 

 

Consolidated

           

Book value

   
   

Allocated

 

Cash flow

 

(with goodwill

   
   

goodwill

 

(CF)

 

and work capital)

 

CF/Book value

CGU and operating segments

               

CGU - UNIB - South

 

926,854

 

7,741,247

 

942,748

 

8.2

Operating segment - Polyolefins

 

939,711

 

22,136,662

 

6,379,797

 

3.5

Operating segment - Vinyls

 

192,353

 

4,724,932

 

3,395,587

 

1.4

 

The assumptions adopted to determine the discounted cash flow are described in Note 3.4(b). The WACC used was 13.91% p.a.

 

Given the potential impact on cash flows of the “discount rate” and the “perpetuity”, Braskem conducted a sensitivity analysis based on changes in these variables, with cash flows shown in the table below:

 

 

           

 

 

Consolidated

           

+0.5% on

 

-0.5% on

           

discount rate

 

perpetuity

CGU and operating segments

               

CGU - UNIB - South

         

7,424,446

 

7,396,596

Operating segment - Polyolefins

         

21,346,548

 

21,277,089

Operating segment - Vinyls

         

4,551,687

 

4,536,457

 

(b)               Intangible assets with defined useful lives

 

(b.1)    Brands and patents

 

The technologies acquired from third parties, including those acquired through business combination, are recorded at the cost of acquisition and/or fair value and other directly attributed costs, net of accumulated amortization and provision for impairment, when applicable. Technologies that have defined useful lives and are amortized using the straight-line method based on the term of the purchase agreement (between 10 and 20 years). Expenditures with research and development are accounted for in profit or loss as they are incurred.

 

38


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(b.2)    Contractual customer and supplier relationships

Contractual customer and supplier relationships arising from a business combination were recognized at fair value at the respective acquisition dates. These contractual customer and supplier relationships have a finite useful life and are amortized using the straight-line method over the term of the respective purchase or sale agreement (between 14 and 28 years).

 

(b.3)    Software

All software booked has defined useful life estimated between 3 and 10 years and is amortized using the straight-line method. Costs associated with maintaining computer software programs are recognized in profit or loss as incurred.

 

(c)               Intangible assets by country

 

Consolidated

     

2015

 

2014

           

Brazil

   

2,583,208

 

2,626,099

Mexico

   

80,870

 

 

United States of America

   

220,083

 

205,329

Germany

   

3,415

 

4,245

Other

   

28

 

55

     

2,887,604

 

2,835,728

 

 

14                Borrowings

 

 

                 

 

 

Consolidated

         

Annual financial charges

 

2015

 

2014

Foreign currency

                 

 

 

Bonds and Medium term notes (MTN)

     

Note 14 (a)

     

17,004,617

 

11,776,438

 

Advances on exchange contracts

     

US dollar exchange variation + 2.23%

 

255,809

 

 

 

Export prepayment

     

US dollar exchange variation + 1.10% + semiannual Libor

 

549,036

 

427,074

 

BNDES

     

Note 14 (b)

     

409,076

 

396,439

 

Export credit notes

     

Note 14 (c)

     

1,405,227

 

956,010

 

Working capital

     

US dollar exchange variation + 1.70% above Libor

 

1,907,145

 

633,104

 

Transactions costs

             

(248,838)

 

(260,656)

                       

Local currency

                   
 

Export credit notes

     

Note 14 (c)

     

2,350,965

 

2,435,839

 

BNDES

     

Note 14 (b)

     

3,001,776

 

3,137,035

 

BNB/ FINAME/ FINEP/ FUNDES

     

6.48%

     

642,739

 

762,757

 

BNB/ FINAME/ FINEP/ FUNDES

     

TJLP + 1.90%

     

2,177

 

8,512

 

Fundo de Desenvolvimento do Nordeste (FDNE)

     

6.5%

     

51,939

 

51,090

 

Other

     

CDI + 0.04%

     

23,714

 

26,928

 

Transactions costs

             

(16,582)

 

(14,007)

Total

             

27,338,800

 

20,336,563

                       

Current liabilities

             

1,968,540

 

1,418,542

Non-current liabilities

             

25,370,260

 

18,918,021

Total

             

27,338,800

 

20,336,563

 

39


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

   

 

 

Parent company

   

2015

 

2014

Foreign currency

     
 

Current liabilities

1,361,655

 

1,240,926

 

Non-current liabilities

3,355,752

 

2,349,741

   

4,717,407

 

3,590,667

Local currency

     
 

Current liabilities

1,205,469

 

894,025

 

Non-current liabilities

4,851,260

 

5,513,925

   

6,056,729

 

6,407,950

         

Current liabilities

2,567,124

 

2,134,951

Non-current liabilities

8,207,012

 

7,863,666

Total

10,774,136

 

9,998,617

 

 

(a)                Bonds and MTN

  

     

Issue amount

     

Interest

 

Consolidated

Issue date

 

 

US$

 

Maturity

 

(% per year)

 

2015

 

2014

July 1997

 

(i)

250,000

 

June - 2045

 

8.63

 

 

 

149,394

September 2006

   

275,000

 

January - 2017

 

8.00

 

225,637

 

165,863

June 2008

   

500,000

 

June - 2018

 

7.25

 

539,327

 

381,567

May 2010

   

400,000

 

May - 2020

 

7.00

 

188,088

 

127,945

May 2010

   

350,000

 

May - 2020

 

7.00

 

1,380,764

 

939,251

October 2010

   

450,000

 

no maturity date

 

7.38

 

1,757,160

 

1,216,348

April 2011

   

750,000

 

April - 2021

 

5.75

 

2,953,803

 

2,009,294

July 2011

   

500,000

 

July - 2041

 

7.13

 

2,013,453

 

1,369,631

February 2012

   

250,000

 

April - 2021

 

5.75

 

987,894

 

672,005

February 2012

   

250,000

 

no maturity date

 

7.38

 

976,200

 

675,749

May 2012

   

500,000

 

May - 2022

 

5.38

 

1,969,307

 

1,339,601

July 2012

   

250,000

 

July - 2041

 

7.13

 

1,006,727

 

684,815

Feb-2014

 

(ii)

500,000

 

February - 2024

 

6.45

 

2,004,171

 

1,363,317

May-2014

 

(iii)

250,000

 

February - 2024

 

6.45

 

1,002,086

 

681,658

Total

   

5,475,000

         

17,004,617

 

11,776,438

  

(i)    This transaction, which was due in June 2015, had its maturity extended to June 2045. The subsidiary Braskem Holanda holds 100% of these securities as at December 31, 2015.

(ii)   The effective interest rate considering the transaction costs is 7.78% p.a.;

(iii) The effective interest rate considering the transaction costs is 7.31% p.a..

 

40


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(b)                BNDES borrowings

 

 

               

 

 

Consolidated

Projects

 

Issue date

 

Maturity

 

Charges (% per year)

 

2015

 

2014

                     

Foreign currency

                   

Other

 

2006

 

October - 2016

 

US dollar exchange variation + 6.88

 

3,204

 

4,795

Braskem Qpar expansion

 

2007/2008

 

April - 2016

 

US dollar exchange variation + 6.73 to 6.88

 

2,426

 

6,717

Green PE

 

2009

 

July - 2017

 

US dollar exchange variation + 6.66

 

29,352

 

32,577

Limit of credit II

 

2009

 

January - 2017

 

US dollar exchange variation + 6.66

 

47,353

 

61,946

New plant PVC Alagoas

 

2010

 

January - 2020

 

US dollar exchange variation + 6.66

 

128,806

 

109,077

Limit of credit III

 

2011

 

October - 2018

 

US dollar exchange variation + 6.50 to 6.53

 

149,495

 

141,894

Butadiene

 

2011

 

January - 2021

 

US dollar exchange variation + 6.53

 

48,440

 

39,433

               

409,076

 

396,439

                     

Local currency

                   

Other

 

2006

 

September - 2016

 

TJLP + 2.80

 

13,501

 

31,376

Braskem Qpar expansion

 

2007/2008

 

February - 2016

 

TJLP + 2.15 to 3.30

 

5,372

 

40,617

Green PE

 

2009

 

June - 2017

 

TJLP + 0.00 to 4.78

 

119,201

 

198,608

Limit of credit II

 

2009

 

January - 2017

 

TJLP + 2.58 to 3.58

 

85,004

 

162,815

Limit of credit II

 

2009

 

January - 2021

 

4.00 to 4.50

 

96,698

 

93,875

New plant PVC Alagoas

 

2010

 

December - 2019

 

TJLP + 0.00 to 3.58

 

235,641

 

293,568

New plant PVC Alagoas

 

2010

 

December - 2019

 

5.50

 

26,732

 

33,414

Limit of credit III

 

2011

 

December - 2021

 

TJLP + 0.00 to 3.58

 

1,154,552

 

1,331,699

Limit of credit III

 

2011

 

December - 2021

 

SELIC + 2.32 to 2.78

 

284,263

 

260,508

Limit of credit III

 

2011

 

December - 2021

 

3.50 to 7.00

 

230,198

 

250,505

Butadiene

 

2011

 

December - 2020

 

TJLP + 0.00 to 3.45

 

96,407

 

115,225

Finem

 

2014

 

March - 2021

 

TJLP + 0.00 to 2.78

 

215,372

 

192,827

Finem

 

2014

 

March - 2021

 

SELIC + 2.78

 

160,603

 

129,326

Finem

 

2014

 

March - 2021

 

6.00

 

6,664

 

2,672

Limit of credit IV

 

2015

 

January - 2022

 

TJLP + 0.00 to 2.62

 

140,024

 

Limit of credit IV

 

2015

 

January - 2022

 

SELIC + 2.32

 

131,544

 
               

3,001,776

 

3,137,035

                     

Total

             

3,410,852

 

3,533,474

 

41


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(c)                 Export credit notes (“NCE”)

 

 

     

Initial amount

         

 

 

Consolidated

Issue date

 

 

of the transaction

 

Maturity

 

Charges (% per year)

 

2015

 

2014

                       

Foreign currency

   

US$

               

November - 2006

#####

 

167,014

 

May - 2018

 

Us dollar exchange variation + 8.10

 

308,069

 

209,561

April - 2007

#####

 

101,605

 

March - 2018

 

Us dollar exchange variation + 7.87

 

198,782

 

135,220

May - 2007

#####

 

146,010

 

May - 2019

 

Us dollar exchange variation + 7.85

 

294,840

 

200,518

January - 2008

#####

 

266,430

 

February - 2020

 

Us dollar exchange variation + 7.30

 

603,536

 

410,711

     

681,059

         

1,405,227

 

956,010

                       

Local currency

                     

April - 2010

-

 

50,000

 

October - 2021

 

105% of CDI

 

36,653

 

36,120

June - 2010

-

 

200,000

 

October - 2021

 

105% of CDI

 

146,611

 

144,481

February - 2011

-

 

250,000

 

October - 2021

 

105% of CDI

 

146,611

 

144,481

April - 2011

(i)

 

450,000

 

April - 2019

 

112.5% of CDI

 

464,039

 

461,254

June - 2011

-

 

80,000

 

October - 2021

 

105% do CDI

 

58,644

 

57,792

August - 2011

(i)

 

400,000

 

August - 2019

 

112.5% of CDI

 

405,478

 

404,309

June - 2012

-

 

100,000

 

October - 2021

 

105% of CDI

 

73,305

 

72,241

September - 2012

-

 

300,000

 

October - 2021

 

105% of CDI

 

219,917

 

216,722

October - 2012

-

 

85,000

 

October - 2021

 

105% of CDI

 

62,310

 

61,405

February - 2013

(ii)

 

100,000

 

September - 2017

 

8.00

 

101,118

 

101,161

February - 2013

(ii)

 

100,000

 

February - 2016

 

8.00

 

101,248

 

101,161

February - 2013

(ii)

 

50,000

 

September - 2017

 

8.00

 

50,440

 

50,440

February - 2013

(ii)

 

100,000

 

February - 2016

 

8.00

 

101,118

 

101,096

March - 2013

(ii)

 

50,000

 

March - 2016

 

8.00

 

50,253

 

50,257

June - 2014

(ii)

 

50,000

 

June - 2017

 

8.00

 

50,010

 

50,010

June - 2014

(ii)

 

17,500

 

June - 2017

 

8.00

 

17,504

 

17,504

June - 2014

(ii)

 

10,000

 

June - 2017

 

8.00

 

10,002

 

10,002

September - 2014

-

 

100,000

 

August - 2020

 

108% of CDI

 

104,642

 

103,579

November - 2014

(ii)

 

150,000

 

November - 2017

 

8.00

 

151,062

 

151,094

November - 2014

-

 

100,000

 

April - 2015

 

8.00

 

 

 

100,730

Total

   

2,742,500

         

2,350,965

 

2,435,839

 

(i)         The Company enters into swap transactions to offset the variation in the Interbank Certificate of Deposit (CDI) rate (Note 16.2.1 (b.i)).

(ii)       The Company entered into swap transactions for these contracts (from fixed rate to 67.10% to 92.70% of CDI rate) (Note 16.2.1).

 

42


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(d)                Payment schedule

 

The maturity profile of the long-term amounts is as follows:

 

 

 

 

 

Consolidated

 

2015

 

2014

     

 

2016

 

 

1,253,774

2017

1,737,331

 

1,528,616

2018

2,633,143

 

1,977,384

2019

3,320,800

 

1,997,887

2020

2,757,234

 

1,940,691

2021

4,257,177

 

2,947,526

2022

2,071,030

 

1,417,085

2023

7,540

 

7,652

2024

2,944,726

 

2,008,387

2025 and thereafter

5,641,279

 

3,839,019

Total

25,370,260

 

18,918,021

 

 

(e)                 Capitalized financial charges - consolidated

 

In 2015, the Company capitalized financial charges presented in this note in the amount of R$130,180 (R$95,542 in 2014), including monetary variation and part of the exchange variation. The average rate of these charges in the year was 7.80% p.a. (7.69% p.a. in 2014).

 

(f)                 Guarantees

 

Braskem gave collateral for part of its borrowings as follows:

 

 

       

Total

 

Total

   

Loans

 

Maturity

 

debt 2015

 

guaranteed

 

Guarantees

                 

BNB

 

December - 2022

 

171,041

 

171,041

 

Mortgage of plants, pledge of machinery and equipment

BNB

 

August - 2024

 

247,343

 

247,343

 

Bank surety

BNDES

 

December - 2021

 

3,410,852

 

3,410,852

 

Mortgage of plants, land and property, pledge of machinery and equipment

FUNDES

 

June-2020

 

143,789

 

143,789

 

Mortgage of plants, land and property, pledge of machinery and equipment

FINEP

 

July-2024

 

80,566

 

80,566

 

Bank surety

FINAME

 

February-2022

 

2,177

 

2,177

 

Pledge of equipment

Total

     

4,055,768

 

4,055,768

   

 

43


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

15                Project finance

 

   

US$

         

 

 

Consolidated

Identification

 

Contract value

 

Value received

 

Maturity

 

Charges (% per year)

 

2015

 

2014

Project finance I

 

700.000

 

700.000

 

February - 2027

 

Us dollar exchange variation + quarterly Libor + 3.25

 

2,720,874

 

1,716,943

Project finance II

 

210.000

 

189.996

 

February - 2027

 

Us dollar exchange variation + 6.17

 

740,902

 

378,992

Project finance III

 

600.000

 

600.000

 

February - 2029

 

Us dollar exchange variation + 4.33

 

2,334,133

 

1,388,166

Project finance IV

 

660.000

 

680.004

 

February - 2029

 

Us dollar exchange variation + quarterly Libor + 3.88

 

2,645,645

 

1,757,438

Project finance V

 

400.000

 

400.000

 

February - 2029

 

Us dollar exchange variation + quarterly Libor + 4.65

 

1,557,360

 

982,688

Project finance VI

 

90.000

 

89.994

 

February - 2029

 

Us dollar exchange variation + quarterly Libor + 2.73

 

349,464

 

153,762

Project finance VII

 

533.095

 

533.095

 

February - 2029

 

Us dollar exchange variation + quarterly Libor + 4.64

 

2,075,524

 

1,311,104

Transactions costs

           

(173,240)

 

(111,598)

Total

 

3,193,095

 

3,193,089

         

12,250,662

 

7,577,495

                         
                         

VAT borrowings (i)

       

November - 2029

 

3.00% above TIIE (ii)

 

26,771

 

 

                   

26,771

 

 

                         
                   

12,277,433

 

 

                         

Current liabilities

                 

302,266

 

26,462

Non-current liabilities

             

11,975,167

 

7,551,033

Total

                 

12,277,433

 

7,577,495

 

(i)         Financing for the subsidiary Braskem Idesa obtained in mexican peso and paid exclusively using the reimbursement of value-added taxes (Note 10(e.ii)). During the year ended December 31, 2015, a total of R$535,125 was raised and R$516,496 was settled (R$510,715 as principal and R$5,781 as interest).

(ii)       TIIE – “Tasa de Interés Interbancaria de Equilibrio” – basic interest rate in Mexico, similar to the CDI overnight rate in Brazil.

 

On April 22, 2015, Braskem Idesa received the fifth tranche of the Project Finance in the amount of R$877,040 (US$290,545), and on September 9, 2015 it received the last tranche in the amount of R$89,774 (US$23,608).

 

In line with the Company’s Financial Policy, the investment in the Ethylene XXI project (Note 11(d)) is being financed under the Project finance mode, whereby the project loan must be paid exclusively with the cash generated by the project itself and shareholders must provide limited guarantees. Thus, this financing has the usual guarantees of this type of operation such as assets, receivables, cash generation and other rights from the project, as well commitments by shareholders to inject a limited amount of capital to provide for eventual additional costs of the project.

 

The financing structure was concluded in December 2012, at the ratio of 70% debt and 30% equity. The total financing to meet construction expenses and start operation was US$3,193,089.

 

In the year ended December 31, 2015, the subsidiary Braskem Idesa capitalized the interest on this financing in the amount of R$657,191 (R$527,620 in 2014), which partially includes the exchange variation. The average rate of charges capitalized in the year was 8.28% p.a. (7.76% in 2014).

 

44


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

The maturity profile of this long-term financing, by year of maturity, is as follows:

 

   

 

 

Consolidated

   

2015

 

2014

         

2016

 

 

 

137,360

2017

 

687,211

 

417,129

2018

 

840,247

 

511,886

2019

 

872,994

 

533,244

2020

 

1,025,621

 

630,543

2021

 

1,172,569

 

722,211

2022

 

977,593

 

603,387

2023

 

1,294,219

 

797,728

2024

 

1,400,843

 

863,811

2025

 

1,398,554

 

2,333,734

2026 and thereafter

 

2,305,316

 

 

Total

 

11,975,167

 

7,551,033

 

16                Financial instruments

 

16.1          Non-derivative financial instruments - consolidated

 

           

Fair value

 

Book value

 

Fair value

   

Note

 

Classification by category

 

hierarchy

 

2015

 

2014

 

2015

 

2014

                             

Cash and cash equivalents

 

5

                       

Cash and banks

             

873,966

 

227,237

 

873,966

 

227,237

Financial investments in Brazil

     

Held-for-trading

 

Level 2

 

605,770

 

1,146,880

 

605,770

 

1,146,880

Financial investments in Brazil

     

Loans and receivables

     

1,823,225

 

1,106,768

 

1,823,225

 

1,106,768

Financial investments abroad

     

Held-for-trading

 

Level 2

 

4,136,762

 

1,512,474

 

4,136,762

 

1,512,474

               

7,439,723

 

3,993,359

 

7,439,723

 

3,993,359

                             

Financial investments

 

6

                       

FIM Sol investments

     

Held-for-trading

 

Level 2

 

-

 

85,573

 

-

 

85,573

Other

     

Held-for-trading

 

Level 2

 

1,172

 

4,155

 

1,172

 

4,155

Quotas of receivables investment fund

     

Held-to-maturity

     

46,193

 

42,495

 

46,193

 

42,495

               

47,365

 

132,223

 

47,365

 

132,223

                             

Trade accounts receivable

 

7

         

2,754,966

 

2,717,662

 

2,754,966

 

2,717,662

                             

Related parties credits

 

9

 

Loans and receivables

     

155,140

 

205,117

 

155,140

 

205,117

                             

Trade payables

             

11,755,843

 

10,852,410

 

11,755,843

 

10,852,410

                             

Borrowings

 

14

                       

Foreign currency - Bond

         

Level 1

 

17,004,617

 

11,776,438

 

14,434,854

 

11,900,361

Foreign currency - other borrowings

             

4,526,293

 

2,412,627

 

4,526,293

 

2,412,627

Local currency

             

6,073,310

 

6,422,161

 

6,073,310

 

6,422,161

               

27,604,220

 

20,611,226

 

25,034,457

 

20,735,149

                             

Project finance

 

15

         

12,450,673

 

7,689,093

 

12,450,673

 

7,689,093

                             

Ethylene XXI Project Loan

 

18

         

1,538,784

 

792,188

 

1,538,784

 

792,188

                             

Other payables

 

22

         

273,294

 

296,969

 

273,294

 

296,969

 

45


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(a)               Fair value

 

The fair value of financial assets and liabilities is estimated as the amount for which a financial instrument could be exchanged in an arm’s length transaction and not in a forced sale or settlement. The following methods and assumptions were used to estimate the fair value:

 

(i)      Held-for-trading and available-for-sale financial assets are measured in accordance with the fair value hierarchy (Level 1 and Level 2), with inputs used in the measurement processes obtained from sources that reflect the most recent observable market prices.

 

(ii)    Trade accounts receivable and trade payables correspond to respective carrying amounts due to the short-term maturity of these instruments.

 

(iii)  The fair value of borrowings is estimated by discounting future contractual cash flows at the market interest rate, which is available to Braskem in similar financial instruments.

 

(iv)  The fair value of bonds is based on prices negotiated in financial markets, plus the respective carrying amount of interests.

 

(v)      The fair values of the remaining assets and liabilities correspond to their carrying amount.

 

(b)               Fair value hierarchy

 

The Company adopts CPC 40 and IFRS 7 for financial instruments that are measured in the balance sheet; this requires disclosure of measurements by level of the following fair value measurement hierarchy:

 

Level 1 – fair value obtained through prices quoted (without adjustments) in active markets for identical assets or liabilities, such as the stock exchange; and

 

Level 2 – fair value obtained from discounted cash flow models, when the instrument is a forward purchase or sale or a swap contract, or valuation models of option contracts, such as the Black-Scholes model, when the derivative has the characteristics of an option.

 

46


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

16.2     Financial hedge instruments designated and not designated for hedge accounting

 

16.2.1  Changes

 

           

Operation characteristics

               
       

Fair value

 

Principal exposure

     

Balance at

 

Change in

 

Financial

 

Balance at

Identification

 

Note

 

hierarchy

   

Derivatives

 

2014

 

fair value

 

settlement

 

2015

                                 

Non-hedge accounting transactions

 

-

                           

Exchange swap

 

16.2.1 (a.i)

 

Level 2

 

Argentine peso

 

Dollar

 

1,383

 

(31,314)

 

(9,059)

 

(38,990)

Interest rate swaps

   

Level 2

 

Fixed rate

 

CDI

 

18,588

 

6,489

 

(16,726)

 

8,351

Deliverable Forward

   

Level 2

 

Euro

 

Dollar

 

2,230

 

(6,494)

 

4,264

 

 

                 

22,201

 

(31,319)

 

(21,521)

 

(30,639)

                               

Hedge accounting transactions

                             

Exchange swap

 

16.2.1 (b.i)

 

Level 2

 

CDI

 

Dollar+Interests

 

560,828

 

592,058

 

19,239

 

1,172,125

Interest rate swaps

 

16.2.1 (b.ii.i)

Level 2

 

Libor

 

Fixed rates

 

3,542

 

106,780

 

(75,249)

 

35,073

Deliverable Forward

   

Level 2

 

Mexican peso

 

Dollar

 

30,533

 

19,754

 

(50,287)

 

 

                 

594,903

 

718,592

 

(106,297)

 

1,207,198

                               

Derivatives operations

                             

Current assets

               

(33,555)

         

(53,662)

Non-current assets

               

(39,350)

         

(12,280)

Current liabilities

               

95,626

         

57,760

Non-current liabilities

               

594,383

         

1,184,741

                 

617,104

         

1,176,559

 

 

The counterparties in these contracts are constantly monitored based on the analysis of their respective ratings and Credit Default Swaps – CDS. Braskem has many bilateral risk mitigators in its derivative contracts, such as the possibility of depositing or requesting deposits of a guarantee margin from the counterparties it deems convenient.

 

Financial hedge instruments designated and not designated for hedge accounting are presented in the balance sheet at their fair value in an asset or liability account depending on whether the fair value represents a positive or a negative balance to Braskem, respectively, and are necessarily classified as "held-for-trading". The regular changes in the fair value are recognized as financial income or expense in the period in which they occur, except when designated and qualified for hedge accounting.

 

All financial hedge instruments held at December 31, 2015 were contracted on Over the Counter - OTC markets with large financial counterparties under global derivative contracts in Brazil or abroad and its fair value is classified as Level 2.

 

Braskem’s Financial Policy provides for a continuous short-term hedging program for foreign exchange rate risk arising from its operations and financial items. The other market risks are addressed on a case-by-case basis for each transaction. In general, Braskem assesses the need for hedging in the analysis of prospective transactions and seeks to customize the hedge for each operation and keeps it in place for the whole period of the hedged transaction.

 

Braskem may elect derivatives for the application of hedge accounting in accordance with CPCs 38, 39, 40 and IAS 39-32 and IFRS 7. The hedge designation is not mandatory. In general, Braskem will elect to designate financial instruments as hedges when the application is expected to provide a significant improvement in the presentation of the offsetting effect on the changes in the hedged items.

 

The effective portion of the changes in the fair value of hedge derivatives and of the exchange variation of financial liabilities designated and qualified as sales flow hedge is recognized in equity, under “Other comprehensive income”. These amounts are transferred to profit or loss for the periods in which the hedged item affects the financial results. The ineffective portion is recognized immediately in profit or loss as “Financial result.”

 

47


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

When a hedge instrument matures or is sold or when it no longer meets the criteria for hedge accounting, it is prospectively discontinued and any cumulative gain or loss in equity remains in equity and is recognized in financial result when the hedged item or transaction affects profit or loss. If the hedged item or transaction is settled in advance, discontinued or is not expected to occur, the cumulative gain or loss in equity is immediately transferred to financial result.

 

(a)               Non-hedge accounting transactions

 

(a.i)     Currency swaps

 

            The subsidiary Braskem Argentina has receivables and cash in Argentine peso. Due to the Company’s risk management strategy, Argentine peso–U.S. dollar swap operations were contracted with the purpose of mitigating exchange risk, hedging the amount generated by Braskem operations in the country.

            

Identification

 

Nominal value

 

Hedge

 

Maturity

 

 

 

Fair value

 

US$

 

(argentine peso / US$)

   

2015

 

2014

NDF I

 

15,000

 

9.1100

 

February-2015

   

606

NDF II

 

10,000

 

9.1100

 

February-2015

   

404

NDF III

 

10,000

 

9.1000

 

February-2015

   

373

NDF XXII

 

20,000

 

10.7000

 

February-2016

 

(16,329)

 

NDF XXIII

 

34,000

 

11.5000

 

March-2016

 

(22,661)

 
   

89,000

         

(38,990)

 

1,383

                     

Derivatives operations

                   

Current assets

             

(41,046)

 

 

Current liabilities

             

2,056

 

1,383

Total

             

(38,990)

 

1,383

 

(b)               Hedge accounting transactions

 

(b.i)     Exchange rate swap linked to NCEs

 

In line with the Company’s risk management strategy and based on its Financial Policy, the Management contracted swap operations to offset the CDI and currency risks arising from the financings mentioned in Note 14(c), by maintaining its exposure to long-term financial liabilities in the U.S. dollar.

 

To measure the fair value of derivatives, Braskem adopts PTAX disclosed by the Central Bank on December 31, 2015 as USD/BRL benchmark rate. Due to the high volatility of exchange rate on December 31, 2015, the exchange rate disclosed by the Central Bank differed slightly from the year-end.

 

48


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

Identification

     

Hedge

 

Maturity

 

Fair value

 

Nominal value

 

(Exchange variation
+ interest rate)

   

2015

 

2014

Swap NCE I

 

200,000

 

6.15%

 

August-2019

 

301,325

 

155,961

Swap NCE II

 

100,000

 

6.15%

 

August-2019

 

147,021

 

75,373

Swap NCE III

 

100,000

 

6.15%

 

August-2019

 

144,496

 

73,565

Swap NCE IV

 

100,000

 

5.50%

 

April-2019

 

124,071

 

57,906

Swap NCE V

 

100,000

 

5.50%

 

April-2019

 

123,966

 

57,831

Swap NCE VI

 

150,000

 

7.90%

 

April-2019

 

203,675

 

80,506

Swap NCE VII

 

100,000

 

4.93%

 

April-2019

 

127,571

 

59,686

Total

 

850,000

         

1,172,125

 

560,828

                   

 

Derivatives operations

                   

Current assets

             

(12,616)

 

(33,555)

Non-current liabilities

             

1,184,741

 

594,383

Total

         

1,172,125

 

560,828

 

 

(b.ii)       Hedge operation by Braskem Idesa related to project finance

 

(b.ii.i)     Interest rate swap linked to Libor

 

 

Identification

 

Nominal value

 

Hedge

 

Maturity

 

 

 

Fair value

 

US$

 

(interest rate per year)

   

2015

 

2014

Swap Libor I

 

299,996

 

1.9825%

 

May-2025

 

7,997

 

790

Swap Libor II

 

299,996

 

1.9825%

 

May-2025

 

8,050

 

870

Swap Libor III

 

299,996

 

1.9825%

 

May-2025

 

7,956

 

775

Swap Libor IV

 

129,976

 

1.9825%

 

May-2025

 

3,465

 

330

Swap Libor V

 

132,996

 

1.9825%

 

May-2025

 

3,569

 

386

Swap Libor VI

 

149,932

 

1.9825%

 

May-2025

 

4,036

 

391

Total

 

1,312,892

         

35,073

 

3,542

                     

Derivatives operations

                   

Non-current assets

             

(12,280)

 

(39,350)

Current liabilities

             

47,353

 

42,892

Total

             

35,073

 

3,542

 

This hedge operation shares the same guarantees with the Project Finance.

 

(c)               Value at risk

 

The value at risk of the derivatives held by Braskem which is defined as the loss that could result in one month as from December 31, 2015, with a probability of 5%, and under normal market conditions, was estimated by the Company at US$58,452 for the NCE exchange swap (Note 16.2.1(b.i)), US$5,180 for U.S. dollar to Argentine peso swap (Note 16.2.1 (a.i)); US$318 to the interest rate NCE swap  and US$22,492 for the swap of Libor related to Braskem’s project in Mexico.

 

49


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

16.3     Non-derivative financial liabilities designated to hedge accounting

 

(a.i)     Future exports in U.S. dollars

 

On May 1, 2013, Braskem S.A. designated non-derivative financial instrument liabilities, denominated in U.S. dollars, as hedge for the flow of its highly probable future exports. Thus, the impact of exchange rates on future cash flows in dollars derived from these exports will be offset by the foreign exchange variation on the designated liabilities, partly eliminating the volatility of results. The exchange rate at the date of designation was US$1: R$2.0017.

 

Hedged exports amounted to US$6,757,231, as shown below:

 

 

 

 

Total nominal value

   

US$

 

 

 

2016

 

839,447

2017

 

829,685

2018

 

787,893

2019

 

733,980

2020

 

724,000

2021

 

716,000

2022

 

719,000

2023

 

718,372

2024

 

688,854

 

 

6,757,231

 

The Company considers these exports in the selected period (2016/2024) as highly probable, based on the following factors:

 

 

In order to maintain consistency between the parent company’s results and the consolidated results, the Company selected the hedge instruments with subsidiaries abroad observing the existence of guarantees arising from their operations with third parties. As a result, non-derivative financial liabilities in which the foreign subsidiary acted as an intermediary of the Parent Company in the operations were selected, which effectively maintained the essence of the transactions.

 

On December 31, 2015, the original maturities of the financial liabilities designated as this hedge, within the scope of the consolidated balance sheet, were as follows:

 

50


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

 

 

Total nominal value

   

US$

 

 

 

2016

 

2,258,395

2017

 

105,143

2018

 

1,152,281

2019

 

444,236

2020

 

570,782

2021

 

1,017,703

2022

 

519,837

2024

 

688,854

 

 

6,757,231

 

As the two preceding charts show, export and settlement flows of designated liabilities are not necessarily equivalent per year. To ensure the continuity of the proposed relationship, the Company, in keeping with its hedge strategy, plans to refinance and/or substitute these hedge instruments to adjust them to the schedule and value of the hedged exports. In this regard, the financing facilities considered in the hedge position (export credit notes, bonds and export prepayment agreements) will be renegotiated in accordance with the needs of the Company and in line with its strategy the Company may also substitute financing facilities designated as hedge, always seeking to maintain the proposed protection. Trade payables, especially naphtha, were also considered in the transaction. The rollover or substitution of these liabilities are also considered in the strategy of this hedge. The rollover or replacement of the hedge instrument are provided for in IAS 39 (paragraph 91) and CPC 38. It is important to note that the long period of export flows does not affect the ability of the Company to rollover and/or refinance its liabilities. If the refinancing and/or rolling over of these liabilities does not occur, the exchange variation related to the period in which the hedge was in effect will be recorded under “Other comprehensive income” until the exports are realized.

 

Given favorable market conditions, the Company may prepay or lengthen the maturity of designated liabilities to beyond the periods of the hedged exports. If these transactions do come to occur and cause any inefficiency to the hedge position, they must be discontinued due to their ineffectiveness. In this case, the exchange variation related to the period in which the hedge was effective will be recorded under “Other comprehensive income” until the exports are realized.

 

For the purposes of analyzing the prospective and retroactive effectiveness of the transactions, the Company used the dollar offset and volatility reduction methods, respectively.

 

The realizations expected for 2016 will occur through the payments of financial instruments in conformity with exports made, and the exchange variation recorded in “Other comprehensive income” will be written off to the financial results. Below is the quarterly schedule of hedged exports in 2016:

 

 

 

Total nominal

 

 

value US$

 

 

 

First quarter

 

206,951

Second quarter

 

210,752

Third quarter

 

210,835

Fourth quarter

 

210,909

 

 

839,447

51


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(a.ii)    Liabilities related to the Project Finance of future sales in U.S. dollar

 

On October 1, 2014, the subsidiary Braskem Idesa designated its liabilities in the amount of R$2,878,936 related to Project Finance, denominated in U.S. dollar, as hedge instruments to protect highly probably future sales flows. Due to the new disbursements by the project's financiers in April and September 2015 (Note 15), Braskem Idesa designated the respective amounts of US$290,545 and US$23,608 for hedge accounting. Therefore, the impact of exchange variation on future flows of sales in U.S. dollar derived from these sales in dollar will be offset by the exchange variation on the designated liabilities, partially eliminating the volatility in the results of the subsidiary.

 

The Management of Braskem Idesa believes these exports are highly probable, based on the following:

 

 

On December 31, 2015, hedged sales and the maturities of financial liabilities amounted to US$3,193,089 and were distributed as follows:

 

 

 

 

Total nominal value

   

US$

 

 

 

2016

 

67,774

2017

 

183,253

2018

 

221,790

2019

 

229,270

2020

 

266,690

2021

 

303,392

2022

 

253,204

2023

 

333,093

2024

 

359,559

2025

 

357,903

2026

 

309,240

2027

 

152,103

2028

 

124,654

2029

 

31,164

 

 

3,193,089

 

For the purposes of analyzing the prospective and retroactive effectiveness of the transactions, the Company used the dollar offset and volatility reduction coefficient methods, respectively.

 

52


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

The realizations expected for 2016 will occur as of May through the beginning of payments of project finance, and the exchange variation recorded in “Other comprehensive income” will be written off to the financial results. Below is the quarterly schedule of hedged exports in 2016:

 

 

 

Total nominal

 

 

value US$

 

 

 

Second quarter

 

16,359

Third quarter

 

25,084

Fourth quarter

 

26,331

 

 

67,774

 

16.4     Credit quality of financial assets

 

(a)               Trade accounts receivable

 

Virtually none of Braskem’s clients have risk ratings assigned by credit rating agencies. For this reason, Braskem developed its own credit rating system for all accounts receivable from domestic clients and for part of the accounts receivable from foreign clients. Braskem does not apply this rating to all of its foreign clients because most accounts receivable from them are covered by an insurance policy or letters of credit issued by banks. On December 31, 2015, the credit ratings for the domestic market were as follows:

 

 

 

 

 

 

(%)

 

 

 

2015

 

2014

1

Minimum risk

 

7.67

 

5.09

2

Low risk

 

42.84

 

40.23

3

Moderate risk

 

33.07

 

30.81

4

High risk

 

13.74

 

23.15

5

Very high risk

(i)

2.69

 

0.72

 

 

 

 

 

 

(i) Most clients in this group are inactive and the respective accounts are in the process of collection actions in the courts. Clients in this group that are still active buy from Braskem and pay in advance.

 

Default indicators for the years ended:

 

 

Last 12 months

 

Domestic market

 

Export market

December 31, 2015

0.39%

 

0.70%

December 31, 2014

0.65%

 

0.18%

December 31, 2013

0.14%

 

0.13%

 

 

 

 

 

53


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(b)               Other financial assets

 

In order to determine the credit ratings of counterparties of assets recorded in “Cash and cash equivalents” and “Financial investments”, Braskem uses the following credit rating agencies: Standard & Poor’s, Moody’s and Fitch Ratings. Braskem’s Financial Policy determines “A-” as the minimum rating for financial investments.

                                       

 

     

2015

 

2014

Financial assets with risk assessment

       

 

AAA

   

5,982,393

 

3,765,527

AA

   

27,753

 

65,304

AA-

   

163,188

 

 

A+

   

1,076,803

 

53,229

A

   

69,576

 

180,233

A-

   

120,219

 

13,648

     

7,439,932

 

4,077,941

Financial assets without risk assessment

         

Quotas of investment funds in credit rights

 

(i)

46,193

 

42,495

Other financial assets with no risk assessment

   

963

 

5,146

     

47,156

 

47,641

           

Total

   

7,487,088

 

4,125,582

 

(i)         Investiments approved by Management of the Company, as permitted by policy.

 

16.5          Sensitivity analysis

 

Financial instruments, including derivatives, may be subject to changes in their fair value as a result of the variation in commodity prices, foreign exchange rates, interest rates, shares and share indexes, price indexes and other variables. The sensitivity of the derivative and non-derivative financial instruments to these variables are presented below:

 

(a)               Selection of risks

 

On December 31, 2015, the main risks that can affect the value of Braskem’s financial instruments are:

 

·      Brazilian real/U.S. dollar exchange rate;

·      Mexican peso/Brazilian real exchange rate;

·      Libor floating interest rate;

·      Selic interest rate;

·      CDI interest rate; and

·      TJLP interest rate.

 

For the purposes of the risk sensitivity analysis, Braskem presents the exposures to currencies as if they were independent, that is, without reflecting in the exposure to a foreign exchange rate the risks of the variation in other foreign exchange rates that could be directly influenced by it.

 

(b)               Selection of scenarios

 

In accordance with CVM Instruction No. 475/08, Braskem included three scenarios in the sensitivity analysis, with one that is probable and two that represent adverse effects to the Company. In the preparation of the adverse scenarios, only the impact of the variables on the financial instruments, including derivatives, and on the items covered by hedge transactions, was considered. The overall impacts on Braskem’s operations, such as those arising from the revaluation of inventories and revenue and future costs, were not considered. Since Braskem manages its exposure to foreign exchange rate risk on a net basis, adverse effects from depreciation in the Brazilian real in relation to the U.S. dollar can be offset by opposing effects on Braskem’s operating results.

 

54


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(b.1)    Probable scenario

 

The Market Readout published by the Central Bank of Brazil on December 31, 2015 was used to create the probable scenario for the U.S. dollar/Brazilian real exchange rate, the Selic interest rate and the CDI interest rate, using that same date as reference. The Market Readout presents a consensus of market expectations based on a survey of the forecasts made by various financial and non-financial institutions. According to the Market Readout, at the end of 2016, the U.S. dollar will appreciate by 7.23% against the Brazilian real compared to end-2015, and the CDI and Selic rate will reach 14.97%.

 

The probable scenario for the TJLP is an increase of 0.50% from the current rate of 7.5%, in line with the size of the Government’s most recent decisions to increase or decrease the rate. The Market Readout does not publish forecasts for the Libor interest rate. Therefore, to determine the probable scenario, Braskem considered a 5% increase on current market levels.

 

(b.2)    Possible and extreme adverse scenarios

 

The sensitivity values in the table below are the changes in the value of the financial instruments in each scenario:

 

 

       

Possible adverse

 

Extreme adverse

Instrument / Sensitivity

 

Probable

(25%)

 

(50%)

             

Brazilian real/U.S. dollar exchange rate

           

Bonds and MTN

 

(1,525,934)

 

(4,193,740)

 

(8,387,480)

BNDES

 

(37,212)

 

(102,269)

 

(204,538)

Working capital / structured operations

 

(301,310)

 

(828,093)

 

(1,656,186)

Export prepayments

 

(48,198)

 

(132,463)

 

(264,927)

Project finance

 

(1,114,381)

 

(3,062,665)

 

(6,125,331)

Exchange Agreement Advances

 

(23,270)

 

(63,952)

 

(127,904)

Swaps

 

(189,726)

 

(331,701)

 

(853,128)

Financial investments abroad

 

561,061

 

1,541,971

 

3,083,941

   

-

 

-

 

-

Mexican peso/Brazilian real

 

-

 

-

 

-

Project finance

 

(3,322)

 

(6,693)

 

(13,385)

   

Libor floating interest rate

 

Working capital / structured operations

 

(3,987)

 

(19,937)

 

(39,874)

Export prepayments

 

(3,316)

 

(16,582)

 

(33,165)

Swaps

 

(8,840)

 

(14,209)

 

(28,658)

   

Selic interest rate

 

BNDES

 

(19,358)

 

(101,073)

 

(216,258)

   

CDI interest rate

 

Swaps Export credit notes

 

(23,784)

 

(122,213)

 

(256,225)

Foreign loans / other in local currency

 

(537)

 

(2,741)

 

(5,702)

Agricultural credit note

 

(35,039)

 

(184,950)

 

(401,253)

Swaps NCE

 

(107)

 

(443)

 

(84,010)

Financial investments in local currency

 

8,851

 

43,829

 

87,740

   

 

 

 

 

 

   

Probable

 

Possible adverse

 

Extreme adverse

Instrument / Sensitivity

 

7.5%

 

8.0%

 

8.5%

             

TJLP interest rate

 

BNDES

 

178

 

361

 

548

FINEP

 

(29,907)

 

(60,106)

 

(90,597)

Other government agencies

 

(64)

 

(130)

 

(197)

 

55


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

17                Taxes payable

 

         

Consolidated

 

Parent company

         

2015

 

2014

 

2015

 

2014

Parent Company and subsidiaries in Brazil

-

               
 

IPI

 

-

 

61,784

 

53,536

 

48,579

 

46,518

 

IR and CSL

 

-

 

175,963

 

31,474

 

31,325

 

27,847

 

ICMS

 

-

 

149,811

 

99,328

 

110,669

 

26,758

 

Other

 

-

 

88,198

 

45,177

 

56,557

 

47,207

     

-

 

Other countries

 

-

 
 

IR

     

238,645

 
 

Value-added tax

 

-

 

56,975

 

4,576

 

Total

 

-

 

771,376

 

234,091

 

247,130

 

148,330

     

-

             

Current liabilities

 

-

 

744,660

203,392

 

221,305

117,696

Non-current liabilities

 

-

 

26,716

30,699

 

25,825

30,634

Total

 

-

 

771,376

234,091

 

247,130

148,330

 

18                Ethylene XXI Project Loan

 

The contribution made by the shareholders to the subsidiary Braskem Idesa project (Note 11(d)) can be made via capital or subordinated loan. The loan recorded under this item of the balance sheet is owed to the non-controlling shareholder of Braskem Idesa, and will be paid exclusively with the cash generation from the project. Since this is a subordinated loan to the project finance (Note 15), it will be paid only when a series of obligations related to project finance have been fulfilled. Such obligations include, but are not limited to: (i) debt service payments envisaged until the date; (ii) maintenance of the balance required in the project reserve accounts; and (iii) achievement of specific liquidity and coverage indices prospectively and retrospectively. The loan is denominated in U.S. dollar, carries interest of 7% p.a., and its payment schedule depends on the project’s cash flow.

 

56


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

19                Income tax (“IR”) and social contribution (“CSL”)

 

19.1     Reconciliation of the effects of income tax and social contribution on profit or loss

 

 

   

Consolidated

 

Parent company

   

2015

 

2014

 

2015

 

2014

                 

Income before IR and CSL

 

4,559,685

 

1,178,565

 

4,525,451

 

940,706

                 

IR and CSL at the rate of 34%

 

(1,550,293)

 

(400,712)

 

(1,538,653)

 

(319,840)

                 

Permanent adjustments to the IR and CSL calculation basis

               

IR and CSL on equity in results of investees

 

755

 

23,815

 

246,678

 

357,289

Effects from pre-payment of taxes

   

41,046

 

 

 

41,046

Interests on own capital

   

 

 

(34,457)

 

(27,982)

Other permanent adjustments

(i)

(111,367)

 

(116,413)

 

(58,708)

 

(127,155)

                 

Effect of IR and CSL on results of operations

 

(1,660,905)

 

(452,264)

 

(1,385,140)

 

(76,642)

                 

Breakdown of IR and CSL:

               
                 

Current IR and CSL

 

(406,336)

 

(57,806)

 

(2,725)

 

 

Deferred IR and CSL

 

(1,254,569)

 

(394,458)

 

(1,382,415)

 

(76,642)

Total IR and CSL on income statement

 

(1,660,905)

 

(452,264)

 

(1,385,140)

 

(76,642)

 

(i)       Includes the impact from the difference between IR/CSL tax rate in Brazil (34%) used for the preparation of this note and the tax rates in countries where the subsidiaries abroad are located, as follows:

 

     

Official rate - %

     

Headquarters

   
     

(Country)

 

2015

           

Braskem Alemanha

 

Germany

 

31.00

Braskem America e Braskem America Finance

 

USA

 

35.00

Braskem Argentina

 

Argentina

 

35.00

Braskem Austria e Braskem Austria Finance

 

Austria

 

25.00

Braskem Petroquímica Chile

 

Chile

 

22.50

Braskem Holanda, Braskem Holanda Finance e Braskem Holanda Inc

 

Netherland

 

25.00

Braskem Idesa, Braskem Idesa Serviços, Braskem México

       

    Braskem México Serviços e Braskem México Sofom

 

Mexico

 

30.00

 

In the consolidated, the effective rate is 36.43% (2014 – 38.37%), and in the parent company, the effective rate is 30.61% (2014 – 8.15%).

 

 

19.2          Deferred income tax and social contribution

 

The income tax (“IR”) and social contribution (“CSL”) recorded in the year are determined on the current and deferred tax basis. These taxes are calculated on the basis of the tax laws enacted at the balance sheet date in the countries where the Company operates and are recognized in the statement of operations, except to the extent they relate to items directly recorded in equity.

 

Deferred income tax and social contribution are mainly recognized on the following bases: (i) tax losses and social contribution tax loss carryforwards; (ii) temporarily non-taxable and nondeductible income and expenses, respectively; (iii) tax credits and expenses that will be reflected in the books in subsequent periods; and (iv) asset and liability amounts arising from business combinations that will be treated as income or expenses in the future and that will not affect the calculation of income tax and social contribution.

 

57


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

(a)               Breakdown of and changes in deferred IR and CSL

 

  

   

 

 

 

 

 

 

Consolidated

Assets

 

As of December 31, 2014

 

Impact on the P&L

 

Impact on the equity

 

As of December 31, 2015

Tax losses (IR) and negative base (CSL)

 

444,406

 

1,700,392

   

2,144,798

Goodwill amortized

 

7,411

 

(1,394)

   

6,017

Exchange variations

 

1,302,801

 

1,623,094

   

2,925,895

Temporary adjustments

 

789,330

 

(41,310)

 

(697,392)

 

50,628

Business combination

 

187,859

 

1,544

   

189,403

Pension plan

 

104,227

 

(104,227)

   

 

Deferred charges - write-off

 

24,854

 

(4,006)

   

20,848

   

2,860,888

 

3,174,093

 

(697,392)

 

5,337,589

                 

Liabilities

               

Amortization of goodwill based on future profitability

 

699,179

 

35,840

   

735,019

Tax depreciation

 

694,039

 

121,204

   

815,243

Exchange variations

 

(1,273)

 

1,273

   

 

Temporary differences

 

416,230

 

711,771

 

(606,971)

 

521,030

Business combination

 

232,301

 

(15,119)

   

217,182

Write-off negative goodwill of incorporated subsidiaries

 

594

 

(594)

   

 

Additional indexation PP&E

 

124,762

 

(14,031)

   

110,731

Hedge accounting

 

0

 

3,573,540

 

(3,573,540)

 

 

Amortization of fair value adjustments on

the assets from the acquisiton of Quattor

 

313,422

 

(23,894)

   

289,528

Other

 

114,918

 

38,672

   

153,590

   

2,594,172

 

4,428,662

 

(4,180,511)

 

2,842,323

                 

Net

 

266,716

 

(1,254,569)

 

3,483,119

 

2,495,266

                 

Presentation in the balance sheet:

               

Non-current assets

 

870,206

   

3,226,507

(-) Non-current liabilities

 

603,490

         

731,241

 

58


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

   

 

 

 

 

 

 

Parent company

Assets

 

As of December 31, 2014

 

Impact on the P&L

 

Impact on the equity

 

As of December 31, 2015

                 

Tax losses (IR) and negative base (CSL)

 

276,727

 

11,558

   

288,285

Goodwill amortized

 

7,411

 

(1,394)

   

6,017

Exchange variations

 

1,302,801

 

1,614,899

   

2,917,700

Temporary adjustments

 

526,377

 

297,407

   

823,784

Business combination

 

89,770

 

 

   

89,770

Pension plan

 

104,226

 

(104,226)

   

 

Deferred charges - write-off

 

20,848

 

 

     

20,848

   

2,328,160

 

1,818,244

     

4,146,404

               

Liabilities

             

Amortization of goodwill based on future profitability

 

612,277

 

33,917

   

646,194

Tax depreciation

 

633,414

 

113,018

   

746,432

Temporary differences

 

11,704

 

(2)

   

11,702

Business combination

 

81,349

 

(2,195)

   

79,154

Write-off negative goodwill of incorporated subsidiaries

 

593

 

(593)

   

 

Additional indexation PP&E

 

124,762

 

(14,031)

   

110,731

Other

 

57,335

 

25,973

   

83,308

Amortization of fair value adjustments on the assets from the acquisiton of Quattor

 

313,423

 

(23,895)

   

289,529

Hedge accounting

 

 

 

3,068,467

 

(3,068,467)

 

 

   

1,834,857

 

3,200,659

 

(3,068,467)

 

1,967,050

                 

Net (non-current assets)

 

493,303

 

(1,382,415)

 

3,068,467

 

2,179,354

 

59


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(b)               Net balance of deferred income and social contribution tax assets and liabilities

(c)                                         

 

         

 

 

2015

         

Headquarters

 

 

 

IR and CSL

 

 

       

(Country)

 

Asset

 

Liability

 

Balance

                     

Assets

                   

Braskem S.A.

     

Brazil

 

4,146,404

 

(1,967,050)

 

2,179,354

Braskem Argentina

     

Argentina

 

8,235

   

8,235

Braskem Alemanha

     

Germany

 

104,785

   

104,785

Braskem Idesa

     

Mexico

 

890,723

 

(65,306)

 

825,417

Braskem México Serviços

     

Mexico

 

2,894

 

 

 

2,894

Quantiq

     

Brazil

 

7,811

 

(1,623)

 

6,188

Braskem Petroquímica - business combination effects

 

Brazil

 

99,634

 

 

 

99,634

             

5,260,486

 

(2,033,979)

 

3,226,507

Liabilities

                   

Braskem Petroquímica - business combination effects

 

Brazil

 

 

 

(138,029)

 

(138,029)

Braskem Petroquímica

     

Brazil

 

76,978

 

(160,812)

 

(83,834)

Petroquímica Chile

     

Chile

 

 

 

(509,328)

 

(509,328)

Braskem America

     

USA

 

125

 

(175)

 

(50)

           

77,103

 

(808,344)

 

(731,241)

 

           

 

         

 

 

2014

         

Headquarters

 

 

 

IR and CSL

 

 

         

(Country)

 

Asset

 

Liability

 

Balance

                       

Assets

                   

Braskem S.A.

     

Brazil

 

2,328,160

 

(1,834,857)

 

493,303

Braskem Argentina

     

Argentina

 

3,772

   

3,772

Braskem Alemanha

     

Germany

 

88,999

   

88,999

Braskem Idesa

     

Mexico

 

231,504

 

(52,463)

 

179,041

Quantiq

     

Brazil

 

8,393

 

(1,392)

 

7,001

Braskem Petroquímica - business combination effects

 

Chile

 

98,090

 

 

 

98,090

             

2,758,918

 

(1,888,712)

 

870,206

                       

Liabilities

                   

Braskem Petroquímica - business combination effects

 

Brazil

 

 

 

(150,951)

 

(150,951)

Braskem Petroquímica

     

Brazil

 

101,919

 

(149,897)

 

(47,978)

Petroquímica Chile

     

Chile

 

51

 

(84)

 

(33)

Braskem America

     

USA

 

 

 

(404,528)

 

(404,528)

             

101,970

 

(705,460)

 

(603,490)

 

The tax losses and negative social contribution bases do not expire under the Brazilian taxation regime and tax losses do not expire in Germany.

                 

60


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(c)        Realization of deferred income tax and social contribution

                  

       

 

 

 

 

Consolidated

 

 

 

Parent company

       

Balance at

 

Realization

 

Balance at

 

Realization

       

December 31,

     

2017 and

 

2019 and

 

2021

 

December 31,

     

2017 and

 

2019 and

 

2021

Assets

 

Note

 

2015

 

2016

 

2018

 

2020

 

thereafter

 

2014

 

2016

 

2018

 

2020

 

thereafter

                                             

Tax losses (IR) and negative base (CSL)

 

(i)

 

2,144,798

 

137,840

 

780,823

 

772,028

 

454,107

 

288,285

 

26,705

 

132,443

 

124,428

 

4,709

Goodwill amortized

 

 

 

6,017

 

1,102

 

1,820

 

965

 

2,130

 

6,017

 

1,165

 

1,825

 

702

 

2,325

Exchange variations

 

(ii)

 

2,925,895

   

2,925,895

 

2,917,700

   

2,917,700

Temporary adjustments

 

(iii)

 

50,628

 

22,300

 

1,216

 

802

 

26,310

 

823,784

 

559,093

 

19,570

 

19,570

 

225,551

Business combination

 

(iv)

 

189,403

   

189,403

 

89,770

   

89,770

Deferred charges - write-off

 

(v)

 

20,848

 

9,273

 

11,575

   

20,848

 

9,273

 

11,575

 

 

 

 

     

5,337,589

 

170,515

 

795,434

 

773,795

 

3,597,845

 

4,146,404

 

596,236

 

165,413

 

144,700

 

3,240,055

                                           

Liabilities

                                         

Amortization of goodwill based on future

   profitability

(vi)

 

735,019

   

735,019

 

646,194

   

646,194

Tax depreciation

 

(vii)

 

815,243

   

815,243

 

746,432

   

746,432

Temporary differences

 

(viii)

 

521,030

 

54,074

 

108,147

 

109,737

 

249,072

 

11,702

 

930

 

1,859

 

4,092

 

4,821

Business combination

 

(ix)

 

217,182

 

15,018

 

30,036

 

30,036

 

142,092

 

79,154

 

2,086

 

4,169

 

4,169

 

68,730

Additional indexation PP&E

 

(x)

 

110,731

 

11,085

 

22,170

 

22,170

 

55,306

 

110,731

 

11,085

 

22,171

 

22,170

 

55,305

Amortization of fair value adjustments on

the assets from the acquisiton of Quattor

 

(ix)

 

289,528

 

66,591

 

66,591

 

66,591

 

89,755

 

289,529

 

66,592

 

66,592

 

66,592

 

89,753

Other

   

153,590

   

153,590

 

83,308

   

83,308

     

2,842,323

 

146,768

 

226,944

 

228,534

 

2,240,077

 

1,967,050

 

80,693

 

94,791

 

97,023

 

1,694,543

                                           

Net

   

2,495,266

 

23,747

 

568,490

 

545,261

 

1,357,768

 

2,179,354

 

515,543

 

70,622

 

47,677

 

1,545,512

 

Basis for constitution and realization:

 

(i)         In Brazil and Germany, the use of tax losses is limited to the taxable income for the year. In Brazil, this limit is 30%, whereas in Germany is 60%.

(ii)       In Brazil, the Company opted to tax exchange variation of assets and liabilities denominated in foreign currency under the cash method. Thus, this variation will be realized as assets and liabilities are received/paid. For accounting purposes, exchange variation is recognized under the accrual basis, which results in deferred IR and CSL.

(iii)      Accounting expenses not yet deductible for calculating income tax and social contribution, whose recognition for tax purposes occurs in subsequent periods.

(iv)     Refers to: tax-related goodwill, and contingencies recognized from business combinations. Tax realization of goodwill will occur upon the merger of the investments and contingencies arising from write-offs due to the settlement or reversal of the processes involved.

(v)       Amounts constituted based on the deferred assets written off due to the adoption of Law 11,638/07. Tax realization is based on the application of the amortization rate used prior to the adoption of this law.

(vi)     Goodwill for the future profitability of the merged companies not amortized since the adoption of Law 11,638/07. Tax realization is associated with the write-off of goodwill-generated assets due to impairment or any other reason.

(vii)    For calculation of IR and CSL, assets are depreciated at rates higher than those used for accounting purposes. As tax depreciation is exhausted, these deferred IR and CSL start to be realized.

(viii)  Revenues whose taxation will occur in subsequent periods.

(ix)     Fair value adjustments on property, plant and equipment and intangible assets identified in business combinations, whose tax realization is based on the depreciation and amortization of these assets.

(x)       Additional adjustment of property, plant and equipment, whose tax realization is based on the depreciation of assets.

 

Considering the limitations to the use of tax losses in Brazil and Germany and the known impacts on the position of deferred taxes, the Company estimates that it will be necessary to generate taxable income of around R$3,748,648 in the following years to realize its deferred tax assets registered on December 31, 2015.

 

Annually, the Company revises its projection of taxable income based on its Business Plan (Note 3.1). If this projection indicates that the taxable income will not be sufficient to absorb the deferred taxes, the amount corresponding to portion of the asset that will not be recovered is written off.

 

61


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

19.3          Federal Law 12,973/14

 

Federal Law 12,973 of May 13, 2014, created from the conversion of Provisional Presidential Decree 627 of November 11, 2013, among others, revoked the Transitional Tax System (RTT) and included additional measures.

 

The provisions in this law are applicable from 2015, except in the event of early adoption in 2014. The Company opted for said early adoption.

 

20                Sundry provisions

 

       

Consolidated

 

Parent company

       

2015

 

2014

 

2015

 

2014

Provision for customers rebates

(a)

 

46,929

 

66,702

 

22,606

 

31,572

Provision for recovery of environmental damages

(b)

 

127,227

 

102,534

 

112,887

 

98,659

Judicial and administrative provisions

(c)

 

554,479

 

412,811

 

501,292

 

362,733

Other

   

19,279

 

12,177

 

1,754

 

 

Total

   

747,914

 

594,224

 

638,539

 

492,964

                   

Current liabilities

   

93,942

 

88,547

 

67,190

 

53,049

Non-current liabilities

 

653,972

 

505,677

 

571,349

 

439,915

Total

   

747,914

 

594,224

 

638,539

 

492,964

 

(a)               Provision for client bonus

 

Some sales agreements of Braskem provide for a rebate, in products, should some sales volumes be achieved within the year, six-month period or three-month period, depending on the agreement. The bonus is recognized monthly in a provision, assuming that the minimum contractual amount will be achieved. As it is recognized based on contracts, the provision is not subject to significant uncertainties with respect to their amount or settlement.  

 

(b)               Provision for recovery of environmental damages

 

Braskem has a provision for future expenses for the recovery of environmental damages in some of its industrial plants. The amount provisioned corresponds to the best and most conservative estimate of the expenses required to repair the damages.

 

It is worth emphasizing that the Company is not legally obliged to recover areas because of its operations.

 

62


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(c)               Judicial and administrative provisions

 

       

Consolidated

 

Parent company

       

2015

 

2014

 

2015

 

2014

Labor claims

 

(c.1)

 

158,711

 

141,240

 

148,884

 

127,311

   

 

 

Tax claims

 

(c.2)

 

Income tax and social contribution

(i)

 

48,252

 

35,682

 

8,029

 

 

PIS and COFINS

(ii)

 

49,266

 

39,145

 

49,266

 

39,145

ICMS - interstate purchases

(iii)

 

195,320

 

94,732

 

195,320

 

94,732

ICMS - other

   

36,965

 

12,559

 

36,965

 

12,559

Other tax claims

 

38,337

 

88,202

 

38,317

 

87,735

     

Societary claims and other

 

27,628

 

1,251

 

24,511

 

1,251

     

554,479

 

412,811

 

501,292

 

362,733

 

(c.1)     Labor claims

 

The provision on December 31, 2015 is related to 642 labor claims, including occupational health and security cases (350 in 2014). The Company’s legal advisors estimate that the term for the termination of these types of claims in Brazil exceeds five years. The estimates related to the outcome of proceedings and the possibility of future disbursement may change in view of new decisions in higher courts. The Company’s management believes that the chances of having to increase the existing provision amount are remote.

 

(c.2)     Tax claims

 

On December 31, 2015, the main claims are the following:

 

(i)                 IR and CSL

 

The provisioned derives from assessments in the administrative level of income tax and social contribution on the foreign exchange variation in the account of investments in foreign subsidiaries in 2002. This assessment, which is conducted by Braskem Petroquímica, involves other issues for which provisions have not been accrued. There is no judicial deposit or other type of guarantee for this claim. The Company’s management expects this case to be concluded by 2018.

           

(ii)               PIS and COFINS

 

The Company is assessed for the payment of these taxes in many claims, such as:

 

·                Insufficient payment of COFINS for the period from March 1999 to December 2000, from February 2001 to March 2002, from May to July 2002 and September 2002 due to alleged calculation errors, and non-compliance with the widening the tax calculation base and increasing the contribution rate envisaged in Law 9,718/98;

 

·                Offset of the COFINS dues relating to September and October 1999 using the credit resulting from the addition of 1% to the COFINS rate;

 

·                Rejection of the offset of PIS and COFINS dues relating to the period from February to April 2002 using the PIS credits under Decree-Laws 2,445 and 2,449, calculated between June 1990 and October 1995, under the argument that the time period for using said credits had expired;  and

 

63


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

·                Alleged non-taxation of revenue from foreign exchange variations, determined as a result of successive reductions in the capital of the associated company.

 

Guarantees were offered for these claims in the form of bank guarantee and finished products manufactured by the subsidiary Braskem Petroquímica, which, together, cover the amount of the claims. The Company’s management estimates that these cases should be terminated by 2020.

 

(iii)             ICMS - interstate purchases

 

In 2009, the merged company Braskem Qpar was assessed by the Finance Department of the State of São Paulo for the payment, at the administrative level, of ICMS due to the following alleged tax offenses:

 

·                Undue use of ICMS tax credits in the amount of R$53,478,602.51, in the periods from February/2004 to August/2005, November/2005 to February/2006, and September/2006 to January/2008, due to the recording of credits indicated in the invoices for the sale of “acrylonitrile”, issued by ACRINOR  ACRILONITRILA DO NORDESTE S/A, since the products were to be exported, and were therefore exempt from payment of ICMS tax;

 

·                The fine for the abovementioned tax offense corresponds to 100% of the principal value recorded, as per Article 527, item II, sub-item “j” jointly with paragraphs 1 and 10 of RICMS/SP;

 

·                Fine in the amount of 30% over R$459,722,144.84, due to the issue of invoices under CFOP 6,905, without the corresponding product outflow, based on the provisions of Article 527, item IV, sub-item “b” jointly with paragraphs 1 and 10 of RICMS/SP; and

 

·                Fine due to lack of presentation of tax documents requested under a specific deficiency notice, as per Article 527, item IV, sub-item “j” jointly with paragraphs 8 and 10 of RICMS/SP.

 

Once the administrative discussion reached an end in 2015, legal action was filed by the Company, in which an injunction was granted suspending the payment of the tax credit due to its illiquidity, until the São Paulo Treasury Department rectifies the debt amount, by applying interest on arrears and monetary restatement limited to the SELIC basic interest rate. Based on the decision obtained in the administrative proceeding and the opinion of courts regarding the matter, the external advisers recommended to update the provision to the probable amount for settlement of the litigation.

 

64


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(d)               Changes in provisions

 

 

Consolidated

     

Recovery of

           
     

environmental

 

Legal

       
 

Bonus

 

damage

 

provisions

 

Other

 

Total

                   

December 31, 2014

66,702

 

102,534

 

412,811

 

12,177

 

594,224

 

Additions, inflation adjustments and exchange variation, net

11,269

 

66,336

 

260,287

 

7,102

 

344,994

Write-offs through usage and payments

(31,042)

 

(41,643)

 

(118,619)

   

(191,304)

 

December 31, 2015

46,929

 

127,227

 

554,479

 

19,279

 

747,914

 

     

Parent company

     

Recovery of

           
     

environmental

 

Legal

       
 

Bonus

 

damage

 

provisions

 

Other

 

Total

                   

December 31, 2014

31,572

 

98,659

 

362,733

 

 

 

492,964

                   

Additions, inflation adjustments and exchange variation, net

22,203

 

58,397

 

257,149

 

1,754

 

339,503

Write-offs through usage and payments

(31,169)

 

(44,169)

 

(118,590)

   

(193,928)

 

December 31, 2015

22,606

 

112,887

 

501,292

 

1,754

 

638,539

 

21                Benefits offered to team members

 

21.1          Short-term benefits

 

 

 

Consolidated

 

Parent company

 

2015

 

2014

 

2015

 

2014

               

Health care

126,545

 

108,841

 

83,588

 

64,834

Private pension

60,476

 

44,243

 

32,507

 

23,462

Transport

50,935

 

51,881

 

46,977

 

36,902

Feeding

27,755

 

27,453

 

22,468

 

20,261

Training

19,101

 

27,629

 

9,889

 

17,705

Other

18,789

 

18,167

 

3,909

 

2,361

 

303,601

 

278,214

 

199,338

 

165,525

 

21.2          Post-employment benefits

 

21.2.1   Retirement plans - defined benefit plans and health plants

 

Braskem America

 

The subsidiary Braskem America is the sponsor of Novamont, which is a defined benefit plan of the employees of the plant located in the State of West Virginia. At December 31, 2015, the plan has 42 active participants (53 in 2014) and 168 assisted participants (152 in 2014). The contributions by Braskem America in the year amount to R$3,557 (R$3,094 in 2014). The participants made no contributions in 2015 and 2014.

 

65


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

Braskem Alemanha

 

The subsidiary Braskem Alemanha is the sponsor of the defined benefit plan of the employees of that subsidiary. At December 31, 2015, the plan has 128 active participants (136 in 2014) and the contributions by Braskem in the year amount to R$102 (R$72 in 2014). The participants made no contributions in 2015 and 2014.

 

Health plan

 

According to Brazilian laws, the type of health plan offered by the Company, named contributory plan, ensures to the participant who retires or is dismissed without cause the right to remain in the plan with the same assistance coverage conditions they had during the employment term, provided they assume the full payment of the plan (company’s part + participant’s part). This right is granted as follows:

 

(i)          The participant who was dismissed without cause has the right to remain in the health plan for more 1/3 (one-third) of the plan contribution period, considering the minimum six-month period and the maximum twenty-four-month period.

(ii)          The participant who retires and contributes to the plan due to employment relationship over at least ten (10) years has the right to remain in the health plan for undetermined period. Should the participant have contributed for less than 10 years, they will have the right to remain ad a beneficiary for one (1) more year for each contribution year.

 

In addition to the right granted to the former participants who retired or were dismissed without cause, the Brazilian laws also establish rules for the amount charged by the plan based on beneficiaries’ age bracket. One of these rules define that the amount charged for the highest age bracket may not be six (6) times larger than the amount charged for the lowest age bracket. Thus, the amount charged from the lowest age bracket plans comprises a “subsidy” for highest age bracket plans. This subsidy is also supported by contributions from the Company. On other words, the amount charged from the participants included in the highest age brackets is not enough to cover their expenses. With this in mind, the Company sought for information and criteria to measure on an actuarial basis its current obligation for this future subsidy. Below is the conclusion of this study:

 

 

(i)                 Amounts in balance sheet

  

   

 

 

Consolidated

   

2015

 

2014

Defined benefit

       

Novamont Braskem America

23,722

 

18,356

Braskem Alemanha

76,819

 

50,820

   

100,541

 

69,176

Health insurance

       

Bradesco saúde

 

54,166

 

 

   

154,707

 

69,176

         

Benefit obligations

(146,936)

 

(100,398)

Health care

 

(54,166)

 

 

Total obligations

 

(201,102)

 

(100,398)

Fair value of plan assets

46,395

 

31,222

Funded status of the plan

(154,707)

 

(69,176)

Consolidated net balance (current liabilities)

(154,707)

 

(69,176)

 

66


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(ii)               Change in obligations

 

   

 

 

Consolidated

   

2015

 

2014

         

Balance at beginning of year

100,398

 

67,668

Health care

 

54,166

 

 

Current service cost

5,085

 

2,943

Interest cost

 

4,699

 

3,277

Special retirement

515

 

 

Reduction plan

 

734

 

 

Benefits paid

 

(3,397)

 

(1,927)

Change plan

 

 

 

1,713

Actuarial losses (gain)

(330)

 

20,766

Reduction plan (curtailment)

 

 

1,663

Exchange variation

39,232

 

4,295

Balance at the end of the year

201,102

 

100,398

 

(iii)             Change in fair value plan assets

 

   

 

 

Consolidated

   

2015

 

2014

         

Balance at beginning of year

31,222

 

23,599

Actual return on plan assets

156

 

3,343

Employer contributions

3,659

 

3,166

Benefits paid

 

(3,103)

 

(1,894)

Exchange variation

14,461

 

3,008

Balance at the end of the year

46,395

 

31,222

 

 

(iv)             Amounts recognized in profit or loss

 

   

 

 

Consolidated

   

2015

 

2014

         

Health care

 

54,166

 

 

Current service cost

5,085

 

2,957

Interest cost

 

4,699

 

3,277

Expected return on plan assets

(3,409)

 

(2,045)

Amortization of actuarial loss

1,519

 

135

Amortization of unrecognized service cost

418

 

119

Actuarial losses

 

34

 

12,511

   

62,512

 

16,954

 

The amounts recognized in the statement of operations refer to transactions involving the defined benefit plans that are recognized in “Other operating income (expenses), net” and in “Financial results”, depending on their nature.

 

67


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(v)               Actuarial assumptions

      

     

 

 

(%)

     

 

 

2015

 

 

 

2014

     

Health

 

United

     

United

   
     

insurance

 

States

 

Germany

 

States

 

Germany

                       

Discount rate

   

7.22

 

4.20

 

3.75

 

4.20

 

3.75

Inflation rate

   

6.50

 

n/a

 

2.00

 

3.00

 

1.51

Expected return on plan assets

 

n/a

 

7.50

 

n/a

 

7.50

 

n/a

Rate of increase in future salary levels

 

n/a

 

n/a

 

3.00

 

n/a

 

3.00

Rate of increase in future pension plan

 

n/a

 

n/a

 

n/a

 

n/a

 

n/a

Aging factor

   

2.50

 

n/a

 

n/a

 

n/a

 

n/a

Medical inflation

   

3.50

 

n/a

 

n/a

 

n/a

 

n/a

Duration

   

35.55

 

n/a

 

n/a

 

n/a

 

n/a

 

 

(vi)             Hierarchy of fair value assets

 

On December 31, 2015, the balance of the fair value of assets is represented by the assets of the Novamont defined benefit plan, which has a level-1 fair value hierarchy.

 

(vii)           Sensitivity analysis

 

 

           

 

 

 

 

Impact on the defined benefit obligation

   

Premise change

 

Premise increase

 

Premise reduction

   

Health

 

United

     

Health

 

United

     

Health

 

United

   
   

insurance

 

States

 

Germany

 

insurance

 

States

 

Germany

 

insurance

 

States

 

Germany

Discount rate

 

1%

 

0.5%

 

0.5%

 

13,282

 

4,233

 

8,008

 

(17,950)

 

4,690

 

8,967

Real medical inflation

 

1%

 

n/a

 

n/a

 

17,537

 

n/a

 

n/a

 

(10,389)

 

n/a

 

n/a

Rate of increase in future salary levels

 

n/a

 

n/a

 

0.5%

 

n/a

 

n/a

 

4,072

 

n/a

 

n/a

 

(3,816)

Rate of increase in future pension plan

 

n/a

 

n/a

 

0.3%

 

n/a

 

n/a

 

2,417

 

n/a

 

n/a

 

(2,340)

Life expectancy

 

n/a

 

n/a

 

1 year

 

n/a

 

n/a

 

1,834

 

n/a

 

n/a

 

(1,915)

Mortality rate

 

n/a

 

10.0%

 

n/a

 

n/a

 

1,991

 

n/a

 

n/a

 

2,175

 

n/a

                                     
                                     
           

Health insurance - Impact on cost of services and interests costs

               

Premise change

 

Premise increase

 

Premise reduction

               

Cost of

 

Iterests

 

Cost of

 

Iterests

 

Cost of

 

Iterests

               

services

 

costs

 

services

 

costs

 

services

 

costs

Discount rate

             

1%

 

1%

 

(75)

 

(365)

 

125

 

447

Real medical inflation

             

1%

 

1%

 

135

 

622

 

(46)

 

(369)

 

21.2.2    Retirement plan - defined contribution

The Parent Company and the subsidiaries in Brazil sponsor a defined contribution plan for its employees managed by ODEPREV, a private pension plan entity. ODEPREV offers its participants, which are employees of the sponsoring companies, an optional defined contribution plan in which monthly and additional participant contributions and monthly and annual sponsor contributions are made to individual pension savings accounts. For this plan, the sponsors pay contributions to private pension plan on contractual or voluntary bases. As soon as the contributions are paid, the sponsors do not have any further obligations related to additional payments.

 

68


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

At December 31, 2015, the number of active participants in ODEPREV totals 5,331 (5,545 in 2014). The contributions made by the sponsors in the year amount to R$29,852 (R$28,245 in 2014) and the contributions made by the participants amounted to R$50,899 (R$50,227 in 2014).

 

21.2.3    Others – Petros Plan

On January 6, 2015, the Brazilian Private Pension Plan Superintendence (PREVIC - Superintendência Nacional de Previdência Complementar) issued an official letter to the Management of Braskem requesting the contribution related to the capital deficit of the Petros Copesul plan on the date of the withdrawal of the sponsorship (October 2012), restated by the IPCA consumer price index + 6% p.a. through December 31, 2014. The amount, restated as mentioned earlier, was settled in February 2015 in the amount of R$358,563.

 

22                Other accounts payable

 

(a)               Non-current

 

This includes the amount payable to BNDESPAR due to the acquisition of shares issued by Riopol within the scope of the business combination of Quattor, in 2010. The balance payable, on December 31, 2015, is R$273,294 (2014 – R$296,970).

 

The acquisition price will be paid in three installments, with restatement by the TJLP, as follows:

 

·                Payment made on June 11, 2015, the amount corresponding to 15% of the purchase price;

·                On June 11, 2016, the amount corresponding to 35% of the purchase price; and

·                On June 11, 2017, the amount corresponding to 50% of the purchase price.

 

23                Contingencies

 

Braskem has contingent liabilities related to lawsuits and administrative proceedings arising from the normal course of its business. These contingencies are of a labor and social security, tax, civil and corporate nature and involve risks of losses that are classified as possible. No provisions have been accrued for these lawsuits, except in relevant cases involving business combinations.

 

The balance of contingent liabilities as of December 31, 2015 and 2014 is as follows:

 

 

     

 

 

Consolidated

     

2015

 

2014

           

Labor claims

(a)

 

587,861

 

463,001

Tax claims

(b)

 

5,858,112

 

5,477,192

Other lawsuits

(c)

 

576,096

 

447,411

Total

   

7,022,069

 

6,387,604

 

69


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(a)               Labor

 

The amount at December 31, 2015 is related to 1,127 indemnity and labor claims. Among these claims are:

 

(a.1)    Class actions filed by the Union of Workers in the Petrochemical and Chemical Industries in Triunfo (RS), in the second quarter of 2005, claiming the payment of overtime amounting to R$40 million. The Management of the Company does not expect further disbursements to terminate these lawsuits.

 

All lawsuits in progress are with the Superior Labor Court and Management expects them to be judged in 2016. No judicial deposit or other form of security was accrued for these claims.

 

(a.2)    Class actions filed by the Union of Workers in the Petrochemical and Chemical Industries in Triunfo (RS) in the third quarter of 2010 claiming the payment of overtime referring to work breaks and integration into base salary of the remunerated weekly day-off amounting to R$338 million. The Management of the Company does not expect to disburse any amounts upon their closure.

 

The claims are being analyzed by the Superior Labor Court, and the appeal against the motions by the Union were not accepted. The Company expects the cases will be granted a final and unappealable decision in the last quarter of 2016. No judicial deposit or other form of security was accrued for these claims.

 

(b)               Tax

 

On December 31, 2015, the main tax contingencies, grouped by matter and totaling, at least, R$60 million, are the following

 

(b.1)    ICMS

 

The Company is involved in many ICMS collection claims related to assessment notices drawn up mainly by the Finance Department of the States of São Paulo, Rio de Janeiro, Rio Grande do Sul, Bahia and Alagoas. On December 31, 2015, the adjusted amounts of these claims total R$576 million and the claims include the following matters:

 

·           ICMS credit on the acquisition of assets that are considered by the Revenue Services as being of use and consumption. The Revenue Service understands that the asset has to be a physically integral part of the final product to give rise to a credit. Most of the inputs questioned do not physically compose the final product. However, the Judicial branch has a precedent that says that the input must be an integral part of the product or be consumed in the production process.

 

·           ICMS credit arising from the acquisition of assets to be used in property, plant and equipment, which is considered by the Revenue Services as not being related to the production activity, such as laboratory equipment, material for the construction of warehouses, security equipment, etc.

 

·           internal transfer of finished products for an amount lower than the production cost;

 

·           omission of the entry or shipment of goods based on physical count of inventories;

 

·           lack of evidence that the Company exported goods so that the shipment of the goods is presumably taxed for the domestic market;

 

70


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

·           non-payment of ICMS on the sale of products subject to tax substitution and credit from acquisitions of products subject to tax substitution;

 

·           fines for the failure to register invoices; and

 

·           nonpayment of ICMS tax on charges related to the use of the electricity transmission system in operations conducted in the Free Market (ACL) of the Electric Power Trading Chamber (CCEE).

 

The Company’s legal advisors estimate that: (i) these judicial proceedings are expected to be terminated in 2020, and (ii) in the event of an unfavorable decision to the Company, which is not expected, these contingencies could be settled for up to 40% of the amounts in dispute. This estimate is based on the probability of loss of the Company’s defense theory taking into consideration the case law at the administrative and judicial levels.

 

No judicial deposit or other form of security was accrued for most of these claims, as they are still being discussed administratively.

 

(b.2)    PIS and COFINS sundry

 

The Company is involved in collection actions related to PIS and COFINS assessments in the administrative and judicial courts, which discuss the alleged undue offsetting of credits arising from administrative proceedings and lawsuits, including: (i) Income Tax prepayments; (ii) FINSOCIAL; (iii) tax on net income (ILL); (iv) PIS-Decrees; and (v) the COFINS tax arising from the undue payment or payment in excess, as well the as COFINS levied on Interest on Capital.

 

On December 31, 2015, the adjusted amounts involved of these assessments total R$238 million.

 

The Company’s external legal advisors estimate that: (i) these judicial proceedings are expected to be terminated in 2018; and (ii) in the event of an unfavorable decision to the Company, which is not expected, these contingencies could be settled for up to 50% of the amounts in dispute. This estimate is based on the probability of loss of the Company’s defense theory taking into consideration the case law at the administrative and judicial levels.

 

The Company offered assets in guarantee, in the amount of R$58 million, which cover the amount exclusively involved in these claims.

 

(b.3)    PIS, COFINS, IR and CSL: taxation of tax losses and reductions in debits in connection with the installment payment program under MP 470/09

 

The Company was assessed for not recording as taxable the amounts of the credits from tax losses and social contribution tax loss carryforwards used to settle tax debits paid in installments under Provisional Presidential Decree 470/09. In the specific case of PIS/COFINS taxes, the assessment also includes the reductions applied to fines and interest arising from the adoption of the installment payment plan. Said tax credits and reductions of debits were not taxed, given the understanding of the Company that they did not represent taxable income.

 

On December 31, 2015, the inflation-adjusted amount of taxes recorded and tax effects of disallowances of income tax losses and social contribution tax loss carryforwards is R$1.4 billion. No guarantees have been accrued for these assessments.

 

71


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

The Company’s legal advisors estimate that: (i) the administrative level of these judicial proceedings is expected to be concluded by 2018; and (ii) in the event of an unfavorable decision to the Company, which is not expected, these contingencies could be settled for up to 40% of the amounts in dispute. This estimate is based on the probability of loss of the Company’s defense theory taking into consideration the case law at the administrative and judicial levels.

 

(b.4)    Non-cumulative PIS and COFINS

 

The Company received a deficiency notice from the Brazilian Federal Revenue Service due to the use of non-cumulative PIS and COFINS tax credits in the acquisition of certain goods and services consumed in its production process. The matters whose chance of loss is deemed as possible are mainly related to the following: (i) effluent treatment services; (ii) charges on transmission of electricity; (iii) freight for storage of finished products; and (iv) extemporaneous credits from acquisitions of property, plant and equipment. These matters have already been contested at the administrative level and comprise the period from 2006 to 2011, and as of December 31, 2015 totaled R$817 million.

 

The Company's legal counsel, in view of the recent decisions by the Tax Resources Administrative Board and the evidence provided by the Company, assess as possible the chances of loss at the administrative and legal levels. Any changes in the court’s understanding of the position could cause future impacts on the financial statements of the Company due to such proceedings.

 

The Company’s external legal counsel expect the proceedings at administrative level to conclude in 2020.

 

No judicial deposit or other form of security was accrued for most of these claims, as they are still being discussed administratively.

 

(b.5)    IR and CSL – Charges with goodwill amortization and other

 

The Company was served by the Federal Revenue Service for deducting amortization charges, from 2007 to 2012, relating to goodwill originated from acquisitions of shareholding interests in 2002. In that year, several business groups divested their petrochemical assets, which were consolidated to enable the consequent foundation of Braskem. The Company also received a tax-deficiency notice due to the inclusion in the income and social contribution tax calculation base of interest and exchange variation expenses related to obligations assumed in business combinations.

 

The current value of the recorded taxes and of the tax effects of the canceled tax loss and social contribution tax loss carryforwards through said deficiency notices on December 31, 2015, was R$1.1 billion.

 

There is no judicial deposit or any other type of guarantee for these proceedings.

 

The Management, based on the opinion of its legal advisors, assess the probability of the loss of these cases as possible, therefore no provision has been accrued, with conclusion expected by 2022. This conclusion is based on the following: (i) the equity interests were acquired with effective payment, business purpose and the participation of independent parties; and (ii) the real economic nature of the transactions that resulted in the recording of interest and exchange variation expenses.

 

(b.6)    IOF

 

The Company received a tax-deficiency notice due to the non-payment of IOF on operations relating to Advances for Future Capital Increase (AFAC) and checking account conducted by the merging companies Quattor Participações S.A. and Quattor Química S.A., which were deemed as loans for tax authorities.

 

72


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

On December 31, 2015, the tax-deficiency notice amounted to R$97 million.

 

The Company’s external legal counsels estimate that the conclusion in the administrative level will occur in 2018. There is no guarantee for the collection.

 

(c)               Other court disputes involving the Company and its subsidiaries

 

(c.1)     Civil

 

The Company is the defendant in civil lawsuits filed by the owner of a former distributor of caustic soda and by the shipping company that provided services to this former distributor, which, at December 31, 2015, totaled R$131 million. The claimants seek indemnity for damages related to the alleged non-performance of the distribution agreement by the Company.

 

No judicial deposit or other form of guarantee was accrued for these lawsuits.

 

Management's evaluation, supported by the opinion of its external legal advisors who are responsible for the cases, is that the lawsuits will possibly be dismissed within a period of 8 years.

 

(d)               Allegations

 

In early March 2015, declarations made by defendants under criminal lawsuits filed against individual third parties were made public, in which Braskem and three of its former managers were mentioned in allegations of supposed improper payments between 2006 and 2012 to benefit the Company in raw-material supply contracts entered into with Petrobras ("Allegations"). To the extent of the knowledge of Braskem’s Management, Braskem is not a defendant in any criminal or civil proceeding in Brazil regarding the Allegations.

 

In light of such facts, the Company's Management and Board of Directors approved in April 2015 the internal plan for investigation into the Allegations ("Investigation"), which is being carried out by law firms experienced in similar cases in the United States and in Brazil. The law firms are working under the supervision of an Ad Hoc Committee formed by members of the Company’s Board of Directors, specially created for this purpose.

 

Moreover, several other measures have been taken in connection with the Investigation, such as:

 

(i)      Voluntary announcement about the Investigation and periodical updates sent to regulatory agencies of capital markets in Brazil (Securities and Exchange Commission of Brazil - CVM) and the United States (Securities and Exchange Commission – SEC, and the Department of Justice - DOJ), particularly to provide information and produce the documents requested by such agencies;

(ii)     Publication of three Material Fact notices and three Notices to the Market to clarify the news reports and to keep shareholders and the market informed of actions taken by the Company; and

(iii)   Periodically updating the Fiscal Council and external auditors about the progress of the Investigation and of the actions already taken.

 

Braskem and its subsidiaries are subject to a series of anticorruption and anti-bribery laws in the countries where they operate, and have been implementing a series of procedures and controls are continuously being improved. If any of the allegations proves to be true, the Company may be subject to the penalties provided by law. At this moment, the Company Management has no way of estimating the duration or final outcome of the Investigation and, consequently, whether it will have any impact on financial statements.

 

The Management is committed to taking all the necessary measures to clarify the facts and will keep the market informed of any progress on this matter.

 

Due to the Allegations, a class action has been filed in the U.S. courts by the Boilermaker-Blacksmith National Pension Trust, Lead Plaintiff. The Company hired an U.S. Law firm, specialized in similar cases, and presented its first defense (motion to dismiss) on December 21, 2015. At the current stage of the process, it is not possible to estimate its value and chance of a favorable outcome.

 

73


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

24                Equity

 

(a)                Capital

 

On December 31, 2015, the Company's subscribed and paid up capital stock amounted to R$8,043,222 and comprised 797,265,248 shares with no par value, distributed as follows:

 

             

Preferred

     

Preferred

           
     

Common

     

shares

     

shares

           
     

shares

 

%

 

class A

 

%

 

class B

 

%

 

Total

 

%

                                   

OSP e Odebrecht

   

226,334,623

 

50.11%

 

79,182,498

 

22.96%

       

305,517,121

 

38.32%

Petrobras

   

212,426,952

 

47.03%

 

75,492,222

 

21.88%

       

287,919,174

 

36.11%

BNDESPAR

     

40,102,837

 

11.62%

       

40,102,837

 

5.03%

ADR

(i)

   

28,368,166

 

8.22%

       

28,368,166

 

3.56%

Other

   

12,907,077

 

2.86%

 

120,622,497

 

34.96%

 

593,618

 

100.00%

 

134,123,192

 

16.83%

Total

   

451,668,652

 

100.00%

 

343,768,220

 

99.64%

 

593,618

 

100.00%

 

796,030,490

 

99.85%

Treasuary shares

                         

Braskem shares owned by subsidiary
of Braskem Petroquímica

(ii)

       

1,234,758

 

0.36%

   

1,234,758

 

0.15%

Total

   

451,668,652

 

100.00%

 

345,002,978

 

100.00%

 

593,618

 

100.00%

 

797,265,248

 

100.00%

   

(i)         American Depositary Receipts traded on the New York Stock Exchange (USA);

(ii)       These share are considered “Treasury shares” in the consolidated shareholders’ equity, amounting to R$48,892.

 

(b)               Stock buyback programs

 

On February 11, 2015, Braskem’s Board of Directors approved the fifth program for the repurchase of shares effective for the period between February 19, 2015 and February 19, 2016, through which the Company may acquire up 3,500,000 class “A” preferred shares at market price.

 

During fiscal year 2015, the Company repurchased 80,000 shares for R$927.

 

The weighted average price of repurchased shares is R$11.58 (lowest price of R$10.94 and highest price of R$11.90).

 

(c)               Share rights

 

Preferred shares carry no voting rights but they ensure priority, non-cumulative annual dividend of 6% of their unit value, according to profits available for distribution. The unit value of the shares is obtained through the division of capital by the total number of outstanding shares. Only class “A” preferred shares will have the same claim on the remaining profit as common shares and will be entitled to dividends only after the priority dividend is paid to preferred shareholders. Only class “A” preferred shares also have the same claim as common shares on the distribution of shares resulting from capitalization of other reserves. Only class “A” preferred shares can be converted into common shares upon resolution of majority voting shareholders present at a General Meeting. Class “B” preferred shares can be converted into class “A” preferred shares at any time, at the ratio of two class “B” preferred shares for one class “A” preferred share, upon a simple written request to the Company, provided that the non-transferability period provided for in specific legislation that allowed for the issue and payment of such shares with tax incentive funds has elapsed. During 2015, a total of 200 class “B” preferred shares were converted into 100 class “A” preferred shares.

 

74


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

In the event of liquidation of the Company, class “A” and “B” preferred shares will have priority in the reimbursement of capital.

 

Shareholders are entitled to receive a mandatory minimum dividend of 25% on profit for the year, adjusted under Brazilian Corporation Law.

 

(d)               Capital reserve

 

This reserve includes part of the shares issued in Subsidiary’s several capital increases. This reserve can be used as provided for in Article 200 of the Brazilian Corporation Law.

 

(e)               Legal reserve

 

Under Brazilian Corporation Law, companies must transfer 5% of net profit for the year to a legal reserve until this reserve is equivalent to 20% of the paid-up capital. The legal reserve can be used for capital increase or absorption of losses.

 

(f)                Dividends proposed and appropriation of profit

 

Under the Company’s bylaws, profit for the year, adjusted according to Brazilian Corporation Law, is appropriated as follows:

 

(i)       5% to a legal reserve;

 

(ii)     25% to pay for mandatory, non-cumulative dividends, provided that the legal and statutory advantages of the Class “A” and “B” preferred shares are observed. When the amount of the priority dividend paid to class “A” and “B” preferred shares is equal to or higher than 25% of profit for the year calculated under Article 202 of Brazilian Corporation Law, it is the full payment of the mandatory dividend.

 

Any surplus remaining after the payment of the priority dividend will be used to:

 

·      pay dividends to common shareholders up to the limit of the priority dividends of preferred shares; and

 

·      if there still is any surplus, distribute additional dividends to common shareholders and class “A” preferred shareholders so that the same amount of dividends is paid for each common share or class “A” preferred share.

75


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(f.1)     Profit or loss and dividends proposed

 

 

     

2015

       

Net income for the year of Company's shareholders

   

3,140,311

Amounts recorded directly to retained earnings

   

 

Realization of additional property, plant and equipment

   

28,202

Prescribed dividends

   

479

     

3,168,992

Legal reserves distribution

   

(158,450)

     

3,010,542

Destinations:

     

Proposed dividends

 

(i)

(1,000,000)

Portion allocated to unrealized profit reserves

 

(ii)

(2,010,542)

     

(3,010,542)

       

Composition of the total proposed dividends

     

Minimum dividends - 25% adjusted net income

 

(iii)

(752,636)

Additional proposed dividends

 

(iv)

(247,364)

Total dividends

   

(1,000,000)

       

 

(i)       Unit dividend of R$1.25671835741 for common and class “A” preferred shares, and R$0.60624979930  for class “B” preferred shares.

(ii)     The retained earnings reserve was accrued based on capital budget pursuant to Article 196 of Federal Law 6,404/76, for use in future investments. This budget will be submitted for approval by shareholders assembled in a Shareholders’ Meeting.

(iii)    Recorded in current liabilities.

(iv)    Recorded in shareholders’ equity, under the item “proposed additional dividend”.

 

(f.2)     Dividend payment

 

The Annual Shareholders’ Meeting held on April 9, 2015 approved the declaration of dividends in the amount of R$482,593, the payment of which started to be paid on April 23, 2015, of which R$273,796 was paid to holders of common shares and R$208,437 and R$360 to holders of class “A” and class “B” preferred shares, respectively.

 

76


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(g)               Other comprehensive income – Equity

 

 

     

Consolidated

     

Attributed to shareholders' interest

       
             

Defined

         

Foreign

               
     

Additional

 

Deemed

 

benefit

 

Foreing

     

currency

 

Gain (loss)

 

Total

       
     

indexation of

 

cost of

 

plans actuarial

 

sales

 

Cash flow

 

translation

 

on interest

 

Braskem

 

Non-controlling

   
     

PP&E

 

PP&E

 

Gain (loss)

 

hedge

 

hedge

 

adjustment

 

in subsidiary

 

shareholders'

 

interest in

   
     

(i)

 

(i)

 

(ii)

 

(iii)

 

(iii)

 

(iv)

 

(v)

 

interest

 

Braskem Idesa

 

Total

                                           

On December 31, 2013

 

272,069

 

19,240

 

(11,647)

 

(1,520,336)

 

(85,020)

 

242,407

 

(9,404)

 

(1,092,691)

 

28,501

 

(1,064,190)

                                           

Additional indexation

                                       
 

Realization by depreciation or write-off assets

 

(41,268)

 

 

 

 

 

 

     

 

 

 

 

(41,268)

 

 

 

(41,268)

 

Income tax and social contribution

 

14,030

 

 

 

 

 

 

     

 

 

 

 

14,030

 

 

 

14,030

                                           

Deemed cost of jointly-controlled investment

                                       
 

Realization by depreciation or write-off assets

 

 

 

(1,464)

 

 

 

 

     

 

 

 

 

(1,464)

 

 

 

(1,464)

 

Income tax and social contribution

 

 

 

499

 

 

 

 

     

 

 

 

 

499

 

 

 

499

                           

 

             

Foreign sales hedge

                                       
 

Exchange rate

 

 

 

 

 

 

 

(2,611,655)

     

 

 

 

 

(2,611,655)

 

(164,197)

 

(2,775,852)

 

Income tax and social contribution

 

 

 

 

 

 

 

868,259

     

 

 

 

 

868,259

 

49,259

 

917,518

                                           

Fair value of Cash flow hedge

                                       
 

Change in fair value

 

 

 

 

 

 

     

(332,695)

 

 

 

 

 

(332,695)

 

(46,477)

 

(379,172)

 

Transfer to result

 

 

 

 

 

 

     

26,472

 

 

 

 

 

26,472

 

 

 

26,472

 

Income tax and social contribution

 

 

 

 

 

 

     

101,576

 

 

 

 

 

101,576

 

14,956

 

116,532

                                           

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

     

144,880

 

 

 

144,880

 

2,573

 

147,453

                                         

On December 31, 2014

 

244,831

 

18,275

 

(11,647)

 

(3,263,732)

 

(289,667)

 

387,287

 

(9,404)

 

(2,924,057)

 

(115,385)

 

(3,039,442)

                                           

Additional indexation

                                       
 

Realization by depreciation or write-off assets

 

(41,268)

 

 

 

 

 

 

     

 

 

 

 

(41,268)

 

 

 

(41,268)

 

Income tax and social contribution

 

14,032

 

 

 

 

 

 

     

 

 

 

 

14,032

 

 

 

14,032

       

 

 

 

                             

Deemed cost of jointly-controlled investment

   

 

 

 

                             
 

Realization by depreciation or write-off assets

 

 

 

(1,462)

 

 

 

 

     

 

 

 

 

(1,462)

 

 

 

(1,462)

 

Income tax and social contribution

 

 

 

496

 

 

 

 

     

 

 

 

 

496

 

 

 

496

                                           

Foreign sales hedge

                                       
 

Exchange rate

 

 

 

 

 

 

 

(9,629,237)

     

 

 

 

 

(9,629,237)

 

(397,386)

 

(10,026,623)

 

Income tax and social contribution

 

 

 

 

 

 

 

3,225,996

     

 

 

 

 

3,225,996

 

119,129

 

3,345,125

                                           

Fair value of Cash flow hedge

                                       
 

Change in fair value

 

 

 

 

 

 

     

(589,683)

 

 

 

 

 

(589,683)

 

(24,790)

 

(614,473)

 

Transfer to result

 

 

 

 

 

 

     

(72,518)

 

 

 

 

 

(72,518)

 

 

 

(72,518)

 

Income tax and social contribution

 

 

 

 

 

 

     

221,277

 

 

 

 

 

221,277

 

7,138

 

228,415

                                           

Fair value of cash flow hedge from jointly-controlled

 

 

 

 

 

 

 

 

 

2,295

 

 

 

 

 

2,295

 

 

 

2,295

                                           

Actuarial loss with post-employment benefits, net of taxes

 

 

 

 

 

(849)

 

 

     

 

 

 

 

(849)

 

 

 

(849)

                                         

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

     

709,722

 

 

 

709,722

 

(65,414)

 

644,308

                                           

On December 31, 2015

 

217,595

 

17,309

 

(12,496)

 

(9,666,973)

 

(728,296)

 

1,097,009

 

(9,404)

 

(9,085,256)

 

(476,708)

 

(9,561,964)

                                           

(i)

Transfer to retained earnings as the asset is depreciated or written-off.

(ii)

Transfer to retained earnings when the extinction of the plan.

(iii)

Transfer to the income statement when maturity, prepayment or loss of efficacy for hedge accounting.

(iv)

Transfer to the income statement when write-off of subsidiary abroad.

(v)

Transfer to the income statement when divestment or transfer of control of subsidiary.

 

77


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

25                Earnings per share

 

Basic and diluted earnings (loss) per share is calculated by means of the division of adjusted profit for the year attributable to the Company’s common and preferred shareholders by the weighted average number of these shares held by shareholders, excluding those held in treasury and following the rules for the distribution of dividends provided for in the Company’s bylaws, as described in Note 24 (e), particularly in relation to the limited rights enjoyed by class “B” preferred shares. In view of these limited rights, this class of share does not participate in losses. In this case, the diluted result takes into account the conversion of two class “B” preferred shares into one class “A” preferred share, as provided for in the bylaws of the Company.

 

Class “A” preferred shares participate in dividends with common shares after the mandatory dividends has been attributed in accordance with the formula provided for in the Company’s bylaws, as described in Note 24(f) and there is no highest limit for their participation.

 

Diluted and basic earnings (losses) per share are equal when there is profit in the year, since Braskem has not issued convertible financial instruments.

 

As required by CPC 41 and IAS 33, the table below show the reconciliation of profit (loss) for the year adjusted to the amounts used to calculate basic and diluted earnings (loss) per share.  

 
   

Basic and diluted

   

2015

 

2014

         

Profit for the year attributed to Company's shareholders

 

3,140,311

 

864,064

         

Distribution of dividends attributable to priority:

       

Preferred shares class "A"

 

208,409

 

208,437

Preferred shares class "B"

 

360

 

360

   

208,769

 

208,797

         

Distribution of 6% ​​of unit value of common shares

 

273,824

 

273,796

         

Distribution of plus income, by class

       

Common shares

 

1,509,089

 

216,587

Preferred shares class "A"

 

1,148,629

 

164,884

   

2,657,718

 

381,471

         

Reconciliation of income available for distribution, by class (numerator):

       

Common shares

 

1,782,913

 

490,383

Preferred shares class "A"

 

1,357,038

 

373,321

Preferred shares class "B"

 

360

 

360

   

3,140,311

 

864,064

         

Weighted average number of shares, by class (denominator):

       

Common shares

 

451,668,652

 

451,668,652

Preferred shares class "A"

(i)

343,783,562

 

343,848,120

Preferred shares class "B"

 

593,618

 

593,818

   

796,045,832

 

796,110,590

         

Profit per share (in R$)

       

Common shares

 

3.9474

 

1.0857

Preferred shares class "A"

 

3.9474

 

1.0857

Preferred shares class "B"

 

0.6065

 

0.6062

 

(i)         Calculation of weighted average of outstanding shares at the beginning of the fiscal year, adjusted by the number of shares repurchased during fiscal year 2015, multiplied by a weighted time factor:

  

78


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

     

Preferred shares class "A"

     

Outstanding

 

Weighted

 

Note

 

shares

 

average

 

 

 

 

 

 

On December 31, 2014

 

 

343,848,120

 

343,848,120

 

 

 

 

 

 

Repurchase of treasury shares

24(b)

 

(80,000)

 

(64,658)

Conversion of preferred shares class "B" to "A"

 

 

100

 

100

 

 

 

 

 

 

On December 31, 2015

 

 

343,768,220

 

343,783,562

 

 

26                Net sales revenues

 

     

Consolidated

 

Parent company

 

Note

 

2015

 

2014

 

2015

 

2014

 

-

               

Sales revenue

-

               

 Domestic market

-

 

31,240,509

 

32,964,432

 

30,352,503

 

23,847,100

 Foreign market

-

 

22,884,718

 

20,117,322

 

9,270,097

 

7,658,269

 

-

 

54,125,227

 

53,081,754

 

39,622,600

 

31,505,369

Sales deductions

-

               

Taxes

-

 

(6,520,894)

 

(6,657,794)

 

(5,936,320)

 

(4,301,533)

Customers rebates

20(a)

 

(29,529)

 

(59,818)

 

(12,113)

 

(26,180)

Sales returns

-

 

(291,808)

 

(332,753)

 

(268,134)

 

(249,906)

 

-

 

(6,842,231)

 

(7,050,365)

 

(6,216,567)

 

(4,577,619)

 

-

               

Net sales revenue

-

 

47,282,996

 

46,031,389

 

33,406,033

 

26,927,750

 

Sales revenues represent the fair value of the amount received or receivable from the sale of products and services during the normal course of the Company’s activities.

 

Revenues from sales of products are recognized when (i) the amount of sales can be reliably measured and the Company does not have control over the products sold; (ii) it is probable that the Company will received the economic benefits; and (iii) all legal titles, risks and benefits of product ownership are fully transferred to the client. The Company does not make sales with continued management involvement. Most of Braskem’s sales are made to industrial customers and, in a lower volume, to resellers.

 

The moment when the legal right, as well as the risks and benefits, are substantially transferred to the client is determined as follows:

 

(i)             for contracts under which the Company is responsible for the freight and insurance, the legal right and the risks and benefits are transferred to the client as soon as the goods are delivered at the destination established in the contract;

 

(ii)            for agreements under which the freight and insurance are a responsibility of the client, risks and benefits are transferred as soon as the products are delivered to the client’s carrier; and

 

(iii)          for contracts under which product delivery involves the use of pipelines, especially basic petrochemicals, the risks and benefits are transferred immediately after the Company’s official markers, which is the point of delivery of the products and transfer of their ownership.

 

79


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

The cost of freight services related to sales, transfers to storage facilities and finished product transfers are included in cost of sales.

 

(a)               Net sales revenue by country

 

     

2015

 

2014

Brazil

   

24,561,857

 

26,077,194

United States

   

9,603,033

 

9,125,441

Argentina

   

1,340,037

 

1,264,787

United Kingdom

   

2,282,722

 

1,111,454

Germany

   

1,239,528

 

1,067,563

Mexico

   

968,018

 

949,423

Italy

   

561,457

 

860,765

Netherlands

   

622,558

 

713,301

Singapore

   

1,017,327

 

671,222

Switzerland

   

334,487

 

467,104

Colombia

   

278,358

 

444,040

Spain

   

391,173

 

332,148

Chile

   

503,748

 

331,744

Peru

   

351,166

 

288,051

Uruguay

   

327,597

 

263,648

Japan

   

905,080

 

236,171

Poland

   

199,154

 

206,803

Paraguay

   

170,867

 

187,208

France

   

268,291

 

174,503

Bolivia

   

194,903

 

167,729

Canada

   

184,788

 

135,164

South Korea

   

74,582

 

70,683

Venezuela

   

477

 

 

Other

   

901,788

 

885,243

     

47,282,996

 

46,031,389

 

(b)               Net sales revenue by product

 

     

2015

 

2014

PE/PP

   

28,226,087

 

26,436,519

Ethylene, Propylene

   

2,999,090

 

3,274,529

Naphtha, condensate and crude oil

   

4,432,072

 

3,092,262

Benzene, toluene and xylene

   

2,538,993

 

3,084,916

PVC/Caustic Soda/EDC

   

2,780,075

 

2,709,491

ETBE/Gasoline

   

1,722,391

 

2,128,225

Butadiene

   

1,000,376

 

1,196,602

Specialty chemicals and drugs

   

875,985

 

822,790

Cumene

   

583,608

 

745,252

Solvents

   

431,264

 

620,986

Other

   

1,693,055

 

1,919,817

     

47,282,996

 

46,031,389

 

80


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(c)               Main clients

 

In 2015 and 2014, the Company does not have any revenue arising from transactions with only one client that is equal to or higher than 10% of its total net revenue. In 2015, the most significant revenue from a single client amounts to approximately 4% of total net revenues of the Company and refers to the basic petrochemical segment.

 

27                Tax incentives

 

(a)               Income Tax

 

In 2015, the Company obtained grant in lawsuits claiming the reduction of 75% of IR on income from the following industrial units: (i) PVC and Cloro Soda, established in the state of Alagoas; and (ii) basic petrochemicals unit, PE (2), PVC and Cloro Soda units, all established in the city of Camaçari (BA). The third PE plant established in Camaçari and the second PVC plant established in Alagoas will have the benefit up to 2016 and 2019, respectively.

 

(b)               PRODESIN - ICMS

 

The Company has ICMS tax incentives granted by the state of Alagoas, through the state of Alagoas Integrated Development Program – PRODESIN, which are aimed at implementing and expanding a plant in that state. This incentive is considered an offsetting entry to sales taxes (Note 26). In 2015, the amount was R$71,614 (R$60,033 in 2014).

 

28                Other operating income (expenses), net

 

       

Consolidated

       

2015

Expense and depreciation with hibernate plants

(i)

 

(152,536)

Expenses from fixed assets and investment

(ii)

 

(174,488)

Allowance for judicial and labor claims

(iii)

 

(105,644)

Expenses from Ascent project

 

 

(66,566)

Allowance for enviromental damage recovery (Note 20(b))

   

(65,791)

Allowance health plan

(iv)

 

(54,166)

Other

 

 

(87,962)

       

(707,153)

 

(i)         Includes R$54,011 arising from costs and depreciation in the period when the industrial unit located in the Petrochemical Complex of Capuava, in the city of Mauá (SP), was shut down due to the incident which took place in October 2015;

(ii)       Includes provision for loss with investment in the jointly owned subsidiary Propilsur (R$112,076 – US$26,519);

(iii)      Provisions for labor (R$63,211) and tax and other (R$42,433) claims;

(iv)     Provision for retirees’ health plan (Nota 21.2.1).

 

In fiscal year 2014, the main effects on this item were as follows:

 

Gain/Incomes – (i) gain from the divestment of DAT (Note 1 (a.i)) – R$277,338; (ii) revenue from the recognition of credits of subsidiaries to settle the installment payment – R$98,263; and (iii) discount from the prepayment of the tax installment - R$79,636.

 

81


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

Expenses – (i) additional provision for the Petros Copesul - R$65,000; (ii) depreciation and maintenance of idle plants – R$119,834; (iii) adjustment of inventory and losses of raw materials – R$50,025; (iv) new contingencies included in the installment payment plan – R$71,754; and (v) provision for recovery of environmental damages – R$30,741.

 

29                Financial results

  

         

Consolidated

 

Parent company

         

2015

 

2014

 

2015

 

2014

                       

Financial incomes

                   
 

Interest income

     

394,553

 

282,837

 

272,697

 

250,743

 

Monetary variations

   

142,856

 

74,675

 

120,578

 

52,626

 

Exchange rate variations

   

1,105,353

 

(46,173)

 

2,767,566

 

614,668

 

Other

     

58,265

 

43,882

 

35,168

 

27,543

         

1,701,027

 

355,221

 

3,196,009

 

945,580

                       

Financial expenses

                   
 

Interest expenses

     

(1,688,275)

 

(1,272,839)

 

(1,813,118)

 

(1,283,262)

 

Monetary variations

   

(377,471)

 

(320,497)

 

(377,585)

 

(320,796)

 

Exchange rate variations

   

(1,035,035)

 

(38,901)

 

(2,009,908)

 

(421,728)

 

Monetary variations on fiscal debts

   

(151,700)

 

(221,582)

 

(146,011)

 

(199,217)

 

Tax expenses on financial operations

   

(51,090)

 

(28,614)

 

(42,755)

 

(20,521)

 

Discounts granted

     

(154,114)

 

(110,535)

 

(93,156)

 

(44,746)

 

Loans transaction costs - amortization

   

(64,406)

 

(44,824)

 

(5,003)

 

(5,966)

 

Adjustment to present value - appropriation

(i)

 

(517,739)

 

(527,703)

 

(468,675)

 

(408,831)

 

Other

     

(153,703)

 

(180,369)

 

(61,115)

 

(57,053)

         

(4,193,533)

 

(2,745,864)

 

(5,017,326)

 

(2,762,120)

                       

Total

     

(2,492,506)

 

(2,390,643)

 

(1,821,317)

 

(1,816,540)

 

(i)         The Company calculates the adjustment to present value whose amount has a material impact on its financial statements. 

 

       

Consolidated

 

Parent company

       

2015

 

2014

 

2015

 

2014

                     

Interest income

                   

Held for sale

     

91,119

 

26,012

 

41,266

 

26,012

Loans and receivables

   

199,008

 

168,259

 

175,580

 

157,526

Held-to-maturity

     

36,900

 

34,881

 

36,900

 

34,881

       

327,027

 

229,152

 

253,746

 

218,419

Other assets not classifiable

   

67,526

 

53,685

 

18,951

 

32,324

Total

     

394,553

 

282,837

 

272,697

 

250,743

 

82


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

30                Expenses by nature

 

The Company chose to present its expenses by function in the statement of operations. The breakdown of expenses by nature is presented below:

 

         

Consolidated

 

Parent company

         

2015

 

2014

 

2015

 

2014

                       

Classification by nature:

                 
 

Raw materials other inputs

   

(30,739,399)

 

(34,579,173)

 

(20,959,087)

 

(19,936,243)

 

Personnel expenses

   

(2,537,679)

 

(2,215,484)

 

(1,744,486)

 

(1,393,539)

 

Outsourced services

   

(1,617,443)

 

(1,699,325)

 

(1,179,073)

 

(1,010,427)

 

Tax expenses

   

(13,820)

 

(11,822)

 

(7,326)

 

(8,395)

 

Depreciation, amortization and depletion

   

(2,114,929)

 

(2,041,048)

 

(1,774,973)

 

(1,317,928)

 

Freights

   

(1,858,777)

 

(1,555,125)

 

(1,326,564)

 

(1,015,503)

 

Other expenses

   

(1,350,977)

 

(364,133)

 

(819,793)

 

(109,471)

 

Total

   

(40,233,024)

 

(42,466,110)

 

(27,811,302)

 

(24,791,506)

                       

Classification by function:

                 
 

Cost of products sold

   

(36,902,086)

 

(40,057,341)

 

(25,675,861)

 

(23,544,968)

 

Selling and distribution

   

(1,122,012)

 

(1,155,800)

 

(813,888)

 

(692,879)

 

General and administrative

   

(1,325,342)

 

(1,210,124)

 

(864,572)

 

(801,433)

 

Research and development

   

(176,431)

 

(138,441)

 

(110,583)

 

(96,800)

 

Other operating income (expenses), net

   

(707,153)

 

95,596

 

(346,398)

 

344,574

 

Total

   

(40,233,024)

 

(42,466,110)

 

(27,811,302)

 

(24,791,506)

 

31                Segment information

 

Management defined the organizational structure of Braskem based on the types of business, the main products, markets and production processes, and identified five operating and reportable segments - four production segments and one distribution segment.

 

On December 31, 2015 and 2014, the organizational structure of Braskem was formed by the following segments:

 

·      Basic petrochemicals: comprises the activities related to the production of ethylene, propylene butadiene, toluene, xylene, cumene and benzene, as well as gasoline, diesel and LPG (Liquefied Petroleum Gas), and other petroleum derivatives and the supply of electric energy, steam, compressed air and other inputs to second-generation producers located in the Camaçari, Triunfo, São Paulo and Rio de Janeiro petrochemical complexes.

 

·      Polyolefins: comprises the activities related to the production of PE and PP.

 

·      Vinyls: comprises the activities related to the production of PVC, caustic soda and chloride.

 

·      United States and Europe: operations related to PP production in the United States and Europe, through the subsidiaries Braskem America and Braskem Alemanha, respectively.

 

·      Chemical distribution: consists of Quantiq’s operations related to the distribution of petroleum-based solvents, intermediate chemicals, special chemicals and pharmacons.

 

83


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

(a)               Presentation, measurement and conciliation of results

 

Information by segment is generated in accounting records which are reflected in the consolidated financial statements.

 

The eliminations stated in the operating segment information, when compared with the consolidated balances, are represented by transfers of inputs between segments that are measured as arm’s length sales.

 

The operating segments are stated based on the results of operations, which does not include financial results, and current and deferred income tax and social contribution expenses.

 

The Company does not disclose assets by segment since this information is not presented to its chief decision maker.

 

(b)               Results of operations by segment (consolidated)

 

     

 

 

 

 

 

 

 

 

 

 

 

 

2015

                 

Operating expenses

   
     

Net

 

Cost of

     

Selling, general

 

Results from

 

Other operating

   
     

sales

 

products

 

Gross

 

and distribuition

 

equity

 

income

 

Operating

     

revenue

 

sold

 

profit

 

expenses

 

investments

 

(expenses), net

 

profit (loss)

Reporting segments

                           
 

Basic petrochemicals

 

24,269,768

 

(20,053,106)

 

4,216,662

 

(658,945)

   

(178,113)

 

3,379,604

 

Polyolefins

 

19,986,174

 

(15,461,151)

 

4,525,023

 

(1,224,627)

   

(130,722)

 

3,169,674

 

Vinyls

 

2,780,075

 

(2,415,855)

 

364,220

 

(224,857)

   

(27,005)

 

112,358

 

USA and Europe

 

8,239,913

 

(6,892,131)

 

1,347,782

 

(445,850)

   

(13,449)

 

888,483

 

Chemical distribuition

 

874,624

 

(692,653)

 

181,971

 

(123,402)

   

(4,961)

 

53,608

Total

 

56,150,554

 

(45,514,896)

 

10,635,658

 

(2,677,681)

 

  

 

(354,250)

 

7,603,727

                               

Other segments

(i)

631,512

 

(637,045)

 

(5,533)

 

(94,716)

 

 

 

(70,062)

 

(170,311)

Corporate unit

         

(5,502)

 

2,219

 

(282,841)

 

(286,124)

                                  

Braskem consolidated before

eliminations and reclassifications

 

56,782,066

 

(46,151,941)

 

10,630,125

 

(2,777,899)

 

2,219

 

(707,153)

 

7,147,292

                               

Eliminations and reclassifications

 

(9,499,070)

 

9,249,855

 

(249,215)

 

154,114

   

(95,101)

                               

Total

 

47,282,996

 

(36,902,086)

 

10,380,910

 

(2,623,785)

 

2,219

 

(707,153)

 

7,052,191

                               
                               
     

 

 

 

 

 

 

 

 

 

 

 

 

2014

                 

Operating expenses

   
     

Net

 

Cost of

     

Selling, general

 

Results from

 

Other operating

   
     

sales

 

products

 

Gross

 

and distribuition

 

equity

 

income

 

Operating

     

revenue

 

sold

 

profit

 

expenses

 

investments

 

(expenses), net

 

profit (loss)

Reporting segments

                           
 

Basic petrochemicals

 

25,576,275

 

(23,252,820)

 

2,323,455

 

(692,662)

   

190,292

(ii)

1,821,085

 

Polyolefins

 

18,502,238

 

(15,599,615)

 

2,902,623

 

(965,737)

   

(53,226)

 

1,883,660

 

Vinyls

 

2,709,491

 

(2,551,464)

 

158,027

 

(205,343)

   

57,268

 

9,952

 

USA and Europe

 

7,934,281

 

(7,477,507)

 

456,774

 

(294,923)

   

(82,515)

 

79,336

 

Chemical distribuition

 

842,715

 

(700,917)

 

141,798

 

(105,242)

   

(28,783)

 

7,773

Total

 

55,565,000

 

(49,582,323)

 

5,982,677

 

(2,263,907)

 

    

 

83,036

 

3,801,806

                               

Other segments

(i)

402,655

 

(284,269)

 

118,386

 

(169,976)

 

 

 

(4,135)

 

(55,725)

Corporate unit

         

(181,017)

 

3,929

 

16,695

 

(160,393)

                               

Braskem consolidated before

eliminations and reclassifications

 

55,967,655

 

(49,866,592)

 

6,101,063

 

(2,614,900)

 

3,929

 

95,596

 

3,585,688

                               

Eliminations and reclassifications

 

(9,936,266)

 

9,809,251

 

(127,015)

 

110,535

   

(16,480)

                               

Total

 

46,031,389

 

(40,057,341)

 

5,974,048

 

(2,504,365)

 

3,929

 

95,596

 

3,569,208

 

(i)         This segment includes the results of the subsidiary Braskem Idesa.

(ii)       Includes gain from sale of DAT (Note 1(a)).

 

84


 

Braskem S.A.

 

Notes to the financial statements

at December 31, 2015

All amounts in thousands, except as otherwise stated

 

 

(c)               Long-lived assets by segment (consolidated)

 

 

     

2015

 

2014

Reporting segments

       
 

Basic petrochemicals

 

11,749,880

 

11,949,937

 

Polyolefins

 

5,379,646

 

5,614,133

 

Vinyls

 

2,763,299

 

2,871,964

 

USA and Europe

 

2,130,931

 

1,514,587

 

Chemical distribuition

 

73,873

 

70,827

Total

 

22,097,629

 

22,021,448

 

Other segments

(i)

14,751,938

 

9,815,770

Total

 

36,849,567

 

31,837,218

 

(i)         Includes the long-lived assets of the subsidiary Braskem Idesa.

 

32                Insurance coverage

 

Braskem, aligned with the policy approved by the Board of Directors, maintains a comprehensive risk and insurance management program. The risk assessment practices and procedures of the policy are applied consistently across the Company.

 

In October 2015, the All Risks insurance policies were renewed for the units in Brazil, the United States and Germany for 18 months.

 

Since 2012, the subsidiary Braskem Idesa has All Risks engineering insurance, which covers the construction of its industrial plant in Mexico.

 

The operating risks and engineering all-risks insurance policies of Braskem have maximum indemnity limits per event that are deemed sufficient to cover possible claims in view of the nature of the Company’s activities and based on the guidance of its advisers, as well estimated maximum loss (EML) studies.

 

The information on the all-risks policies in effect is presented below:

 

         

Maximum indemnity limit

 

Amount insured

     

Maturity

 

US$ million

 

US$ million

Units in Brazil

 

April 8, 2017

 

2,000

 

21,223

Units in United States and Germany

April 8, 2017

 

250

 

1,868

Braskem Idesa

 

March 31, 2016

 

5,161

 

5,161

Quantiq

 

April 8, 2017

 

78

 

78

Total

         

28,330

 

Additionally, the Company contracted civil liability, transportation, export credit, sundry risk and vehicle insurance. The risk assumptions adopted are not part of the audit scope and, therefore, were not subject to review by our independent accountants.

 

85


 

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: February 18, 2016
  BRASKEM S.A.
 
 
  By:      /s/     Mário Augusto da Silva
 
    Name: Mário Augusto da Silva
    Title: Chief Financial Officer

 

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. These statements are statements that are not historical facts, and are based on management's current view and estimates offuture economic circumstances, industry conditions, company performance and financial results. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.